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Introduction to Topic 
Although nutrient interactions are important in human 
nutrition (1), chromium nutrient interactions have not been 
extensively studied. Because minerals often carry positive 
or negative charges which change based upon local pH, they 
can associate loosely with or bind chemically with a variety 
of compounds. Components in food or ingested drugs may 
affect mineral absorption and excretion. Intake of chromium 
from self-selected diets in the United States may be below 
the estimated safa and adequate amount of 50-200 ug, chromium 
per day (2). Marginal intake is of concern because chromium 
deficiency has been'linked to elevated blood cholesterol and 
impaired glucose tolerance (3). The extent of interaction 
of chromium with other nutrients is not known. However, 
chromium supplementation (10 ugjg diet) has increased 
vitamin C concentrations in adrenal and liver tissues of 
rats (4). Nutrient and drug interactions affecting chromium 
retention and utilizatipn, the role of chromium in 
.cholesterol metabolism, and the impact of chromium on 
essential nutrients are problems that warrant investigation. 
1 
2 
Significance of Problems/Description of Experiments 
Most research on interactions between minerals and 
carbohydrates in non-ruminants has emphasized nondigestible 
carbohydrates (fiber) (5). Reports of digestible 
carbohydrate effects on mineral absorption have involved 
copper (6) and.iron (7). The ability of supplemental 
chromium to lower serum cholesterol in rats was different 
with diets containing sucrose versus diets containing starch 
. ' 
(8). In humans, diets high in simple sugars (35% of 
calories) increased urinary chromium excretion compared to 
diets with 35% of calories from complex carbohydrates (9). 
Therefore, experiment 1 was designed to determine whether 
tissue concentrations of chromium and 51crcl3 ~bsorption are 
altered either when chromium is supplemented and or when 
sources of carbohydrate are altered. Genetically obese mice 
and their lean littermates were used because obese mice 
exhibited insulin resistance (10) and sensitivity to Cr 
depletion (11). 
Effects of common over-the-counter drugs on chromium 
status have not been inve~tigated. The elderly may be at 
risk for adverse drug-nutrient interactions because of their 
chronic use of medications (12). Gastrointestinal tract 
disorders may promote antacid abuse in the elderly, and an 
increasing number of women have responded to recommendations 
for increased calcium intakes (13) by taking calcium based 
antacids. In inverted sac experiments, calcium appreciably 
depressed 51cr transport (14). Chromium formed insoluble 
complexes under alkaline conditions in vitro (15). Vitamin 
c may facilitate the absorption of chromium by preventing 
the formation of insoluble chromium complexes (1~). Vitamin 
c enhanced iron absorption (17). Therefore, experiment 2 
evaluated 51cr retention and excretion in rats from 51crc13 
dosed concurrently either with vitamin c, with an antacid 
composed of calcium carbonate, or with water. 
Elderly persons (18), multiparous women (19), patients 
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receiving long-term total parenteral nutrition (20) and 
diabetics (21) are most likely to be at risk for chromium 
deficiency. Less than 2% of dietary chromium is absorbed 
(22). Effects of chromium status on chromium absorption and 
excretion have not been clarified (23), but in one study, 
chromium absorption (estimated by urinary excretion) was 
related inversely to dietary intake in human subjects (24). 
Cr absorption may be impaired in chronic vitamin c 
deficiency. In scorbuti,c guinea pigs the total acidity of 
gastric juice was decreased (25); this could reduce chromium 
absorption if alation and subsequent precipitation occurred 
in the more alkaline environment (16). Therefore, 
experiment 3 utlli~~d 51crc13 to evaluate chromium retention 
and excretion in chromium andjor vitamin c depleted guinea 
pigs. 
Insulin is needed for the transport of vitamin C into 
certain tissues (26), and inadequate insulin depressed 
vitamin c retention in tissues (27). If chromium 
facilitated the transport of vitamin C as it does glucose 
(28), then a chromium deficiency should affect intracellular 
vitamin C. In experiment 4, the effects of vitamin C and 
chromium status on tissue retention of 14c from 14c-
ascorbate were determined using guinea pigs. Metabolism of 
14c-ascorbate was also evalu~ted by.measuring 14c in urine 
and expired carbon dioxide. Other effects of vitamin C and 
chromium status were determined by measuring tissue vitamin 
c, hydroxyproline, creatinine, blood urea nitrogen, cortisol 
and tissue .minerals. 
Serum cholesterol levels have been elevated in rat~ fed 
low chromium diets (29), and in chronic vitamin C 
deficiency, guinea pigs had lower bile acid production and 
higher hepatic and serum cholesterol than controls (30). 
Serum cholesterol elevation was exacerbated by combined 
chromium and vitamin C deficiencies in guinea pigs (31). 
Therefore, experiment 5 investigated the effects of 
chromium, vitamin c, and their ,interactions on cholesterol 
biosynthesis through analysis of hepatic 3-hydroxy-3-
methylglutaryl coenzyme A reductase activity. 
Objectives 
The following research objectives were developed: 
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1. To determine if type of dietary carbohydrate, either 
glucose, fructose, sucrose or starch, and chromium 
supplementation would alter tissue concentration of chromium 
or retention and excretion of 51crcl3 in obese and lean 
mice; 
2. To determine if vitamin c or a calcium carbonate 
antacid would alter tissue accumulation and excretion of 
51crcl3 in rats; 
3. To investigate effects of chromium depletion andjor 
chronic vitamin C deficiency on tissue accumulation and 
excretion of 51cr from a dose of 51crc13 . 
4. To determine if chromium depletion andjor chronic 
vitamin c deficiency would affect 14c in plasma, tissues, 
urine and carbon dioxide after a 14c-ascorbate dose, tissue 
trace minerals' (copper, zinc, chromium, manganese), blood 
urea nitrogen, cortisol, tissue vitamin c, and urinary 
excretion of hydroxyproline and creatinine in guinea pigs; 
and 
5. To determine if hepatic 3-hydroxy-3-methylglutaryl-
coenzyme A activity is affected by chromium depletion and/or 
chronic vitamin C deficiency. 
Hypothesis 
The following hypothesis were developed for this study. 
1. There will be no statistically significant effects 
of carbohydrate source (glucose, fructose, sucrose or 
starch), or qf chromium,suppleme~tation, or genetic obesity 
on tissue chromium or 51cr retention and excretion from 
51crcl3 ; 
2. In rats dosed with 51crc13 there will be no 
statistically significant difference in 51cr tissue 
5 
accumulation or excretion following a dosage of vitamin c, 
calcium carbonate antacid, or water; 
3. Deprivation of chromium and vitamin C will not 
significantly alter 51cr appearance in tissues, blood, and 
urine of guinea pigs; 
4. Chromium or vitamin c status will not statistically 
alter either 14c in blood, tissues, urine and expired carbon 
dioxide from, a 14c ascorbate dose or tissue mineral 
concentrations, tissue vitamin c, blood urea nitrogen, 
cortisol, and urinary excretion of hydroxyproline and 
creatinine; 
5. Chromium depletion and chronic vitamin C deficiency 
will not statistically alter hepatic 3-hydroxy-3-
methylglutaryl-coenzyme A (HMG-CoA) reductase activity. 
Limitations 
6 
Nutrient and drug interactions that affect chromium are 
difficult to assess because chromium concentrations in 
tissues are very low (32). Furthermore, circulating 
chromium may not be in equilibrium with tissue stores making 
it difficult to determine chromium status. Although data 
from animal models cannot be extrapolated directly to 
humans, mechanisms of chromium-drug and chromium-nutrient 
interactions determined utilizing animal models can help 
direct human research. 
Format of Dissertation 
Each of the five experiments was organized as an 
individual manuscript for publication in an appropriate 
journal. Chapter III was written using the Guide for 
Authors for the Journal of Nutrition. Chapter IV was 
written according to the g~idelines for Nutrition Research. 
Chapter V was written according to directions for 
' ' 
contributors to Internation~l Journal for Vitamin and 
Nutrition Research using the research note format. Chapter 
VI and Chapter VII were written following the guidelines of 




REVIEW OF LITERATURE 
This chapter includes a review of absorption, excretion, 
and tissue distribution of the trace mineral cqromium. 
Evidence that chromium influence's cholesterol metabolism is 
evaluated. Metabolism of vitamin C is discussed as well as 
effects of vitam~n c on mineral bioavailability and 
synthesis of cholesterol. Factors influencing 
hydroxyproline and creatinine excretion are reported. A 
review of factors affecting the activity of 3-hydroxy-3-
methylglutaryl coenzyme A reductase is included. 
Chromium Absorption, Excretion, Tissue Distribution 
Chromium deficiency is characterized by impaired growth 
and longevity in experimental animals and by disturbances in 
glucose, lipid, and protein metabolism (29). Chromium (Cr) 
is a metal of the first transition series with atomic number 
of 24 and atomic weight of 52 gjmole. Of the five 
radioactive isotopes, only 51cr with a half-life of 27.8 




The absorption of chromium (Cr) is dependent on the type 
of chromium complex (28). Trivalent chromium was absorbed 
at 0.5% compared to hexavalent chromium at 2% (22). Any 
chromates present in the diet appear to be reduced in the 
gastrointestinal tract fro~ the hexavalent (+6) to 'the 
trivalent (+3) valence (22). 
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In an alkaline medium, chromium (III) is alated, i.e., 
forms gel-like complexes with hydroxyl and water molecules 
(15). Olation' starts at pH values above 3.5 and increases 
with increasing pH and temperature (16). Ligands that 
increase absorption may function by preventing alation and 
precipitation of chromium. In rats, Chen et al (34) found 
that oxalate increased and phytate decreased Cr absorption 
both in vitro and in vivo~ Chromium transport by inverted 
sacs was strongly stimulated by substances that formed 
chelates with the element .< 14) . . A mixture of amino acids 
doubled the rate of transport as did penicillamine. Without 
chelation, chromium was precipitated at alkaline pH. 
InteFactions with other metals may affect chromium 
absorption. Whole body contents of an oral dose of 
radioactive Cr were greater in zinc-deficient rats than in 
zinc-adequate controls (35). Zinc, cobalt, and chromium 
eluted in the same low-molecular weight fraction when 
mucosal supernatant extracts were separated by gel 
filtration, suggesting that they combined with the same 
intestinal ligand. 
Chromium and iron may share a common gastrointestinal 
transport mechanism. Iron deficient animals absorbed more 
Cr than iron supplemented controls and iron depressed 
chromium binding to transferrin {36). Transferrin also 
forms a complex with manganese (37). Manganese (Mn) 
deficiency in the guinea pig induced a diabetes-mellitus 
like syndrome {38) which suggested an interaction between Cr 
and Mn. However, in rats, supplementation with 1600 ng Cr 
as CrCl3/g diet did. not alte~ hepatic zinc, iron, copper and 
manganese concentrations (39). 
Chromium absorption was greatest in the jejunum (34). 
Mertz and Roginski (14) used inverted jejunal sacs with 
51crc13 and found that the rate of chromium uptake 
diminished as the amount of chromium in the medium 
increased; this suggested that the number of absorption 
sites were finite. Chromic chloride uptake followed a 
facilitated diffusion process (14). Neither glucose, 
acetate, nor inhibition of cellular energy generation 
influenced the process. Iron, manganese, calcium, and 
titanium depressed chromium transport in vitro. Disodium 
ethylenediamine tetracetate (EDTA) in the medium overcame 
calcium inhibition; however, even in the absence of calcium, 
EDTA stimulated chromium transport. 
The average daily intake of chromium from US diets is 
below the minimum safe and adequate recommended level of so 
10 
to 200 micrograms per day (24). Offenbacher and co-workers 
reported that net absorption of Cr in subjects in a 
metabolic unit was 1.8% (40). But Donaldson and Barreras 
found an average absorption of only 0.5% of an oral dose of 
51crCl3 in normal subjects (41). In elderly human subjects, 
51cr absorpti9n was not significantly different from young 
adults; but insulin requiring-diabetics absorbed two to four 
times more chromium than normal subjects did (21). Along 
with increased absorption, diabetics had increased urinary 
excretion of ch'romium (21). Streptozotocin diabetic animals 
retained a highe~ percentage of a 51cr dose in the serum 
than normal animals, but there were no differences in 51cr 
retained in the muscle, spleen, liver, heart and pancreas 
(42). Insulin administration increased tissue retention of 
51cr in diabetic an,imals ( 43) . 
There is some disagreement on effects of prior chromium 
intake on chromium absorption. Mertz et al (23) failed to 
detect any influence of previous chromium intake on 
absorption or excretion of 51crcl3 in rats. Hopkins and 
Schwarz (44) also concluded that the percentage of chromium 
absorbed from an oral dose was independent of dose or 
chromium status of the rat. However, Anderson and Kozlovsky 
(24) reported that in humans chromium absorption was 
inversely related to dietary intake. At a. dietary chromium 
intake of 10 micrograms, absorption (measured as urinary 
excretion) was approximately 2%; as intake increased to 40 
micrograms, chromium absorption decreased to 0.5%. 
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Foods rich in chromium include brewer's yeast, meats, 
cheeses, whole grains, mushrooms, black pepper, nuts, and 
asparagus (45). Chromium in foods generally decreased with 
processing, ( 4 6) . For example, molasses contains 0. 2 6 ug 
chromiumjg, unrefined sugar contains 0.16 ugjg, and refined 
sugar contains 0.02 ugjg. As compared to whole wheat bread, 
white bread was 71% lower in Cr (47). However, chromium may 
be increased ~n some processed foods due to non~pecific 
contamination during processing (48) ., At high temperatures 
and low pH (2.5-3.0), 16 to 59 ugjg chromium was released 
from stainl~ss steel cooking vessels into water; no chromium 
leached into unacidified water in the same vessels. 
Mertz and Roginski (14) concluded that some sources of 
dietary chromium were more available for absorption than 
chromic chloride. Whether foods themselves contain 
substances that increase chromium retention and utilization 
has received little attention. Supplemental vitamin C 
increased hepatic i:ton (49) -and serum iron (50) while 
reciprocally decreasing hepatic copper (49). Whether 
vitamin C increases ,or decreases chromium absorption has not 
been determined. 
Excretion 
Once absorbed, chromium is excreted almost exclusively 
via urine; therefore, Mertz (51) suggested that the 
measurement of urinary chromium can be used to detect gross 
abnormalities in chromium metabolism (51). Only very small 
12 
amounts of chromium are lost in hair, perspiration and bile 
{44). Anderson et al (52) suggested that, although urinary 
chromium excretion was not a meaningful indicator of 
chromium status, it is meaningful as an indicator of 
chromium intake and absorption. In the dog nearly all the 
urinary 51cr was dialyzable, and at l~ast 63% of filtered Cr 
was reabsorbed (53). Ultrafilterabl~ plasma 51cr 
concentration anp glomerular filtration rate appeared to be 
the primary determinants of renal 51cr excretion (54). 
Early studies indicatep that glucose loading increased 
urinary chromium excretion in rats (15), diabetics (55), and 
normal humans (56), but methodological difficulties in 
analyzing chromium make these data difficult to interpret. 
One early study indicated that both glucose administration 
and insulin injection increased plasma chromium 
concentration; this may mean that the response of plasma 
chromium to glucose is occurring via insulin secretion (28). 
Kozlovsky et al (9) reported that chromium loss in 37 adults 
increased when they were fed diets containing 35% of 
kilocalories as simple sugar compared to diets conta~ning 
' ' 
35% of kilocalories as complex carbohydrate. In rats, 
neither insulin nor glucose influenc~d the rate of 
disappearance of 51cr in blood within a few hours after an 
intravenous dose of 51crci3, but some response to insulin 
and glucose was observed in 51cr disappearance from the 
blood after three days (14). 
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Liu and Morris (57) reported that serum chromium levels 
dropped in response to a glucose load in hypoglycemic 
subjects with inadequate chromium storage. In subjects 
receiving 5 g brewers' yeast extract containing 4 micrograms 
chromium daily for 3 months, serum chromium rose in response 
to a glucose load. Anderson_et al (58) noted that urinary 
chromium excretion increased in response to a glucose load 
for nonsupplemented normal subjects but not for subjects 
supplemented d~ily with trivalent chromium. 
Mertz (59) ,reported that when 51cr was injected into 
rats intravenously, approximately 14% of the dose had 
appeared in the feces by day a. Contamination of feces with 
urine complicates quantitative assessment of fecal chromium 
excretion from intravenously injected chromium in animals. 
Fecal chromium from an intravenous dose could arise from 
bile, because the liver, accumulates chromium. Another 
source is sloughed mucosal cells' that had incorporated 
chromium (36). 
Tissue Distribution of Chromium 
The tissue distribution of chromium is affected by 
chemical form, age, species and the presence of diabetes 
(60). A variety of metabolic poisons strongly inhibit 
cellular uptake of chromium (61). Hexavalent 51cr has been 
used extensively as a cell label because it binds to 
erythocytes, tumor cells, platelets and leukocytes (61). 
Visek and co-workers (60) found that after intravenous 
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administration of 51cr as sodium chromate, almost all 51cr 
was localized in the reticuloendothelial system; in 
contrast, after administration of chromium chloride, 55% of 
retained 51cr was found in the liver. However, when 51crc13 
was buffered with acetate or ·citrate, most was excreted in 
the urine and less than 5% remained in the liver. 
Kraintz and Talmage, '( 62) injected rats intravenously 
with 51crcl3. By 24 hr, 40% of the 51cr was excreted in the 
urine while the bone marrow had the highest percentage of 
re~aining activity. Although 51cr in the bone marrow was 
deposited in the reticuloendothelial system, it was not 
retained by red cell precursors. 
In rats only 1.2 to 2.3% of a 51cr dose from chromium 
labelled foods remained in the animals by day nine (63). 
Hopkins and Schwarz (36) observed that 51cr from chromium 
chloride peaked in the blood at 30 to 60 minutes after 
administration by stomach tube. Whole blood values ranged 
from 0. 07 to 0. 48 percent .o-f the dose. Even with low doses 
(10 to 100 ng) of chrom~um, chromium accumulated in the 
spleen (44). In human9 injected intravenously with 5.1crc13 , 
the principal concentrations of 51cr were found in the 
liver, spleen, bone, muscle and adipose tissue (64). The 
tissues extracted 51cr very rapidly; 'more than 50% of plasma 
51cr was taken up by the tissues within hours after 
intravenous administration. 
In exercise trained rats, tissue chromium increased 
(65). In mice, age led to decreased 51cr uptake in some 
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tissues, specifically liver, testes, and epididymal fat pads 
(66). Mature rats, however, retained less 51cr in bone but 
more in spleen, kidney and testes than immature rats (44). 
Chromium and Stress 
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Stress may be a major factor in chromium metabolism (14) 
and human chromium need {67). Stress, including trauma, 
infection, surgery, intense heat or cold, elevated the 
secretion of hormones, which altered glucose metabolism and 
apparently affected chromium metabolism (67). Chromium 
deficiency in animals has been associated with growth 
retardation {68), shortened life span, and decreased ability 
to cope with various forms of physiologic stress {69). In 
experimental animals, stress induced by low protein diets, 
controlled exercise, acute blood loss or infection increased 
the severity of depressed growth and decreased survival of 
animals fed low chromium diets (70}. 
Under physiological conditions, blood glucose 
concentrations are regulated by the hormones insulin, 
glucagon and growth hormone (45). Cortisol and 
catecholamines are elevated in various forms of stress 
including trauma, infection, surgery, and intense heat or 
cold (14). Catecholamines stimulate glucagon secretion and 
inhibit pancreatic insulin release (71), with a net effect 
of stimulating gluconeogenesis by the liver and causing 
hyperglycemia. 
Increased serum levels of glucagon, growth hormone, 
catecholamines and cortisol occurred during strenuous 
exercise in humans (45). Anderson and co-workers (72) 
observed increased glucose utilization and urinary chromium 
excretion increased five-fold in humans two hours after 
running. Elderly men with ischemic heart disease had 
elevated serum_cortisol dur~ng.exercise whereas, cortisol 
declined in similar subjects without ischemic heart disease 
(73). The effects of cortisol on chromium retention and the 
possible link of stress to heart disease deserves further 
evaluation. 
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After trauma, plasma cortisoi is elevated (45). Pekarek 
and co-workers reported subjects infected with sandfly fever . 
had lower fasting serum chromium than healthy subjects (74). 
The mean urinary chromium concentration of traumatized 
patients 42 h following admission was 10 times greater than 
the urinary chromium concentration of normal, healthy 
subjects (75). Eff~cts of cortisol on tissue distribution 
of chromium have not been studied, but circulating plasma 
cortisol has been linked to stress related increases in 
sodfum and calcium excretion in the r.at (76). Increased 
zinc and chromium excretion have been reported in human 
runners with elevated plasma cortisol (77). 
Measurement of changes in chromium metabolism as a 
result of stress is difficult. Currently there are no 
established biochemical indices of chromium status; 
confirmation of human chromium deficiency is dependent on 
beneficial effects of dietary chromium supplementation. 
Chromium deficiency in man causes glucose intolerance, 
neuropathy, high free fatty acid concentrations, and 
abnormalities of nitrogen metabolism (20,78), but these 
symptoms are not specific enough to be used as chromium 
status indicators. "Therefore, a clinical measure of· 
chromium status is needed. 
Chromium and Cholesterol 
Chromium supplementation has resulted in lowered blood 
cholesterol and chromium deficient diets have produced 
elevated cholesterol in animals (8). However, mechanisms 
for these effects are speculative. Chromium may affect 
cholesterol through. effects'on synthesis andjor degradation 
of cholesterol. 
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Evidence that chromium functions in the biosynthesis of 
cholesterol is limited. Using labelled acetate, Curran (79) 
was the first to demonstrate tha.t chromium enhanced the 
synthesis of cholesterol and of fatty acids in rat liver. 
When chicks were fed 20 ug Cr/g diet, the chromium increased 
14c (icetate incorporation into hepatic fatty acids compared 
to the controls (80). Xu and co-workers reported increased 
plasma cholesterol in guinea pigs supplemented with 4 ug Cr 
from crc13;g diet versus 2 ug Cr/g diet (81). Yet chromium 
has not been implicated in the function of 3-hydroxy-3-
methylglutaryl coenzyme reductase, the rate limiting step in 
cholesterol biosynthesis. 
Mertz and co-workers found that chromium from glucose 
tolerance-like compounds enhanced glucose uptake by 
epididymal fat tissue of rats (82). Glucose uptake by 
adipocytes from chromium deficient rats did not differ from 
controls in the absence of insulin; however, addition of 
chromium in vitro or in vivo to the donor animals increased 
the response of the tissue to exogenous insulin (59). 
Serum cholesterol was elevated and increased with age in 
rats receiving sucrose; in rats given sucrose plus Cr serum 
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cholesterol lev~ls were lower (83). Feeding 1 ugjg chromium 
decreased serum cholesterol in,~ale rats, while 5 ugjg Cr 
lowered serum cholesterol in female rats (84). Potassium 
chromate injected intraperitoneally reduced the size of 
aortic plaques and decr~ased aortic cholesterol in rabbits 
fed a high cholesterol diet .(85). However, Preston and 
colleagues (86) demonstrated that addition of 0.5 ug Crjg 
diet for 21 weeks had no effect on serum cholesterol of 
pregnant guinea pigs. 
Total hepatic lipid was significantly lower in obese 
mice fed chromium supplemented (2 ug Cr as crcl3jg) diet 
compared to chromium depletion diets (11). In male rats fed 
5 ug Crjg diet, the ~ecrease of circulating cholesterol with 
normal levels of aortic·lipids suggested that chromium may 
function in the catabolism .of cholesterol (87). In female 
animals, comparable changes in serum cholesterol were not 
observed, which suggests sex differences in response to Cr 
supplementation (87). 
Schroeder et al (88) found decreased chromium in aortic 
tissue from individuals who died of atherosclerotic heart 
disease compared to those who died in traffic accidents. 
Although problems with chromium measurement make 
interpretation of the data difficult, these authors 
hypothesized chromium functions in the catabolism of 
cholesterol and may have a basic role in atherosclerosis. 
In a double-blind 12 week study of 23 men (31-60 yr of 
age) supplemented with 200 ug trivalent Cr in water, high 
density lipoprotein cholesterol increased in,the Cr 
' ' 
supplemented group (89). This study was well controlled 
with half of the subjects ingesting a water placebo. 
Several studies which have reported cholesterol lowering 
effects of supplemental chrom~um have lacked a placebo 
group. When twenty-four non-insulin-dependent diabetics 
were fed fruit juice containing either chromium-rich Brewers 
yeast or chromium-poor Torula yeast (the control) (90), 
cholesterol decreased (p<O.OOl) with the chromium-rich 
Brewers yeast. Elwood et al (91) gave 20 g Brewers yeast to 
11 adults with normal lipids and 16 adults with hyperlipemia 
and reported a 10% and 9% reduction respe~tively in 'the two 
groups. 
Not all studies have found a decrease in total 
cholesterol as a result of chromium supplementation. When 
Offenbacher and co-workers supplemented non-
institutionalized elderly volunteers with 200 ug crc13 , 5 g 
Brewers yeast 1 or placebo for ten weeks, no changes in blood 
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cholesterol or triglycerides were noted (92). When Riales 
and Albrink (89) supplemented 12 healthy adults with 200 ug 
Cr, blood cholesterol did not change; however, there was a 
12% increase in high density lipoprotein (HDL) cholesterol. 
Grant and McMullen (93) supplemented 37 non-insulin 
dependent diabetics with 1.6 g brewers yeast and reported no 
change in total cho'lesterol, but HDL cholesterol increased 
by 36%. Polansky et al (94) using 200 ug Cr as crc13 , 8 g 
Brewers• yeast or placebo during three separate three month 
periods found no change in total cholesterol in 30 adults 
with normal oral glucose tolerance tests. 
The conflicting results obtained in these 
supplementation experiments may indicate that diets of 
subjects not responding to chromium supplementation were 
adequate or that cholesterol elevation was not present prior 
to supplementation., , These results could further reflect 
dietary factors.and other physiological factors, such as 
stress, not controlled in these experiments. 
Individually, chromium. (83) and vitamin c deficiencies 
(30) have contributed to elevated serum cholesterol. 
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Studies in guinea pigs haye shown that the cholesterol 
elevation is exacerbated by combined chromium and vitamin C 
deficiencies (31). Synergistic effects of chromium and 
vitamin c need,evaluation as do mechanisms by which chromium 
supplementation may affect cholesterol metabolism. 
Vitamin C Metabolism 
Vitamin c, C6H60a, is a six carbon compound with a 
molecular weight of 176 (95). A critical function of 
vitamin c is its ability to donate electrons while itself 
undergoing reversible oxidation to dehydroascorbic acid 
which has a half-life of only a few minutes (96). Metabolic 
functions of ascorbic acid include hydroxylation of dopamine 
to form norepinephrine, hydroxylation of peptidyl proline to 
form hydroxyproline, and enhanced secretion of procollagen 
(95) . 
Absorption 
In guinea pigs, vitamin C was absorbed primarily in the 
duodenum, whereas in the rat the greatest absorption was in 
the ileum (97). In,intestinal tissue from guinea pigs 
vitamin C was transported by a sodium-dependent active 
transport system, but the transport of dehydroascorbic acid 
was by simple diffusion (98). In addition to the carrier-
mediated process that was saturated at low ascorbic acid 
concentrations, ascorbate entered the tissue from the 
intestinal lumen by simple diffusion (99). 
Ascorbate transport across the brush border in the 
guinea pig small intestine was inhibited by D-glucose (100) 
and aspirin (101). ~scorbic acid accumulated in mucosal 
cells of scorbutic guinea pigs indicating impaired 
intestinal absorption (102). Likewise, the transport of 
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ascorbic acid in vitro was significantly reduced in brush 
border membranes from scorbutic animals (103). 
Ascorbic acid was reabsorbed in the kidney by a sodium-
dependent active transport mechanism that operates by 
concentra~ing ascorbic acid in the cellular fluid. Both rat 
and guinea pig kidneys handled ascorbic acid similarly 
(104). Rose (105) suggested a cytosolic enzyme functions in 
reduction of dehydroascorbic acid .to maintain the redox 
state of ascorbic acid in the process of reabsorption in the 
kidney. Otsuka and co-workers (106) reported that 
utilization of injected dehydroascorbate in vitamin C 
deficient guinea pigs was less than in control animals and 
suggested that the reduction mechanism of dehydroascorbic to 
ascorbate was impaired in guinea pigs deficient in vitamin 
c. 
Distribution 
The tissue distribution of vitamin C is similar in man 
and other species dependent upon dietary intake. The 
highest concentrations were observed in glandular tissues 
(pituitary gland, adrenal glands, corpu~· luteum, and 
salivary glands), whereas the vitamin c concentration in 
muscle tissue was relatively low. Pancreas, liver, lungs, 
brain, spleen, thymus, and kidneys were intermediate (107). 
Damron and colleagues (108) determined that dehydroascorbic 
acid and 2,3-diketogulonic acid were present in guinea pig 
tissues only in negligible concentrations. 
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Ginter and co-workers (109) reported that guinea pigs 
fed ascorbic acid in the diet had higher ascorbate in the 
tissues than animals where ascorbic acid was administered 
orally once a day. There was a linear relationship between 
ascorbic apid concentrations in the tissues and t~e graded 
oral dose (110). Five and ten minutes after intravenous 
injection of ascorbic acid, the pituitary and adrenal 
glands, spleen, pancreas and parotid glands had the highest 
accumulation of label as visualized by autoradiography 
(111). Uptake of ascorbate was significantly greater in 
platelets of ascorbate deficient guinea pigs than in 
controls (112). In guinea pigs fed a scorbutogenic diet, 
the loss of ascorbate from the brain and lens was slower 
than the loss from the adrenal glands and spleen (113). 
In Rhesus monkeys, plasma ascorbate was directly related 
to liver ascorbic acid levels (r=.48, p<0.05) but leukocyte 
ascorbate was the best indicator of the vitamin c status 
(114). Veen-Baigent and colleagues (115) suggested that 
ascorbic acid may not be-freely exchangeable among tissues 
or between blood and tissues. At very low levels of intake, 
tissue asco~bic acid rose at the' apparent expense of 
leukocyte ascorbic acid. The data were suggestive of a 
preferential transfer of vitamin C from blood (including 
leukocytes) to tissues supporting essential ascorbic-acid 
dependent functions when ascorbic acid intakes were low 
(0.05 to 0.15 mg/100 g body weight). At adequate intakes 
(0.5 to 2.0 mg/100 g body weight), blood and some tissues 
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(kidney, heart, and spleen) remained relatively constant as 
liver and adrenal ascorbic acid increased. Above 2.0 
mg/100 g body weight, ascorbic acid in all tissues rose 
until saturation was attained. 
Half Life 
From depletion experiments in guinea pigs, Pelletier 
(116) calculated the half-life of 1-14c-ascorbic acid in the 
liver, heart, kidneys, adrenals and spleen to be 2-3 days, 
whereas the brain was about 5 days. Ginter et al (117) 
found the time for ascorbate depletion in nine organs to be 
similar in guinea pigs receiving 0.5 mgjday and 
approximately 150 mgjday. The half-life of ascorbic acid 
was shorter in tissues of younger guinea pigs; younger 
animals were depleted much more rapidly than older animals 
( 118) 0 
The half-life of ascorbate in the guinea pig (4 days) 
was much shorter than in humans (16 days) (119). Likewise, 
a larger dose of ascorbic acid was required to maintain an 
equivalent body pool of the vitamin in the guinea pig than 
in humans (119). 
Transport 
The active transport of 14c-labelled ascorbic acid into 
rat brain cortex and ovary slices was inhibited by 
corticosteroids, estrogen, and testosterone, but uptake was 
not affected by ACTH (120). There was no active uptake by 
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ascorbate uptake (126); however, equimolar concentrations of 
fructose did not inhibit uptake. The absence of insulin 
also significantly reduced ascorbic acid uptake. Kapeghian 
and Verlangieri (27) confirmed that ascorbic acid uptake by 
the cell was comprqmised by decreased insulin andjor 
increased extracellular glucose levels. 
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Bianchi and Rose (1986) (127) demonstrated in vitro a 
facilitated diffusion pathway of dehydroascorbic acid 
transport in human erythrocytes that was not influenced by 
external glucose. Physiological levels of D-glucose limited 
dehydroascorbic transport on the hexose transporter as 
proposed by Mann and Newton ( 122.) , but high levels of 
glucose did not interfere with transport of dehydroascorbic 
by the alternate p~thway. Mooradian (128) studied brain and 
muscle uptake of glucose with various concentrations of 
ascorbate and dehydroascorbate. Dehydroascorbic acid, but 
not ascorbic acid, inhibited in vivo uptake of glucose by 
brain, but not by muscle which suggested a common carrier 
system at the level of the blood-brain barrier. 
catabolism 
The metabolic fate of ascorbic acid and its derivatives 
in animals depends on a number of faqtors including species, 
age, route of administration, quantity of material and 
nutritional status (129). Urinary ascorbate excretion 
increased in older compared to younger guinea pigs (130), 
and animals fed lower ascorbic acid had a higher retention 
of a radioactive dose (130). 
The major pathway of catabolism of ascorbic acid in the 
guinea pig is the oxidation of its lactone carbonyl carbon 
to carbon dioxide with subsequent oxidation of the entire 
carbon chain to carbon dioxide (131). A biphasic pattern of 
expired 14c-carbon dioxide evolution has been noted in 
guinea pigs; the first peak occurred at two hours and the 
second peak at five hours after administration of the dose 
(132). The in vivo catabolism of 1-14c-ascorbate to carbon 
dioxide was related to the route of administration (132). 
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Dehydroasco~bic acid is a major intermediate in the 
breakdown of ascorbate, and L-xylose and oxalate are formed 
as subsequent products (133). A 14c-labelled excretory 
product, ascorbic acid-2~sulfate, has been identified in 
excreted bile (134), but Kipp and Rivers found less than 1% 
of a 14c-ascorbate,dose in the feces (135). Incorporation 
of 14c in expired carbon dioxide, urinary oxalate and liver 
glycogen was via dehydroascorbic acid and diketogulonic acid 
(136). 
In the guinea pig, 66% of the 14c from a dose of 1-14c-
ascorbic acid was excreted as, carbon dioxide, 10% was in the 
urine and less than 1% of the administered radioactivity 
appeared in the feces during the ten days following 
injection of the isotope. Approximately 5 to 24% of the 
dose was catabolized to carbon dioxide during the first 6 h; 
30-40% at 24 hr (137). Burns et al (137) noted no 
difference in total excretion (formation of carbon dioxide 
and urinary metabolites) in scorbutic guinea pigs and in 
those fed 2, 15, and 50 mg ascorbate daily. However, 
Schuching and co-workers (138) found that guinea pigs fed 
the highest level of ascorbic acid exhaled the most labelled 
carbon dioxide. The amount of 14c-carbon dioxide ~xhaled 
after administration of,l-14c-ascorbic acid was dependent on 
the previous dietary intakes of vitamin c. The lower the 
ascorbic-acid intake, the lower the 14c-carbon.dioxide 
excretion (138). 
Guinea pigs metabolized 14c-ascorbic acid much faster to 
14c-carbon dioxide (peak exhalation at 30 min) than rats 
(peak exhalation at 2 to 3 h) following a single oral dose 
(139). Urinary excretion of 14c in rats and guinea pigs was 
approximately 5-10% of-the ~dministered 14c-ascorbate dose 
during the first 24 h arid 21-22% after 48 h (140). 
Unchanged 1-14c-ascorbate, dehydroascorbic, 2,3-
diketogulonic acids (2-3% of the dose), and 14c-oxalate (7% 
of the dose) were isolated {140). 
Hormones and Vitamin C Metabolism 
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In humans, ascorbic acid needs of individuals vary 
widely due to changes of metabolism, hormonal activities, 
and stages of development (141). In guinea pigs deprived of 
food to produce a mean weight loss of 246 g in 16 days, 
vitamin c retention of adrenals, spleen, liver, but not 
brain decreased (142). Older animals had lower tissue 
ascorbate concentrations than young ones (143). Davies et 
al (143) suggested that the difference in ascorbate 
saturation was a reflection of a reduced capacity of "aged" 
tissue to abstract or retain ascorbate. 
Compounds dependent on the pituitary gland may influence 
ascorbate uptake by various tissues in the rat; a lower 
uptake of a single orally administered dose of 1-14c-
ascorbate was observed, in hypophysectomized ·rats, but 
concentration in circulating blood was higher (144). 
Horning et al (144) suggested participation of pituitary 
hormones in regulating the transport, tissue binding or 
catabolism of vitamin c. 
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Scorbutic guinea pigs had decreased pancreatic insulin. 
Insulin administration corrected the abnormal glucose 
tolerance in the scorbutic animals (145). In scorbutic 
animals, blood ketone bodies were elevated (146). Urinary 
excretion of vitamin c decreased in rats injected 
intraperitoneally with ketone 'bodies, and the ketone bodies 
brought about a significantly high destruction of vitamin C 
( 14 7) . 
Increasing concentrations of insulin increased transport 
of radioactive vitamin c into fetal bovine heart endothelial 
cells. A linear relationship was found between the log of 
the insulin concentration and the uptake.of vitamin c. In 
media containing 180 mgjdl glucose, there was approximately 
a five-fold decrease in vitamin c uptake which Verlangieri 
and Sestito (126) attributed to the-competition for insulin 
receptor sites. 
Acute vitamin C depletion in guinea-pigs was accompanied 
by increased uptake of 131I by the thyroid in vivo (148). 
However, as vitamin c deficiency,progressed, there was 
subsequent inanition and weight loss. Under these 
conditions the uptake of 131I in vitro was decreased (149). 
Increased peripheral de-iodination of thyroxine (T4) and 
triiodothyronine (T3) has been reported in guinea pigs fed a 
low vitamin c ·diet (rabbit rat-ion) (150). Added ascorbate 
strongly inhibited thyroxine (T4 ) deiodinase of rat liver 
microsomal homogenate and thus protected T4 from'excessive 
degradation ( 151) ., Ascorbic acid and dehydroascorbic acid 
in liver and kidney of thyroidectomized rats decreased and 
total vitamin c in urine increased (152). In 
hyperthyroidism, plasma ascorbic acid content was reduced as 
well as urinary excretion of ascorbic acid (153). 
Stress may affect ti~sue and plasma levels of vitamin c. 
Chronic immobilization, stress decreased vitamin c in serum, 
liver, adrenal glands, and urine of rats (154). Other 
researchers reported increased serum ascorbate in rats 
subjected to acute immobilization stress (155). Adrenal 
vitamin c decreased gradually with a marked accumulation of 
corticosterone in the rat tissues (155). The physical 
stress of swimming resulted in decreased vitamin c 
concentrations in the adrenal glands, spleen and brain of :, 
guinea pigs (156). 
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Higher plasma corticosteroids were found in vitamin c 
deficient guinea pigs (157). Odumosu and Wilson (158) 
reported that as vitamin C concentrations in adrenals 
increased in surviving guinea pigs deprived of vitamin c, 
plasma cortisol concentrations diminished. Adrenal vitamin 
C may modulate production of adrenal st.eroids during stress 
in guinea pigs {159). Adrenal vitamin C falls as cortisol 
secretion into the plasma increases. 
Adrenalectomy affects the·degradation of ascorbate and 
its concentration in selected tissues (160). 
Adrenalectomized rats excreted ~ignificantly less 
radioactivity from 14c-ascorbate resulting in a longer 
estimated half-li.fe of ascorbate than in the sham-operated 
controls. The concentration of ascorbate was significantly 
higher in the heart and lower in the liver of 
adrenalectomized animals. 
Elevated adrenal corticosteroids were found in guinea 
pigs fasted for 3 days (161). Elevated plasma corticoids 
were also found in non-fasted animals ingesting massive 
amounts of ascorbate; ascorbic acid may competively inhibit 
catecholamine inactivation (162). 
Interactive Effects of Vitamin c and Minerals 
The role of several metal ions in alterations of tissue 
levels and urinary excretion of vitamin c in rats has been 
studied (4). Chromium or tungsten at 5 ugjg diet increased 
the concentration of vitamin c in liver and adrenals of rats 
(4), and chromium at 10 ugjg diet increased concentration of 
vitamin C in the spleen and adrenals of rats and the spleens 
of chicks (163). Lower brain vitamin C was reported in 
brindled mice, which exhibit signs of copper deficiency. 
Injection,.of cupric chloride into pups deficient in copper 
raised brain ascorbate and returned catecholamine levels to 
normal (164). Zihc supplementation decreased the urinary 
excretion of ascorbate (165) and administration of 
molybdenum, cadmium, or mercury decreased hepatic vitamin C 
of rats (4). 
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The effects of vitamin c on the absorption and retention 
of several minerals have been reported. Solomons and co-
workers (166) found vitamin G over a range of dosages 
commonly consumed by man had no demonstrable effect on the 
absorption of zinc sulfate. In male guinea pigs 
supplemented daily with excess vitamin C (25 mg/100 g bw per 
day), two-to-three-fold decreases in liver copper compared 
to controls were noted (167). S,erum and hepatic iron levels 
also increased as the vitamin dose increased. Smith and 
Bidlack (49) reported similar results in female guinea pigs. 
Very high dietary vitamin c (225 mgjanimal) increased tissue 
vitamin C levels, increased hepatic iron stores, and 
produced a reciprocal decrease in hepatic copper. Finley 
and Cerklewski (168) confirmed that vitamin c intake of 500 
mgjday is antagonistic to copper status of adult men as had 
been demonstrated in laboratory animals. 
In guinea pigs, administration of vitamin c (5 mg/100 g 
bw) along with 5 mg of iron sulfate not only counteracted 
the toxic effect of decreased growth and mortality of the 
iron suppl~ment, but also led to a greater utilization of 
iron as revealed by increased hemoglob~n and serum iron 
levels (50). Iron administration increased vitami~ c 
destruction as revealed by lower urinary, blood, and tissue 
levels of the vitamin (50). Tissue ascorbate tends to be 
low in iron overloaded human patients (169). 
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In summary,. vitamin C functions to donate electrons 
while itself undergoing.reversible oxidation to 
dehydroascorbic acid (96). In guinea pigs, the major 
pathway of catabolism of ascorbic acid is oxidation to 
carbon dioxide (131). ~ctive uptake of ascorbate was· 
demonstrated in brain and ovaries but not in liver, spleen, 
testes, pancreas, and diaphram (120). Uptake of vitamin c 
into tissues was compromised by decreased insulin andjor 
increased extracellular glucose levels (27) • Stress 
decreased tissue and plasma ascorbate levels of guinea pigs 
which illustrated the orchestration of hormonal control on 
ascorbate metabolism (156). The effects of, ascorbic acid on 
absorption of most minerals have not been thoroughly 
investigated; the experiments thus fa'r have used extremely 
high ascorbate doses. The effects of smaller ascorbate 
doses on mineral status also need evaluation. Due to the 
frequency of ascorbate supplementation by humans, 
ascorbate/mineral interactions are an ongoing concern in 
human nutrition. 
Vitamin c and Cholesterol 
In guinea pigs with chronic ascorbic acid deficiency the 
catabolism of cholesterol to bile acids was significantly 
decreased ( 3 o) • Cholesterol accumulated i,n serum and in 
liver of guinea pigs with chronic latent vitamin c 
deficiency. Hepatic ascorbic acid concentration was 
negatively correlated (p<0.001) with cholesterol of liver 
and serum (170). Elevated cholesterol in ascorbate-
deficient animals was reported to be due to the decreased 
rate of transformation of cholesterol to bile acids (171). 
Supporting this suggestion, acutely scorbutic guinea pigs 
injected with 14c-cholesterol labelled in the 26 position of 
the side chain exhaled subnormal amounts of 14co2 (171). 
Shefer and co-workers (172) were the first to report 
that regulation of bile acid biosynthesis was exerted in 
vivo via cholesterol 7 alpha-hydroxylase'. Bjorkhem and 
Kallner (173) assayed cholesterol 7 alpha-hydroxylase 
activity in liver microsomes from guinea pigs supplemented 
with ascorbate and from ascorbate-deficient guinea pigs 
(173). The 7 alpha-hydroxylation was markedly reduced in 
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the ascorbate-deficient animals. Chronic ascorbate 
deficiency was associated with a decline of hepatic ascorbic 
acid concentration: the rate of cholesterol transformation 
to bile acids was reduced resulting in cholesterol 
accumulation in plasma and liver of deficient animals (174). 
Holloway and Rivers (175) and Peterson and co-workers 
(176) demonstrated the susceptibility of cholesterol 7 
alpha-hydroxylase activity in guinea pigs to both inadequate 
and excessive dietary extremes of ascorbate. Both deficient 
and excess groups exhibited lower cholesterol 7 alpha-
hydroxylase activity, lower bile acid turnover rate and 
increased plasma and liver cholesterol. 
Male guinea"pigs fed a scorbutogenic diet supplemented 
with 1 mg ascorbate per anim~l per day responded with high 
blood cholesterol. Those animals fed 500 mg ascorbate/kg 
diet or 5000 mg ascorbate/kg diet displayed decreased blood 
cholesterol, but guinea pigs fed excess ascorbate (20,000 
mgjkg diet) demonstrated blood cholesterol not significantly 
different from the ascorbatedeficient group (177). 
Hornig and Weiser (178) reported that cholesterol 
oxidation was dependent on the. ascorbic acid status in 
depleted animals, but could not be further stimulated by 
ascorbic acid in animals fed adequate amounts of the 
vitamin. These data suggested that ascorbate has a 
cholesterol lowering,effect only over a limited range of 
ascorbic acid intakes. 
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Human studies of ascorbate supplementation have produced 
conflicting results which appear to be related to ascorbic 
acid status. Young female volunteers (21-28 yr), all 
meeting the Recommended Dietary Allowance for ascorbate, 
were given 1 g ascorbate/day for 4 wk (179). No effect was 
found on plasma lipids or lipoprotein cholesterol. In a 
long term experiment in 82 older adults, 1 g ascorbic 
acid/day reduced blood cholesterol values and these effects 
persisted"6 wk after termination of the experiment (180). 
The average intake of ascorbate per day for these elderly 
subjects was 20 mg. A similar decline in serum cholesterol 
was found in patients with non-insulin dependent diabetes 
mellitus who wer~ supplemented with 500 mg ascorbate per day 
for 12 months (181). Before treatment, ascorbate 
concentration in blood and leukocytes of these diabetic 
subjects was substantially lower than in healthy subjects. 
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In guinea pigs a short term ascorbate deficiency (10 
days) reduced both excreted"bile acid and bile acid pool 
size by 50% (182). Cholesterol 7 alpha-hydroxylase activity 
also was decreased in the deficient animals. In these 
studies, short-term ascorbate deficiency impaired bile acid 
metabolism independent of any apparent side effects of 
clinical scurvy. In contrast,"Holloway and Rivers (183) 
found prolonged cons~mp~ion (7-9 wk) of inadequate or 
excessive ascorbate by guinea pigs resulted in little or no 
change in bile acid metabolism and biliary lipid composition 
except that bile adid pool size was increased 12% as a 
result of excessive asco~bate ingestion. Therefore, there 
may be important differences in metabolic response to 
ascorbic acid deficiency depending on the length of the 
experimental period or some other aspect of the experimental 
protocol, i.e., Holloway and Rivers administered ascorbate 
in 1 ml of 5% glucose solution. 
In guinea pigs the predominant bile acid in gall bladder 
bile and in ~he small intestine was chenodeoxycholic acid 
(184); 89-90% of total cholesterol was converted to 
chenodeoxycholic acid (185). In guinea pigs with chronic 
marginal vitamin C deficiency, the activity of the 
cholesterol 7 alpha-hydroxylating system was depressed 
resulting in cholesterol accumulation in the liver, plasma, 
and arteries and in cholesterol gallstone formation (180). 
Ascorbate administration to deficient guinea pigs enhanced 
cholesterol hydroxylation at the. seven position resulting in 
the formation of 7 alpha-hydroxycholesterol (185). 
Jenkins (186) reported that gallstone formation in 
vitamin c deficient guinea pigs fed a 0.5% cholesterol diet 
was associated with qualitative changes in the gallbladder 
bile including a high cholesterol concentration,, a lowered 
bile acid content and ~iminished phospholipid-to-cholesterol 
and bile acid-to-cholesterol ratios. Jenkins (187) 
concluded that, in the chronically ascorbate depleted 
' 
animal, there was a reduction in gallbladder bile acid and 
impaired conversion of cholesterol to chenodeoxycholic acid 
which favored cholesterol precipitation and gallstone 
formation. 
Feeding rabbits a 0.3% cholesterol diet resulted in 
atherosclerotic fatty streaks most pronounced in the aortic 
arch and a decrease in the prostacyclin production by the 
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aortic endothelium. , Addition of ascorbic acid resulted in 
decreased lipi~ infiltration and intimal thickening with a 
tendency to restore the prostacyclin output (188). Ginter 
and Ondreicka (189)' maintain that the effects of vitamin c 
on cholesterol metabolism may be hormonal effects on enzyme 
systems involved in the synthesis or catabolism of 
cholesterol. 
Banerjee and Singh (190) fou~d total body cholesterol 
content increased in scorbutic guinea pigs in comparison 
with normal controls. However, treatment of scorbutic 
animals with insulin lowered the cholesterol content to that 
of controls. Cholesterol content of the intestines also 
increased as a result of ascorbate deficiency and was 
lowered with insulin. 
Only a few researchers have suggested that ascorbic acid 
affects cholesterol levels by metabolic pathways unrelated 
to cholesterol 7 alpha-hydroxylase. Terada et al (191) 
reported that the hypolipidemic and lipotropic effects of 
ascorbate were due to sulfation of cholesterol by ascorbic 
acid 2-sulfate and the resultant fecal excretion of 
cholesterol sulfate. Durr and Shukairy (192), proposed that 
ascorbate stimulated synthesis of nonsteroidal compounds 
thus diverting mevalonate into pathways other than 
cholesterol synthesis. Holloway and co-workers (193) found 
that the activity of 3-hydroxy-3-methylglutaryl coenzyme A 
reductase (the rate limiting step in cholesterol 
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biosynthesis) was significantly reduced in guinea pigs fed 
either inadequate or excessive dietary ascorbate. 
To summarize, in ascorbic acid deficient guinea pigs, 
reduced activity of _cholesterol 7 alpha-hydroxylase (194) 
and decreased catabolism of cholesterol to bile acids (30) 
resulted in cholesterol accumulation and gallstone formation 
(187). However, the negative effects of both high and low 
ascorbate intakes on 7 alpha-hydroxylase may be more evident 
in short-term versus long-term ascorbate depletion 
(182) (183). Ascorbate status also affected cholesterol 
synthesis (193) and fecal excretion as cholesterol sulfate 
( 191) . 
Hydroxyproline 
Hydroxyproline is found almost exclusively in collagen 
in the tissues of vertebrates.. Except for the small amount 
of hydroxyproline in ela~tin, and complement component Clq, 
no animal protein except collagen contains significant 
amounts of this amino acid. Urinary hydroxyproline reflects 
changes in the metabolism of collagen in various 
experimental ,conditions and disease states. Conditions 
which alter hydroxyproline excretion include abnormalities 
of growth (195), and thyroid disorders (196), as well as 
bone conditions including osteoporosis (197), rheumatoid 
arthritis (198), osteomalacia (199) and rickets (200). 
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Hydroxyproline and hydroxylysine in collagen arise 
through the hydroxylation of prolyl and lysyl residues after 
they have been incorporated into peptide linkage. 
Hydroxylation appears to occur primarily while the 
polypeptide chain is being formulated and is therefore still 
attached to the ribosome (201). 
Ascorbic acid may have three functions in collagen 
synthesis. Ascorbate supplied hydrogen equivalents for the 
hydroxylation of proline residues to form 4~hydroxyproline 
(202), it reactivated proly-4-hydroxylase by reducing the 
enzyme-bound Fe (III) (203) and promoted collagen production 
by a specific stimulation of procollagen mRNA (204). 
Nemethy and Scheraga (205) demonstrated that'hydroxyproline 
stabilized not only the triple-h~lical collagen molecule but 
also its assembly into microfibrils. 
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Hydroxyproline produces no known intermediates of 
physiological utility and its energy contribution is 
insignificant (206). In·. animal tissues a pathway from 
hydroxyproline to pyruvate exists for oxidizing the 250 mg 
(or more) of free hydroxyproline arising daily from collagen 
turnover (206). 
Urinary Excretion of Hydroxyproline 
Urinary excretion of 4-hydroxyproline has been used as 
an index of whole-body collagen degradation. As a means of 
non-invasive quantitation of whole body bone resorption, the 
excretion rate of hydroxyproline appeared comparable with 
isotopic methods in patients with primary osteoporosis 
( 2 07) • 
When the hydroxyproline in collagen was labeled by 
administering radioactive proline, changes in the excretion 
of labeled hydroxyproline made it possible to distinguish 
between the rate of collagen synthesis and the degradation 
of soluble collagen or of insoluble' collagen (208). The 
differences in 14c~hydroxyproline excretion between young 
and old animals suggested that in young animals most urinary 
hydroxyproline originated from the degradation of soluble 
collagen, while in older animals the major part of urinary 
hydroxyprolin~ originated from the degradation of insoluble 
collagen. It is· estimated that only 5-10% of the 
hydroxyproline released by the degradation of insoluble 
collagen under normal conditions is recovered as 
hydroxyproline in .urine.. Therefore, relativ_ely large 
changes in collagen metabolism are required to produce 
significant changes in the amount of hydroxyproline excre~ed 
in urine. 
Total body content of insoluble collagen increased more 
rapidly with age than did,body weight. Thus even though 
total soluble collagen remained unchanged or increased 
somewhat, the ratio of soluble collagen to insoluble 
collagen decreased. One hundred week old rats had more than 
twenty times as much collagen as three week old rats, but 
their hydroxyproline excretion was only one-third that of 
younger rats. Collagen pool sizes increased while the 
amount of collagen degraded decreased; therefore, the 
42 
percentage of collagen degraded decreased markedly as 
animals grew older (200). 
When growth hormone was administered to animals, 
synthesis of soluble and insoluble collagen increased as did 
the amount of hydroxyproline excreted (200). Biochemically, 
hydroxyproline is related to growth; more hydroxyproline was 
excreted by children and young, animals than by adults and 
old animals (209). 
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Increased urinary hydroxyproline is an indicator of bone 
growth in health and the turnover of structural protein 
within bone (195). Stolley and co-workers (210) found a 
close correlation between urine hydroxyproline excretion and 
growth velocity in children. In children suffering from 
kwashiorkor and marasmus, hydroxyproline excretion is 
depressed (211). 
In young rats a protein aQd calorie deficiency markedly 
reduced urinary hydroxyproline within 1 wk of feeding the 
deficient diet (212) '(213). Protein deficiency affected 
urinary excretion of- hydroxyproline more severely than 
calorie deficiency and might be explained by slow turnover 
of collagen in these animals (212). 
Hydroxyproline in Vitamin c Deficiency 
In scorbutic guinea pigs, ,proline in collagen was 5-10% 
less hydroxylated than that normally occurring in collagen 
(214). Barnes et al (215) likewise suggested that ascorbic 
acid deprivation decreased hydroxylation of proline in 
elastin resulting in a polymer deficient in hydroxyproline. 
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Bates (216) reported that the age-related increase in 
hydroxyprolirie:creatinine ratio in young guinea pigs was 
significantly larger in vitamin c-deficient animals than in 
pair-fed controls. He proposed that the increase in 
hydroxyproline excretion in vitamin C-deficient animals 
represented the rapid turnover of underhydroxylated 
collagen. Degradation of soluble collagen normally accounts 
for a disproportionately large share of urinary 
hydroxyproline, thus an increase in the proportion of 
soluble collagen could in itself· explain an increase in 
hydroxyproline excretion (200). , Of several tissues examined 
for collagen synthesis, the greatest effect of vitamin C 
deficiency was observed in skin (216). 
Not all researchers have found an increased excretion of 
hydroxyproline in scurvy. Robertson and Hewitt (217) found 
decreased urinary hydroxyproline in scorbutic guinea pigs. 
They suggested that when collagen synthesis was depressed, 
both the amount of soluble collagen and the amount of 
collagen degraded were decreased. Barnes and colleagues 
(218) reported a decreased u~inary excretion of total amino 
acids and hydroxyproline,'in scorbutic guinea pigs commencing 
at approximately the fift~enth day of vitamin deficiency. A 
reduction in hydroxyproline excretion in guinea pigs after 
21 days of ascorbic acid deprivation compatible with reduced 
collagen synthesis and reduced excretion of hydroxyproline 
has also been reported (219). 
Hormonal Effects on Hydroxyproline 
Schneir and co-workers (220) characterized degradation 
products of recently synthesized collagen in skins of 
control and diabetic rats killed after 3H-proline injection. 
Free and peptidyl 3H-hydroxyproline were dramatically 
' ' 
enhanced by streptozotocin-induced diabetes. ·They suggested 
the source of the degradation products was procollagen. 
Cortisone produced changes in collagen metabolism 
similar to those sometimes seen in scurvy. The principal 
effect of cortisone or cortisol is to decrease collagen 
synthesis (221) •. In two-month old rats the concentration of 
free hydroxyproline in the serum and the excretion of free 
and total hydroxyproline in the urine decreased 
significantly after the adminYstratiori of cortisone (222). 
By contrast, in seven-month-old rats, no changes were 
observed after the administration of cortisone (222). 
Similar results were found with administration of 
pharmacological doses of cortisone, cortisol, or other 
glucocorticoids. The excretion of hydroxyproline in urine 
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was markedly reduced in young rats, whereas in older rats no· 
effect or only a tendency to ~ecrease was found (223). 
Early studies in rats indicated that urinary excretion 
of hydroxyproline was greatly increased in experimental 
hyperthyroidism and decreased in experimental hypothyroidism 
(224). In hypothyroid animals, hydroxyproline excretion 
decreases to less than one-half of control values. The 
decreased hydroxyproline excretion is secondary to both 
decreased collagen synthesis and decreased collagen 
degradation (224). 
In summary, hydroxyproline' is found almost exclusively 
in collagen. Measurement of hydroxyproline has been the 
most useful in abnormalities of bone metabolism (200). 
Hydroxyproline stabilizes the collagen molecule (205), and 
the increased hydroxyproline excretion sometimes reported in 
scurvy has been attributed to a rapid turnover of 
underhydroxylated collagen (216). Not all researchers have 
reported increased hydroxyproline excretion in guinea pigs 
with scurvy (217). Therefore, vitamin C deficiency may not 
result in increased hydroxyproline excretion in guinea pigs. 
Creatinine 
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Most creatine is found in skeletal muscle where it 
exists both as creatine and as creatine phosphate; creatine 
phosphate is converted to creatine in muscle with synthesis 
of ATP (225). Creatinephosphokinase was inhibited by a low 
vitamin c diet which is of physiological significance since 
activity of creatinephosphokinase is closely associated with 
the contractile function of muscle (226). Creatine is 
synthesized extramuscularly and then is transported to 
muscle. Both creatine phosphate and creatine undergo a 
nonenzymatic irreversible dehydration to form creatinine. 
Unlike creatine, creatinine is not retained by muscle but is 
distributed in total body water and cleared from the body by 
the kidney (225). 
Heymsfield and co-workers (227) reviewed the validity qf 
urinary creatinine as an estimator for muscle mass. 
Parallelism between total body. creatine and urinary 
excretion of creatinine has been reported in a variety of 
species. Stress increased creatinine output. Mice exposed 
to cold stress demonstrated increasingly greater plasma 
creatinine levels with longer.exposure times compared to 
non-exposed controls (228). ,Creatinine excretion increased 
with growth (229) and declined with aging which presumably 
reflected the diminution of muscle mass (227). Creatinine 
measurement is probably.not ~valid measure of muscle mass 
in the presence of stress such as infection, fever or trauma 
which increased its excretion (227). In diabetics with 
renal disease there was decreased excretion of creatinine 
when the glomerular filtration rate fell (227). 
Creatinine and Hormones 
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Asplin and co-workers .(230) hypothesized that an 
increased cortisol to creatinine ratio in overnight urine 
samples reflected nocturnal hypoglycaemia in insulin-treated 
diabetics. Prasad et al (231),. noted increased excretion of 
creatinine at weeks four and eight in alloxan diabetic rats. 
However other researchers have suggested that elevated serum 
creatinine values in diabetics may be an artifact caused by 
ketoacidosis interference in the creatinine assay (232). 
Low plasma creatinine has been reported in diabetes 
without ketonuria (233). Ditzel and co-workers (234) found 
mean values of plasma creatinine of 63 male and female 
diabetics without evidence of renal disease or ketoacidosis 
to be significantly lower than those in 123 healthy 
subjects. Glomerular filtration may be a factor in 
contradictory creatinine measurements reported in diabetics. 
The average glomerular filtration rate was significantly 
increased in insulin-treated diabetic subjects showing no 
signs of diabetic angiopathy ~2i5). Because plasma 
creatinine is predominantly cleared by glomerular 
filtration, the reduced mean level of creatinine in plasma 
may be a result of the increased glomerular filtration rate 
and consequently of ·increased creatinine excretion found in 
some diabetics without angiopathy •. 
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Steers treated with alloxa'n had a marked increase in 
serum creatinine concentrations; insulin treatment of the 
alloxanized animals decreased serum creatinine 
concentrations (236). Koszalska and Andrew (237) found that 
creatinuria induced by creatin~ loading can be prevented in 
the rat by the prior administration of insulin. 
Furthermore, the hypercreatinemia which was observed shortly 
after the intraperitoneal injection of a creatine load was 
suppressed by insulin, suggesting creatinuria prevention was 
related to insulin's effect on the blood 6reatine 
concentration per se rather than to an effect on the 
kidneys. 
Creatinine Measurement 
Ketosis, specifically elevation ,of acetoacetate in serum 
may cause elevated creatinine levels by the picric acid 
method (238). Bilirubin also interfered with the 
measurement of plasma creatinine by the Jaffe reaction 
(239). Pyruvate, glucose, fructose, ascorbate and protein 
also interfered with the Jaffe reaction for creatinine by 
means of a side 'reaction with the alkaline picrate reagent 
(240). Major overestimation ~f creatinine was obtained in 
presence of acetoacetic acid, with relatively slight 
overestimation in the pre~ence of acetone and glucose (241). 
Picric acid methods for estimating creatinine greatly 
overestimated serum creatinine in mice. Both mouse and rat 
serum seem to have s~bstances 'which gave nonspecific color 
and thus interfered with the ~nalysis of creatinine by 
alkaline picrate methods. Thus HPLC is recommended to 
accurately measure rodent creatinine (242). 
The conversion of creatine, and creatine phosphate to 
creatinine in stored urine samples is affected by pH and 
temperature (241). The maximum rate of conversion of 
creatine to creatinine was found between pH 3.5 and 4.0. 
Thus at pH 3.5-4.0 and a temperature of 37 degrees c for 24 
h, the creatinine content of urine rose by about 20%. 
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Longer periods of storage were associated with a greater 
increase in creatinine. 
In summary, creatinine excretion is increased in stress 
(228), infection, fever, trauma (227) and in alloxan 
diabetes (231) (236). Increased glomerular filtration in 
diabetic subjects without angiopathy resulted in decreased 
' ' 
plasma and increased urinary creatinine excretion (235). 
Elevated serum creatinine in alloxan treated animals (236) 
and creatinurea produced by intraperitoneal injections (237) 
were prevented by insulin treatment. 
Factors Affecting 3-Hydroxy-3-Methyl Glutaryl 
Coenzyme A Reductase Activity 
Sterol synthesis rate in _the guinea pig was similar to 
those in the human. Depending on the time of day, the rate 
of sterol synthesis in the ileum was from 6 to 14 times that 
in the liver, while in the lung the rate was up to 3 ~imes 
that of the liver (243). Sable-Amplis and,Sicart (244) 
determined in the guinea pig that the cecum as well as the 
ileum of the guinea pig incorporated acetate into 
cholesterol and phospholipids at a rate greater than, that of 
liver. Therefore, measurements of sterol synthesis in 
guinea pigs should focus as much on the intestine as on the 
liver. 
In a chain of biochemical reactions any factor which 
modifies the rate-limiting step also modifies 
proportionately the rate of synthesis of the final product. 
Under most physiologial conditions the rate limiting enzyme 
for cholesterol synthesis is 3-hydroxy-3-methyl glutaryl 
coenzyme A (HMG CoA) reductase (245,246). The reaction 
catalyzed by HMG CoA reductase (mevalonate: NADP 
oxidoreductase, EC 1.1.1.34) involves reductive deacylation 
of HMG CoA to mevalonate and requires 2 moles of NADPH 
(245). 
A circadian rhythm of hepatic cholesterol synthesis was 
first demonstrated in mice by Kandutsch and Saucier (247); 
In rats hepatic cholesterol synthesis and HMG CoA reductase 
exhibit peak activities near midnight (245). However, peak 
activity of HMG CoA reductase was related to the time of 
feeding and did not require the onset of darkness (248). 
sterol synthesis in guinea pig liver peaked at 3 h after the 
onset of the dark period; but variation between animals was 
high and the rate did not differ significantly with the time 
of day (243). The differences in the rat and guinea pig in 
the diurnal patterns of hepatic and intestinal 
sterologenesis may thus be explained by the marked 
difference in the feeding patterns of the two species. The 
rat has only one peak of eating activity during a 24 hr 
cycle and consumes at least 70% of its total daily intake 
during the dark period.- The guinea pig, on the other hand, 
has three periods of increased eating activity during a 24 
hr cycle with similar total feed consumption in the light 
and dark periods. 
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Diets high in carbohydrate and low in fat decreased the 
activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase 
(249). The activity of HMG CoA reductase was regulated by 
the degree of unsaturation of dietary fats; the more 
unsaturated the fatty acids, the lower the activity (250). 
HMG CoA reductase was lower in rats fed a semipurified diet 
containing sucrose, casein, ·and cellulose than in those fed 
a stock diet (251). Citrus pectin added to the semipurified 
diet produced HMG CoA levels equal to the stock diet (251). 
Fiber was hypothesized to be responsible for binding bile 
acids and increasing the turnover rate of cholesterol (251). 
Whether bile acids themselves or the enterohepatic 
circulation of endogenous cholesterol play a direct role on 
hepatic cholesterol synthesis is questioned. When bile . 
salts were infused into the portal vein, cholesterol 
synthesis was not inhibited (252). Harry et al (253) 
produced biliary obstructipn in rats by surgical ligation. 
The biliary obstruction increased hepatic cholesterol to 
levels greater than those found at the peak of normal 
diurnal variation. In another study, bile acid content of 
52 
the.liver was increased by biliary diversion which increased 
sterol synthesis 2.5-fold (254). Increased sterol synthesis 
in rats with biliary diversion was prevented by the infusion 
of cholesterol in the form of,chylomicrons. Weis and 
Dietschy (254) suggested there was no relationship between 
tissue content of bile acid and hepatic cholesterol 
synthesis. However, when Shefer et al (255) administered 
bile acids at 1% of the diet, they found HMG CoA reductase 
activity was reduced. 
Higgins (256) stated HMG CoA reductase activity was 
regulated by at least two mechanisms: the concentration of 
enzyme protein determined by modulation of its synthetic 
rate, and a more direct modulation of specific activity. 
These mechanisms were affected by cells' environment. Rao 
and co-workers (257) demonstrated that the depressed 
activity of hepatic HMG CoA reductase in starved or 
cholesterol-fed rats was stimulated by administering small 
quantities of ATP. Edwards (258) noted that catecholamines 
had a stimulatory effect on HMG CoA reductase activity which 
did not involve elevated concentrations of cyclic AMP as an 
intermediary. 
Functioning adrenal glands and cortisol may be necessary 
for maximal activity of HMG CoA reductase. Konstantinos and 
colleagues (259) found that the diurnal rhythm was 
maintained for HMG CoA after adrenalectomy, but the 
amplitude of variation for the activity of the enzyme was 
greatly decreased. A single injection of cortisol 
administered to adrenalectomized rats 3 h before the 
expected maximum in enzyme activity resulted in a two-fold 
increase in enzyme activity. Other compounds including 
glucagon, dibutyryl cyclic AMP, actinomycin D and 
hydrocortisone suppress HMG CoA reductase activity in rats. 
Activity of HMG CoA reductase was stimulated by thyroid 
hormone given in vivo to hypothyroid animals (260). 
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Fletcher and Myant (261) investigated the synthesis of 
cholesterol after' destruction of the thyroid or injections 
of thyroxine. Thyroidectomy in guinea pigs depressed the 
rate of synthesis .of cholesterol. Thyroxine stimulated 
cholesterol synthesis at low concentrations and inhibited at 
high concentration. 
When normal or hypophysectomized rats fed a diet 
containing mevinolin and colestipol (a potent inhibitor of 
HMG CoA reductase and a bile acid sequesterant, respectively 
which act synergistically to stimulate the levels of 
reductase mRNA protein) were switched to a normal chow diet, 
HMG CoA reductase mRNA fell rapidly (262). In normal rats 
reductase activity and immunoreactive protein fell in 
parallel with the mRNA after·a 90 min lag period. In 
hypophysectomized rats, reductase activity and protein 
required 10 and 18 hrs respectively to fall to 50% of their 
original levels. · Administration of thyroid hormones to 
hypophysectomized rats resulted· in a stabilization of 
reductase mRNA suggesting that·the increased mRNA levels 
were due in part to a posttranscriptional -regulatory effect 
of thyroid hormones (262). 
Stimulation of reductase activity in hypophysectomized 
diabetic rats requires the mediation.of both insulin and L-
triiodothyronine (263). Neither hormone alone was 
effective. The rapid stimulation of reductase activity by 
insulin and the delayed stimulation elicited by 
Ltriiodothyronine are both inhibited by either glucagon or 
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hydrocortisone (263). Sample and Ness suggested that 
insulin acted by increasing the portion of HMG CoA reductase 
in its active free sulfhydryl form (264). 
In streptozotocin induced diabetic rats, the major site 
of cholesterol synthesis was shifted from the liver to the 
small intestine. After one week, total reductase activity 
in small intestine was two and one-half times normal, 
whereas activity in liver remained low (265). Chronic 
insulin therapy markedly stimulated hepatic HMG CoA 
reductase activity in diabetic rats but did not increase gut 
enzyme activity (266). 
' 
Low hepatic'HMG CoA reductase activity in alloxan 
diabetic rats was, restored to normal by insulin treatment 
(267). Lakshmanan et al (268) reported a two to seven-fold 
increase of HMG CoA reductase activity and conversion of 
acetate to cholesterol after subcutaneous administration of 
insulin in normal or streptozotocin-treated diabetic 
animals. However, reductase act'ivity was not changed when 
glucagon was administered in conjunction with insulin. 
Nepokroeff and co-workers (269) also reported stimulation of 
HMG CoA reductase activity to normal levels within two hours 
in streptozotocin-induced diabetic rats. 
Phosphorylation/Dephosphorylation Control of HMG CoA 
Beg and co-workers (270) in an in vitro experiment 
established that the reversible inactivation of HMG CoA 
reductase by ATPjmagnesium was due to a covalent 
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phosphorylation-dephosphorylation reaction. Beg and 
colleagues (271) subsequently presented evidence that 
hepatic HMG CoA reductase undergoes covalent phosphorylation 
in vivo as well as in vitro. Ingebritsen et al (272) found 
added insulin enhanced and glucagon depressed cholesterol 
synthesis. Because reductase is active in the 
dephosphorylated state, ~he data indicated insulin signals 
net dephosphorylation, while glucagon brings about net 
phosphorylation. 
Within 20 minutes of intravenous infusion of insulin 
into diabetic rats, HMG CoA reductase was totally 
dephosphorylated. Four hours of intravenous infusion of 
insulin into diabetic rats produced a five to six fold 
increase in total enzyme activity (273). Intraperitoneal 
injection of glucose (to raise serum insulin) into rats 
resulted in a transient (30 min) increase in the _activity of 
HMG CoA (261). Conversely,' intravenous injection of guinea 
pig anti-insulin serum,depressed HMG CoA activity within 20 
min. Intravenous injection of glucagon and adrenaline into 
normal rats did not affect the degree of phos~horylation of 
the _HMG -c_oA :reductase desp'ite an increase in hepatic cyclic 
AMP concentration induced by glucagon and adrenaline 
treatment. However, when insulin secretion was inhibited, 
either by the induction of .streptozotocin diabetes or by 
simultaneous infusion of somatostatin, glucagon treatment 
depressed the activity of HMG CoA reductase. Easom and 
Zammit (274) concluded that insulin had a dominant role in 
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regulating the phosphorylation state of hepatic HMG CoA 
reductase. 
Scallen and Sanghvi (275) proposed phosphorylation and 
dephosphorylation were involved in the control of three key 
enzymes of· cholesterol regulation. If cholesterol enters 
the liver cell, HMG CoA reductase would be inhibited by 
phosphorylation and biosynthesis of cholesterol would be 
reduced; however, reactions utilizing cholesterol would be 
activated due to the phosphorylation of acyl-CoA cholesterol 
acyltransferase (ACATase) and cholesterol 7 alpha-
hydroxylase providing an elegant short-term mechanism for 
the homeostatsis of intracellular unesterified cholesterol. 
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Some researchers do not agree that short-term 
physiological changes in HMG CoA reductase are by 
phosphorylation. Dugan and co-workers (276) and Kleinsek et 
al (277) performed immunotitrations of rat liver HMG CoA 
reductase. They concluded ~hat short-term physiological 
changes in HMG CoA reductase activity were created by a 
change in the quantity of enzyme due to conversion of enzyme 
to immunounreactive products and not by reversible 
phosphorylation of pre-existing enzyme. Kleinsek ahd co-
workers (277) also reached a similar conclusion using 
immunotitrations of microsomal HMG CoA reductase. 
Vitamin C Effects' on HMG CoA Reductase 
Activity of HMG CoA reductase was suppressed in human 
fibroblasts cultured in the presence of serum (278). Brown, 
Dana, and Goldstein {279) indicated that apolipoprotein B, 
which is a component of low density lipoproteins {LDL) and 
very low densitiy lipoproteins (VLDL) is specifically 
involved in the suppression of the enzyme by serum. Binding 
of low density lipop~oteins to membrane receptor sites of 
cultured fibroblasts resulted in the delivery of cholesterol 
to the cell in a form which decreased HMG CoA reductase 
activity. However, cultured cells from subjects with a 
homozygous form of familial hypercholesterolemia lacked the 
high affinity binding process and were resistant to 
suppression of HMG CoA reductase by low density lipoproteins 
(280). 
Ginter and Juvcovicova {2Sl) reported that chronic 
vitamin c deficiency lqwered fractional catabolic rate of 
low-density lipoproteins in guinea pigs, decreased 
production of LDL receptors on the surface of liver cells, 
and,prolonged half-life of plasma LDL. Based on these 
results, effects of vitamin C de~iciency on HMG CoA 
reductase might be secondary to effects of the deficiency on 
LDL or LDL receptors. 
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The a,cti ve ( dephosphorylated) form , of hepatic HMG CoA 
reductase was significantly reduced in guinea pigs fed 
inadequate or excessive dietary ascorbate (193). Greene and 
co-workers (282) found similar effects ~ith hepatic 
microsomal incubations using deficient, physiologic, and 
supraphysiologic concentrations of sodium ascorbate. Thus, 
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dietary extremes of vitamin C may depress reductase 
activity. 
Mineral Effects on HMG CoA Reductase 
Information about'mineral ef_fects on HMG CoA reductase 
and cholesterol synthesis is limited. Gebhard and co-
workers (2S3) reported increased activity of HMG CoA 
reductase in ileal mucosal homogenates in zinc-deficient 
rats. Curran (79) demonstrated that chromium enhanced the 
synthesis of cholesterol and of fatty acids in rat liver. 
cupo and Donaldson (80) reported that chromium (20 ugjq 
diet) increased 14c-acetate incorporation into liver fatty 
acids of chicks. Xi and co-workers (81) reported increased 
cholesterol in guinea pigs fed 4 ug Cr as CrCl3/g diet 
versus 2 ugjq. However, whether chromium affects the 
' ' ' 
activity of HMG CoA reductase has not been determined. 
In summary, the rate-limiting enzyme for cholesterol 
synthesis is 3-hydroxy-3-methylglutaryl coenzyme' A reductase 
(245,246). Catecholamines (25S), cortisol (259), thyroid 
(260) and insulin (267) increased HMG CoA reductase 
activity, whereas cholesterol infus.ion (254), glucagon 
(259), and hydrocortisone in the absence of insulin (259) 
depressed cholesterol synthesis. Chronic ascorbate 
deficiency lowered LDL receptor sites; high affinity binding 
of LDL to these sites is a mechanism whereby cholesterol 
decreased activity of HMG CoA reductase (281). Both 
ascorbic acid deficiency and excessive ascorbic acid 
depressed the enzyme's activity (193). Insulin appears to 
have a dominant role in the regulation of the 
phosphorylation state of HMG CoA reductase {274). Although 
chromium enhanced the synthesis of cholesterol in rat liver 
slices (79) and reduced circulating cholesterol in other 
studies (284), effects of chromium on the activity of HMG 
CoA reductase have not qeen reported. 
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CHAPTER III 
EFFECTS OF STARCH, SUCROSE', FRUCTOSE, AND GLUCOSE ON 
CHROMIUM ABSORPTION AND TISSUE CONCENTRATIONS IN OBESE AND 
LEAN MICE 
Carol D. Seaborn and Barbara J. Stoecker 
Shortened Title: 
CARBOHYDRATE EFFECTS ON CHROMIUM IN MICE 
ABSTRACT 
Forty-eight male genetically obese (OB) mice (C57BL/6J-
OB) and 48 lean male litter.mates were randomly assigned 
within main plots (OB or lean) to one of eight diets. Diets 
were low cr (-Cr) or supplemented with 1 mgjkg Cr as CrCl3 
(+Cr). Starch (ST), sucrose (S), fructose (F) or glucose 
(G) composed 50% of the diet which met AIN recommendations 
except for Cr. Experimental diets and deionized water were 
available ad libitum for 26 d. Mice were fasted 10 h and 
were intubated 2 h before sacrifice with 15 uci of 51crc13 
in a 25% carbohydrate solution (2 mg carbohydratejg body wt) 
of either starch, sucrose, glucose, or fructose 
corresponding to the diet previously fed. 51cr 




liver, spleen, epididymal fat pad, testes and femur of 
animals given their carbohydrate load as starch than in 
animals fed sucrose, fructose, or glucose. Carbohydrate had 
a significant effect on cr concentrations of testes, spleen, 
kidney and liver with values generally being higher with the 
starch diet. Cr supplementation increased bone and kidney 
Cr concentrations and heart and muscle glycogen. These data 
indicate that source of carbohydrate can alter Cr absorption 
and retention. 
KEY WORDS: Chromium, 51crc13 ,' chromium absorption, 
carbohydrate, obese mice 
Interactions between essential trace elements and dietary 
carbohydrates have not been investigated thoro~ghly despite 
the major contributions of .carbohydrate to the diet. Recent 
( 
Teports of carbohydrate effects on mineral absorption and 
metabolism have involved copper (1-7) and iron (8). Diets 
high in sucrose or fructose promoted deficiency of copper 
(2~4,7). However, iron retention was lower in iron-
deficient starch-fed rats. than in iron-deficient rats. fed 
simple sugars (8). 
Schroeder, Mitchener and Nason (9) noted a difference in 
the utilization of Cr with sucrose ve'rsus starch diets. 
Staub, Reussner and Thiessen (10) also reported that serum 
cholesterol was lower in rats fed starch than in those fed 
sucrose. Diets containing 60% glucose, fructose, or sucrose 
promoted more rapid induction of diabetes in the C57BL/KsJ-
db/db genetically diabetic mouse than a diet containing 60% 
dextrin (11). In human beings, diets high in simple sugars 
increased urinary Cr excretion (12). 
Decreased sensitivity of peripheral tissue to insulin was 
observed in chromium deficiency (13). Obese mice (C57BL/6J-
objob) and their lean littermates were used in the present 
study because obese mice exhibit insulin resistance (14) and 
a previous study has shown them to be sensitive to chromium 
depletion (15). 
The study was designed to determine if tissue 
concentration of Cr would be altered by the type of dietary 
carbohydrate fed and if 51cr absorption from 51crcl3 
differed when intubated concurrently with one of four 
sources of carbohydrate (starch, fructose, glucose, and 
sucrose). Effects of Cr depletion and of the obese gene on 
Cr absorption and metabolism also were tested. 
MATERIALS AND METHODS 
Animals and Diets 
Forty-eight male genetically obese (OB) mice (C57BL/6J-
OB) and forty-eight lean mice (Jackson Laboratories, Bar 
Harbor, ME) were obtained at 4-s'wks of age. They were 
housed in plastic cages with wood shavings as bedding. The 
wood shavings were analyzed and were found not to be a 
source of Cr. The diet, provided in ceramic cups, and 
deionized water, in glass or plastic bottles with glass 
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sipper tubes, were available ad libitum. For the first 2 
wks, animals were fed the American Institute of Nutrition 
(AIN) diet for mice and rats (16) modified to be low in Cr 
(.061 mgjkg). This basal diet contained 20% casein, 0.3% 
DL-methionine, 15% cornstarch, 50% sucrose, 5% celufil, 5% 
corn oil, 1% AIN 7?-A vitamin mix (17), 0.2% choline and 
3.5% AIN 76 mineral mix without .Cr (prepared in our 
laboratory). 
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After the adaptation period, a.nimals were randomly 
assigned within main plots (OB or lean) to one of eight 
experimental diets for 26 days. The 50% sucrose in the AIN 
diet was replaced by starch, fructose or glucose to form the 
following diet groups: starch, sucrose (AIN), fructose, or 
glucose. Each diet was formulated to have either a low Cr 
content (-Cr) or had 1 mgjkg of Cr as crc1 3 added (+Cr). 
The analyzed Cr content of the low Cr diets (in mgjkg) was 
starch (.071), sucrose (.061), fructose (.057), and glucose 
(.047). These dietary concentrations do deplete animals of 
Cr; however, ingredients and contamination are continuously 
monitored to produce lower Cr diets. 
Necropsy 
Prior to killing, animals were fasted for 10 h. Animals 
were intubated (0700-0900) with a 25% carbohydrate solution 
(2 mgjg body weight) of either starch, sucrose, fructose or 
glucose corresponding to the carbohydrate previously fed. 
Fifteen microcuries of 51crc13 (New England Nuclear, Boston, 
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MA) in 50 uL dilute HCl (pH 2.45) was mixed with the 
carbohydrate load for each mouse immediately preceding 
intubation. Two hours after the carbohydrate load, urine 
was collected and mice were anesthetized by soqium 
pentobarbital injection (1.5 mg for lean and 2.5 mg for 
obese) in 0.9% saline. Mice were exsanguinated by cardiac 
puncture using syringes containing 2 mg EDTA. Blood samples 
were held in ice, individually counted in a gamma counter, 
weighed and centrifuged. Plasma was frozen for subsequent 
analyses. Liver, heart, and muscle samples were solubilized 
in 30% KOH for glycogen analysis immediately after 
exsanguination. The remaining tissues were removed 
carefully to avoid Cr contamination and were either weighed 
into glass tubes for gamma counting or were individually 
- -
wrapped and frozen for Cr analysis. 
Analytical Methods 
Glycogen was assayed spectrophotometrically using 
anthrone reagent (0.2 g anthrone in 100 mL of 95% H2S04) 
(18). Plasma glucose was determined using the glucose 
oxidase'method with a gluc9se analyzer (Beckman Instruments, 
Inc., Fullerton, CA) (19). Plasma cholesterol 
concentrations were measured enzymatically (Method #352, 
Sigma Chemical Co., St. Louis, MO) (20). 
51cr in blood was counted immediately in a gamma counter. 
Other tissues were counted as soon as possible and corrected 
I I I I II 
for isotope decay. The total counts for each tissue are 
presented as a percent of the initial dose. 
For dietary Cr analysis, samples of diets (200-250 mg) 
were weighed into acid-washed_borosilicate glass tubes and 
dried for 24 h at 100°c. Samples then were ashed in a 
muffle furnace with no exposed metal heating elements 
(Lindberg, Watertown, WI) using a modification of the method 
of Hill and coworkers (21) with a dry ashing temperature of 
450°C. (The ashi~g temperature of 375°C as specified in the 
method now is being used in our laboratory.) After ashing, 
samples were diluted with lN HCl (G. Fredrick Smith, 
Columbus, OH) and analyzed at 357.9 nM using a Perkin Elmer 
Model 5000 atomic absorption spectrophotometer with graphite 
furnace and Zeeman background correction (Perkin Elmer 
Corp., Norwalk, CT). 
Glass knives were used to cut tissues and to clean the 
femur and tibia for Cr analysis. Drying and ashing 




The Statistical Analysis System (SAS) was used to 
evaluate treatment effects. Data were analyzed as a split 
plot design with obesity as the main effect and carbohydrate 
source and chromium supplementation as subplot factors. Log 
transformations were performed for statistical analyses when 
data were not normally distributed (noted in the tables). 
The generalized linear model (GLM) was used for analysis of 
variance and least squares means determination. 
RESULTS 
Lean mice weighed less than obese mice (Table 1). The 
liver and epididymal fat pad of obese mice were heavier than 
lean mice whereas spleen, testes, and femur of obese mice 
weighed less than lean mice. Obese and lean .mice did not 
differ in heart and kidney weight. ,Final body weight was 
not significantly affected (p>O.OS) by either carbohydrate 
type or Cr level. Spleen weight was higher in sucrose than 
starch, fructose, or glucose groups. Mice fed Cr 
supplemented diets had increased femur wet we~ght and 
percent water in the bone. Weights of other tissues were 
not affected by dietary carbohydrate or by Cr 
supplement~tion. 
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Muscle and cardiac glycogen were higher in Cr 
supplemented animals but were not. affected by carbohydrate 
or the presence of the obesity gene (Table 2). Hepatic 
glycogen increased with Cr supplementation (32 mgjg vs 25 
mgjg) in obese but not in l~an animals. An interaction of. 
genetics and carbohydrate source on hepatic moisture was 
detected. Hepatic water content was ~igher in lean than in 
obese mice; carbohydrate effects were noted only in lean 
mice. The only variable that significantly affected plasma 
glucose and cholesterol was obesity; these both were greater 
for obese than lean mice. 
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Two hours after the 51cr dose, more 51cr was found in 
blood of animals given their carbohydrate load as starch 
than as sucrose, fructose, or glucose (Table 3}. To 
calculate 51cr in blood, total blood supply of the mouse was 
estimated to be 7% of body weight. These values reflect a 
relatively high absorption of 51cr because absorption of Cr 
from CrCl3 usually is low. 
Obese animals fed starch had more 51cr in their livers 
than did lean mice; this differencecgenerally was 
proportional to the liver weights of the two types of 
animals. In the spleen and testes, radioactivity likewise 
! 
was higher in animals fed starch.than other carbohydrates 
, tested. However, total uptake by spleen and testes was very_ 
low. In the epididymal fat pad, obese animals had more 51cr 
than lean animals and differences due to dietary 
carbohydrates 'paralleled those in other tissues. More 51cr 
was found.in the femur of the groups fed starch compared to 
sucrose and fructose, but starch was not significantly 
higher than glucose. 
51cr in the kidney was highly variable and was not 
significantly affected by obesity or treatment.· An 
interaction between carbohydrate and obesity affected 51cr 
excretion in urine. Obese mice given a carbohydrate load of 
starch excreted significantly more 51cr in the urine than 
mice given loads of sucrose or fructose (Figure 1). Lean 
animals given fructose loads had more urinary 51cr than lean 
mice fed sucrose or glucose. Lean animals given a fructose 
load excreted more 51cr in urine than ·did obese animals. 
The obese gene affected Cr concentration in all tissues 
analyzed except kidney (Table 4). The Cr concentration in 
the testes, spleen, and bone of obese animals was 
significantly higher than lean animals despite the 
interaction noted between Cr and obesity in the spleen and 
bone (Figures 2 & 3). In con~rast, lean mice had more Cr 
per gram liver than did obese mice. 
Type of carbohyd~ate fed affected cr concentration in all 
tissues analyzed except bone. In the testes, starch and 
sucrose groups had higher cr levels than did fructose or 
glucose groups. In the kidney, starch-fed animals had 
higher Cr than sucrose and fructose.but not glucose-fed 
animals. In both spleen and liver, starch feeding 
significantly increased hepatic Cr concentration over 
glucose, fructose, or sucrose feeding. 
Supplementation with 1 mgjkg Cr significantly increased 
Cr concentration in the kidney and bone. In the spleen an 
interaction between Cr and obesity occurred. In obese 
animals Cr supplementation increased splenic Cr 
concentration (149 ngjg vs 113 ngjg) while in lean animals 
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Cr supplementation had no effect on Cr concentrations in the 
spleen (79 ngjg for both groups). 
DISCUSSION 
Differences in body and tissue weights due to gene were 
similar to results from a previous study (22). Although 
significant, the effect of carbohydrate on spleen weight was 
very small. The higher percent water in the bone of cr-fed 
mice suggests that the organic matrix may change with 
supplementation. Whether this difference reflects protein, 
collagen, or some other factor remains to be determined. 
Both obese and lean mice had higher muscle and cardiac 
glycogen with Cr supplementation which confirmed results 
reported by Mertz (23). Cr supplementation was a 
significant factor in increasing the hepatic glycogen of 
obese mice but not of lean mice in this study. Obese mice 
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have elevated circqlating in~ulin concentrations and insulin 
resistance (14). Because Cr potentiates the action of 
insulin (13), its effects on hepatic glycogen synthesis may 
be greater in obese than in lean mice. Hepatic moisture was 
higher in lean than obese mice which may reflect less lipid 
accumulation. Obese mice characteristically display 
elevated lipogenesis (14), and elevated ,hepatic lipid has 
' 
been observed in response to Cr depletion (15). 
Plasma glucose was not significantly affected by either 
Cr or carbohydrate. Gastric emptying pa~terns vary for 
different sugars (24). Because glucose was measured at a 
single time period, the high variability of the values 
reflects differences in absorption patterns of the 
carbohydrates as well as animal-to-animal variation. Plasma 
cholesterol was not affected by dietary variables but our 
26-day feeding period may have been too short to affect 
cholesterol. 
At 2 h, a load of 2 mgjg body weight of starch increased 
5lcr absorptionjretention c~mpared with loads of glucose, 
fructose and sucrose in all tissues analyzed except kidney. 
Previous data have shown very ~apid t~ansit of 51crcl3 
through the gastrointestinal tract (25) and ~apid peaks in 
51cr in the blood (26). While a longer tim~ period for Cr 
absorption and tissue equilibration might have proven 
revealing, some mice at 2 h already had detectable amounts 
of 51cr in their feces and a longer absorptive period would 
have created more potential for contamination of urine from 
51cr in the feces. 51cr in muscle was not counted but also 
would contribute to the total. 
The high 51cr absorption in our study may reflect the 
fasting state preceding the· 51crcl3 and lack of other 
dietary components in the gut to bind cr or to alter the 
acidity of the 51cr dose. Dosing the 51crc1 3 with the 
carbohydrate load may have stimulated absorption. There 
also may be species d,ifferences in absorption/retention of 
Cr. Absorption of 51cr in both rats and guinea pigs at 3 h 
was considerably lower (25,27) than observed in the present 
study. 
Feeding supplemental Cr for 26 days did not affect uptake 
of 51cr. Some other studies also have reported no effect of 
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Cr status on absorption of Cr (28). However, in guinea pigs 
which had been fed a Cr depletion diet for 22 weeks, 51cr 
was greater in blood and liver of the Cr depleted groups 
(27); and in a human study, urinary Cr excretion (and 
presumably absorption) was related to intake when Cr intake 
was low (29). 
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Chromium concentration after 26 days on the experimental 
diets was higher in the testes, spleen and bone and lower in 
the liver of obese mice compared to lean mice. In a 
previous study, obese and lean mice were fed diets 
containing 1 mgjkg Cr, no differences in tissue Cr 
concentrations were attributed to obesity (30); however, the 
levels of Cr reported were several-fold higher than in 
tissues we measured and differences in analytical techniques 
need evaluation. Tissue concentrations of zinc, copper, 
manganese and iron were reported to be lower in obese than 
in lean mice but tissue Cr was not analyzed (31). 
Cr supplementation significantly increased Cr in the 
kidney and in the bone in this study. Bone previously has 
been shown to reflect Cr supplementation (15). The effect 
of Cr, supplementation on Cr concentration of bone and spleen 
- ' ! ' 
was greater in obese than in lean mice. A similar trend was 
observed in the kidney.. Hepatic Cr was not increased with 
Cr supplementation which indicates that the liver is not a 
major storage site for cr. Data from studies using 51cr 
also show more accumulation of the isotope in kidney and 
bone than in other tissues (32,33) 
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Cr concentrations generally were higher in tissues from 
animals consuming the starch diet than in tissues from those 
consuming diets containing simple carbohydrates; differences 
parallel data from the 2 h 51crcl3 dose. The starch diet 
was slightly higher in Cr than the other diets, but the sub 
plot means for tissue Cr concentration for the starch group 
appeared higher than the subplo't means for Cr 
supplementation; hence, these differences should not have 
been created by small variations in the cr concentrations in 
the unsupplemented diets. 
A diet containing starch should slow digestion or the 
passage of intestinal contents through the gut compared with 
diets containing more simple sugars. Initially the starch 
would exert less osmotic potential and draw less water into 
the intestine. Presumably Cr travels,very rapidly through 
the gastrointestinal tract, possibly with water (25). If 
this hypothesis is correct, dietary components which would 
increase water entry into the intestine might decrease cr 
absorption. Conversely, components which slow passage 
through the gut may increase cr absorption. 
In diabetic mice, a much higher mortality rate was 
observed with diets containing fructose or sucrose than with 
dextrin diets (11). Rats made diabetic with streptozotocin 
and fed sucrose containing diets also showed more severe 
signs of the disease than rats fed starch (34). Differences 
in Cr action have been noted in rats fed sucrose and starch 
diets (9), and urinary Cr losses in humans are stimulated by 
II 
diets high in simple sugars (12). Data from our study 
indicate clearly that consumption of starch enhances 
absorption and retention of Cr in several tissues. 
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In conclusion, a carbohydrate load of starch facilitated 
51cr uptake compared with carbohydrate loads of sucrose, 
fructose or glucose. Similarly, starch-fed animals had 
higher tissue Cr than did fructose, glucose, or sucrose-fed 
animals. Thus, type of dietary carbohydrate affects Cr 
absorption and retention. Effects of consumption of dietary 
carbohydrates on Cr status of humans and research animals 
warrants further ~nvestigation. 
ACKNOWLEDGMENTS 
The authors wish to thank Y. c. Li, H. C. Lin, and X. X. 
Xu for valuable technical assistance. 
LITERATURE CITED 
1. FIELDS, M., FERRETTI, R.J., SMITH, J.C., JR.& REISER, S. 
(1983) Effect of copper deficiency on metabolism and 
mortality in rats fed sucrose or starch diets. J.Nutr. 
113: 1335-1345. . 
2. REISER, S., FERRETTI, R.J., FIELDS, M.& SMITH, J.C.JR. 
(1983) Role of dietary fructose in the enhancement of 
mortality and biochemical changes associated with copper 
deficiency in rats. Am.J.Clin.Nutr. 38: 214-222. 
3. FIELDS, M., FERRETTI, R.J., REISER, S.& SMITH, J.C., JR. 
(1984) The severity of copper"deficiency in rats is 
determined by the type of dietary carbohydrate. Proceedings 
of the Society for Experimental Biology and Medicine 175: 
530-537. 
4. FIELDS, M., FERRETTI, R.J., .SMITH, J.C., JR.& REISER, S. 
(1984) The interaction of type of dietary carbohydrates 
with copper deficiency: Am.J.Clin.Nutr. 39: 289-295. 
5. FIELDS, M. , FERRETTI, R. J. ,' SMITH, J. C. , JR. & REISER, S. 
(1984) Effect of dietary carbohydrates and copper status on 
blood pressure of rats. Life Sci. 34: 763-769. 
6. FIELDS, M., HOLBROOK, J.,.SCHOLFIELD, D., ROSE, A., 
SMITH, J.C.& REISER, S. (1986) Development of copper 
deficiency in rats fed fructose or starch: weekly 
measurements of copper indices in blood. 
Proc.Soc.Exper.Biol.Med. 181: 120-124. 
7. FIELDS, M., CRAFT, N.~ LEWIS, C., HOLBROOK, J., ROSE, 
A., REISER, S.& SMITH, J.C. (1986) Contrasting effects of 
the stomach and small intestine of rats on copper 
absorption. J. Nutr. 116: 2219-2228. 
8. JOHNSON, M.A.& GRATZEK, J.M~ (1986) Influence of 
sucrose and starch on the develoment of anemia in copper-
and iron-deficient rats. J.Nutr. 116: 2443-2452. 
9. SCHROEDER, H.A., MITCHENER, M.& NASON, A.P. (1971) 
Influence of various sugars, chromium, and other trace 
metals on serum cholesterol and glucose of rats. J.Nutr. 
101 =- 24 7-258. 
75 
10. STAUB, H.W., REUSSNER, G.& THIESSEN, R., JR. (1969) 
Serum cholesterol reduction by chromium in 
hypercholesterolemic rats. Science 166: 746-747. 
11. LEITER, E.H., COLEMAN, D.L., INGRAM, O.K.& REYNOLDS, 
M.A. (1983) Influence of dietary carbohydrate on the 
induction of diabetes in C57BL/KsJ-dbjdb diabetes mice. 
J.Nutr. 113: 184-195. 
12. KOZLOVSKY, A.S., MOSER, P.B., REISER, S.& ANDERSON, R.A. 
(1986) Effects of diets high in simple sugars on urinary 
chromium losses. Metabolism 35: 515-18. 
13. MERTZ, W., TOEPFER, E.W., ,ROGINSKI, E.E.& POLANSKY, M.M. 
(1974) Present knowledge of the role of chromium. 
Fed.Proc. 33: 2275-2280. 
14. COLEMAN, D.L. (1982) Diabetes-obesity syndromes in 
mice. Diabetes 31 (Suppl. 1): 1-6. 
15. LI, Y.-C.& STOECKER, B.J. (1986) Chromium and yogurt 
effects on hepatic lipid and plasma glucose and insulin of 
obese mice. Biological Trace Element Research 9: 233-242. 
16. AMERICAN INSTITUTE OF NUTRITION. (1977) Report of the 
American Institute of Nutrition Ad Hoc Committee on 
standards for nutritional stud,ies. J.Nutr. 107: 1340-1348. 
17. AMERICAN INSTITUTE OF NUTRITION. (1980) Second report 
of the Ad Hoc Committee on Standards for Nutritional 
Studies. J.Nutr. 110: 1726. 
18. SEIFTER, S., DAYTON, S., NOVIC, B.& MUNTWYLER, E. (1950) 
The estimation of glycogen with the anthrone reagent. 
Arch.Biochem. 25: 191-200. 
76 
19. KADISH, A.H., LITLE, R.L.& STERNBERG, J.C. (1968) A new 
and rapid method for the determination of glucose by 
measurement of rate of oxygen consumption. Clinical 
Chemistry 14: 116-131. 
20. ALLAIN, C.C., POON, L.S., CHAN, C.S.G.,' RICHMOND, W.& 
FU, P.C. (1974) Enzymatic determination of total serum 
cholesterol. Clin.Chem. 20: 470-475. 
21. HILL, A.D., PATTERSON, K.Y., VEILLON, C.& MORRIS, E.R. 
{1986) Digestion of biological materials for mineral 
analyses using a combination of wet and dry ashing. 
Anal.Chem. 58: 2340-2342. 
22. STOECKER, B.J., LI, Y.-C., WESTER, D.B.& CHAN, S.-B. 
(1987) Effects of torula and brewer's yeast diets in obese 
and lean mice. Biol.Trace Elem.Res. 14: 249-254. 
23. MERTZ, w. (1969) Chromium.occurrence and function in 
biological systems. Physiol.Rev. 49: 163-239. 
24. MORAN, T.H.& MCHUGH, P.R. (1981) Distinctions among 
three sugars in their effects on gastric emptying and 
satiety. Am.Physl.Soc. R25-30. 
25. OBERLEAS, D., LI, Y.C.& STOECKER, B.J. (1987) 
Intestinal transit of 51-Cr in the rat. Fed.Proc. 64: 904. 
26. HOPKINS, L.L., JR.& SCHWARZ, K. (1964) Chromium (III) 
binding to serum proteins, specifically siderophilin. 
Biochim.Biophys.Acta 90: 484-491. 
27. STOECKER, B.J., SEABORN, C.D., LIN, H.C., XU, X.X.& LI, 
Y.C. (1988) ·Effects of chromium and ascorbate depletion on 
51chromium absorption and urinary excretion in guinea pigs. 
FASEB J. 2: A840. (abs.) 
28. HOPKINS, L.L., JR. (1965) Distibution in the rat of 
physiological amounts of injected Cr-51(111) with time. 
Am.J.Physiol. 209: 731-735. 
77 
29. ANDERSON, R.A.& KOZLOVSKY, A.S. (1985) Chromium intake, 
absorption and excretion of subjects consuming self-selected 
diets. Am.J.Clin.Nutr. 41: 1177-1183. 
30. BERGGREN, P.& FLATT, P.R. (1985) Effects of trivalent 
chromium administration on endogenous chromium stores in 
lean and obese hyperglycaemic mice. Nutr.Reports Int. 31: 
213-218. 
31. KENNEDY, M.L., FAILLA,. M.L.& SMITH, J.C., JR. {1986) 
Influence of genetic obesity on tissue concentrations of 
zinc, copper, manganese and iron in mice. J.Nutr. 116: 
1432-1441. 
32. KRASZESKI, J.L., WALLACH, S.& VERCH, R.L. (1979) Effect 
of insulin on radiochromium distribution in diabetic rats. 
Endocrinology 104: 881-885. 
33. JAIN 1 R., VERCH,· R. L . .t ·WALLACH, S. & PEABODY, R.A. ( 1981) 
Tissue chromium exchange in the rat;'Am.J.Clin.Nutr. 34: 
2199-2204. 
34. HALLFRISCH, J., LAZAR, F.L.&' RESlER, S. (1979) Effect 
of feeding sucrose or starch to rats made diabetic with 
streptozotocin. J.Nutr. 109: 1909-1915. 
TABLE 1 
Body and tissue weights of obese and Jean mice fed four carbohydrates with or without added chromium {Cr}1•2 
Eptdtdymal Femur Femur 
Body wt Ltver fat pad Spleen Testes Heart K1dney wet wt mOisture 
g g g g g g g g % 
Mam plot means 
08 44 6 :!: 0 SA 3 09 :+- 0 Q6A 2 88 :!: 0 Q5A Q 046 :!: Q 0028 0 176 :!: 0 0048 0 155 :!: 0 004 0 33 :!: 0 01 0 053 :!: 0 OQ2B 30 4:!: 1 0 
Lean 30 4 :!: 0 58 1 24 :!: 0 068 0 57 :!: 0 QSB 0 062 :!: 0 OQ2A 0 197 :!: 0 OQ4A 0 158 ::t 0 004 0 34 ::t O.Dl 0075 :±: 00Q2A 32 6:!: 1 0 
Subplot means 
Starch 37 3 :!: 0 7 2 13 :!: 0 09 1.80 ± 0 07 0 052 ± 0 003b 0 186 ± 0.005 0149 ± 0006 032 ± 001 0 065 ± 0 003 32 3 ± 1 3 
Sucrose 38 2 ± 0.7 -2 30 ± 0.09 1 70 ± 0 07 0 063 ± 0.003• 0 188 :!: 0 005 0 160 :!: 0 006 0 34 ± 0 01 0 067 ± 0 003 32 7 ± 1 3 
Fructose 36 3 ± 0 7 210±009 1.62 :!: 0 07 0 050 ± 0 003b 0 179 ± 0 005 0.156 :!: 0 006 0 34 :!: 0 01 0063 ± 0003 30 6 ± l 3 
Glucose 38 1 ± 0 6 2 14 ± 0 08 1 79 ± 0 07 0 054 :!: 0 002b 0 192 ± 0 004 0161 ± 0006 034 ± 001 0.062 ± 0 002 30.5 :!: 1 2 
-Cr 37.4 ± 05 217±006 1 72 ± 0 OS 0 OS5 '± 0 002 0187 ± 0003 0 160 :!: 0 004 0 33 :!: 0 01 0.061 ± 0 0Q2Y 29 5 ± 0 9Y 
+Cr 37.6 :!: 0 5 2 16 ± 0 06 1.73 ± .0.05 0 054 ± 0 002 0 186 ± 0 003 0.153 ± 0.004 0 34 ± 0 Q1 o 067 :±: o ooz· 33 6 ± 1 ox 
Source of vanat10n P-values 
GENE <0 0001 < 0 0001 < 00001 < 0001 < 0.0005 067 044 < 0 0001 0 45 
CHO 0 13 0.32 023 < 0.005 028 0 40 020 048 048 
Cr 080 0 97 092 0 79 0 77 020 006 < 0007 < 0002 
CHO x Cr 092 010 0 so 010 0 85 0.14 0 91 0 83 0 61 
GENE x Cr 0 87 0 31 0 15 < 005 0 76 093 0.55 094 049 
CHO x GENE 077 010 040 037 0.72 0 75 0 79 0.99 032 
CHO x GENE 
x Cr 090 034 0 88 011 0 78 0.69 0.90 0.44 0 53 
1Values are least squares means ± SEM (GENE, n = 40-48; CHO, n = 20-24; Cr, n = 40-48). 
2Wtthm mam plot or subplot means, means not shanng a common superscnpt letter are stgmftcantly dtfferent (P < 0.05) Stgmftcant 
mteractwns requinng further mterpretatton are discussed m the text. 










Source of variation · 
TABLE 2 
Tissue glycogen, hepatic moisture and plasma glucose and cholesterol of obese 
and lean mice fed four carbohydrates with or without added chromium {Cr}1•2 
Muscle Cardiac Hepatic Hepatic 
glycogen glycogen glycogen mmsture 
mglg mglg mglg % 
2 11 ± 0.19 1.60 ± 0.11 28.4 ± 1 9A 48.7 ± 0.48 
2.11 ± 0.19 1.21 ± 0.11 19.5 ± 1.98 62.2 ± 0 4A 
1 98 ± 0.27 1.52 ± 0.15 25.2 ± 2.6 55.8 ± 0.6 
2 18 ± 0.26 1.32 ± 0.14 22.6 ± 2.6 55.7 ± 0.6 
. 1.97 ± 0.26 ].34 ± 0.14 22.9 ± 2.6 55.9 ± 0.6 
'2.31 ± 0.24 1.44 ± 0.13_ - 25.1 ± 2.4 54.2 ± 0.5. 
} 83 ± 0 18Y 1.26 ±" O.lOY 23.0 ± L8 55.0 ± 0.4 





264 ± 14A 
210 ± llB 
258 ± 22 
251 ± 16 
206 ± 16 
234 ± 14 
2A2 ± 13 
231 ± 11 
GENE 0.99 0.10 < 0.0003 < 0.0001 < 0002 
CHO 0,73 0.70 0.82 0.08 0.14 
Cr < 0.03 < 0.04 0.45 0.15 054 
CHO x Cr 0.36 0.72 049 039 0 47 
GENE x Cr 0.62 0.51 < 0.05 0.74 0.51 
CHO x GENE 0.43 0.61 0.85 < 0.05 0.10 
CHO x GENE x Cr 0.32 0.79 0.79 0.83 0.07 




262 ± lQA 
122 ± 98 
211 ± 14 
202 ± 14 
173 ± 14 
185 ± 13 
197 ± 9 
189 ± 10 







2Withm main plot or subplot means, means not sharing a common superscript letter are stgmficantly dtfferent IP < 0.05) Stgmftcant 
interactions requuing further mterpretatwn are discussed in the text. 
3Animals were gtven a carbohydrate load (2 mg/g body wtl 2 h before ktlling. 














CHO x Cr 
GENE x Cr 
CHO x GENE 
CHO x GENE x Cr 
TABLE 3 
51 Chromium (CrJ in tissues and urine of obese and lean mice 2 h after intubation with 
specified carbohydrate { 2 mglg body wt} and 51 CrCl1 1 •2 
Epididymal. 
Blood Liver Spleen Testes fat pad3 Kidney Unne 
%of dose 
23:t023 0 46 :t 0 04" 0.014 :t 0 003 0 021 :t 0 001 0.153 ::!:: 0 047A 0 29 :t 0 04 0 61 ::!:: 0 09 
1 4 :t 0 24 0 22 :t 0 048 0019 :t 0003 0 025 :t 0 001 0 034 :t 0 0478 0 14 :t 0 04 0 74 :t 0 lO 
2 8 :t 0 33•. o 49 :t o o5• 0.028 :t. 0 004• 0.032 :t 0 002• 0 232 :t 0.064• 0 27 :t 0 06 0 99 :t 0 12 
14:t031b 0 28 ~ 0 OSb 0 013 :t 0.004b 0 018 :t 0 002< 0 045 ::!:: 0 064b 0 21 :t 0 06 0 38 :t 0 13 
16±031b 0 27 :t 0 05b 0012::!:: 0004b 0 019 ::!:: 0 002bc 0040 ±0 064b 0 18 :t 0 06 0 70 ::!:: 0 12 
1 8 :t 0 JOb 0 32 :t 0 OSb 0 012 ::!:: 0 004b 0 024 :t 0 0()2b 0 058 ::!:: 0.059b 0 20::!:: 0 06 063±012 
1 8 ::!:: 0 22 o 33 :t n o4 0 018 ::!:: 0 003 0 023 ::!:: 0 001 0 128 ::!:: 0 044 022±004 0 73 ::!:: 0 09 
20:t023 0 36 ::!:: 0 04 O.Dl5 ::!:: 0 003 0 024 ::!:: 0 001 0059 ::!:: 0 046 0 21 :t 0 04 0 62 :t 0 09 
P-values 
010 < 005 039 0 18 < 0004 0 21 048 
< 0007 < 002 < 003 < 0 0001 < 0 0001 0 69. <. 0 007 
0 61 0 55 035 0 58 0 55 0 89 033 
032 0 25 047 035 0 20 0 32 080 
010 0 1R 0 20 008 032 0.73 010 
0 49 043 0 13 007 0 19 038 < 003 
0 48 0 26 0 70 0 48 0.07 023 0 29 
•values are least squares means ± SEM (GENE, n = 40-48; CHO, n = 20-24; Cr, n = 40-48). 
Femur 
0 49 :t 0 07 
0 40 :t 0 07 
0 67 :t 0 09• 
0.32 :t 0 09b 
0 36 :t 0 09h 
0 44 :t 0 09•h 
0 49 ::!:: 0 06 








2Withm main plot or subplot means, means not shanng a common superscnpt letter are sigmficantly different (P < 0.05). Sigmhcant 
mteracuons reqmnng further mterpretauon are discussed m the text. 




~ Tissue chromium concentration (nglg dry wt} of obese and lean mice 
fed four carbohydrates for 26 d with or without added chromium {Cr}1 •2 
Testes Kidney Spleen Liver Bone3 
Mam plot means 
OB 74 :±:: 6A 78 ± 6 135 ± SA 27 :±:: JB 42 :±:: JA 
Lean 54± 68 77 ± 6 78 ± 88 55 :±:: JA 25 ± 38 
Subplot means 
Starch 77 ± ga 95 ± 7a 132 ± ua 53 ± sa 38 ± 4 
Sucrose 76 ± 8a 58 :!::: 8c 103 ± 10b 33 ± 5b 26 ± 4 
Fructose 52 ± Sb 68 :!::: 8bc 92 ± 10b 40 ± 4b 38 ± 4 
Glucose 52 ± 7b 83 ± 7ab 101 ± 10b 37 :!::: 4b 33 ±.4 
-Cr 62 ± 6 63 ± 5Y 98 ± 7 44 ± 3 25 ± JY 
+Cr 66 ± 6 89 ± 5X 116 ± 8 37 ± 3 42 ± 3" 
Source of vanauon P-vah.ies 
GENE < 003 0.74 < 0.02 < 0001 < 0.0001 
CHO < 0.03 < 0.005 < 0.05 < 002 0.12 
Cr 0.57 < 00005 0.07 o:l2 < 0 0001 
CHO x Cr 0.64 0.10 0.80 0 12 0.10 
GENE x Cr 098 0.06 < 0.05 0 78 < 0.05 
CHO x GENE 0.28 0.06 0.59 .043 0.40 
CHO x GENE x Cr 0.85 0.27 0.42 0.84 0.58 
1Values are least squares means ± SEM (GENE, n = 40-48; CHO, n = 20-24; Cr, n = 40-48). 
2Wtthm main plot or subplot means, means not shanng a common superscnpt letter are s1gmhcantly dtfferent (P < 0.05). Stgmftcant 
mteracttons requinng further mterpretauon are discussed m the text 
3 Femur plus ttbta. 
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Legends for Figures 
FIG. 1. Urinary 51cr excretion of lean and obese mice fed 
starch (open bars), sucrose (vertially hatched bars), 
fructose (diagonally hatched bars), or glucose (horizontally 
hatched bars) . 
FIG. 2. Splenic chromium of mice not supplemented (open 
bars) or supplemented (hatched bars) with chromium. 
FIG. 3. Bone chromium of mice not supplemented (open bars) 
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CHAPTER IV 
EFFECTS PF ANTACID OR ASCORBIC ACID ON TISSUE ACCUMULATION 
AND EXCRETION OF 51cHROMIUM 
carol D. Seaborn, M.S. and Barbara J. Stoecker, Ph.D. 
Department of ,Food, Nutrition and Institution Administration 
Oklahoma State University 
Stillwater, .Oklahoma 74078 
ABSTRACT 
Absorption of trivalent chromium is low. Unbound chromium 
can form insoluble complexes in the gastrointestinal tract. 
In this study, effects of a calcium-based antacid, ascorbic 
acid or water on 51chromium from chromium chloride were 
investigated. Rats were dosed with 1 mL of test substance 
(containing 150 mg calcium carbonate or 10 mg ascorbic acid) 
or 1 mL water. Twenty-four hours after dosing, 51chromium 
in cumulative urine was lower (p<0.02) in the group dosed 
with calcium carbonate than in the groups dosed with 
ascorbic acid or water. Accumulation of 51chromium in the 
kidney, testes, and spleen was lower (p<0.05) in rats dosed 
with antacid than in those dosed with ascorbic acid or 
water. These data confirm that absorption of chromium 
86 
chloride is low and suggest that antacids have a negative 
effect on chromium absorption from chromium chloride. 
Key Words: Chromium, chromium chloride, antacid, ascorbic 
acid, calcium carbonate, 51cr 
INTRODUCTION 
Adequate trace mineral intakes cannot be assumed for 
all population subgroups. Recent estimates of chromium 
intakes in the United States were quite low with group means 
of 25-89 ugjday (1-4). Thus, many persons consume less than 
the current estimated safe and adequate intake of 50-200 ug 
chromium per day (5). 
The elderly may be particularly at risk for adverse 
drug-nutrient interactions because of their chronic use of 
medications (6,7). In 1983 Americans spent 600 million 
dollars on antacids; sales of drugs for digestive diseases 
were increasing at a 10% rate (8). Gastrointestinal,tract 
symptoms such as pain, flat~lence and belching, as well as 
the gastric side effects of drugs including corticosteroids 
and aspirin, may promote antacid abuse in the elderly. In 
addition to use of antacids for gastrointestinal tract 
symptoms, an increasing number of women have responded to 
recommendations for increased calcium intakes (9) by taking 
calcium-based antacids. 
Interactions of antacids and minerals have not been 
investigated thoroughly. Freeman and Ivy reported that 
87 
calcium carbonate and aluminum hydroxide reduced the 
retention of iron from iron sulfate fed to anemic rats (10). 
Magnesium trisilicate (35 g) given to iron deficient 
patients along with 5 mg of radiolabeled iron diminished 
iron retention in mildly iron deficient subjects (11). In 
normal, iron-replete subjects', 15 mL of either aluminum 
hydroxide, magnesium hydroxide, or magnesium carbonate-
aluminum hydroxide antacid also reduced iron absorption from 
iron sulfate as measured by serum ~ron concentrations (12). 
Copper status also may be affected by antacids. A patient 
with decreased gastric emptying time who received a normal 
diet supplemented with antacids developed a severe copper 
deficiency (13). 
Chromium can form insoluble complexes under alkaline 
conditions (14), raising the question of the impact of 
antacid use on chromium absorption. Several reports suggest 
that less than 2% of dietary chromium is absorbed (1,14,15), 
but information on drug-chromium interactions is not 
available. Because antacids are used widely by the elderly, 
their side effects on chromium stat~s must,be considered. 
Several nutrient interactions 'affect trace mineral 
absorption. Although iron absorption is enhanced by 
ascorbic acid (16), effects of ascorbic acid on chromium 
absorption need investigation. 
The measurement of chromium status in human beings is 
difficult; circulating chromium may not be in equilibrium 
with tissues store and its low concentrations require 
88 
sophisticated instruments for measurement (17,18). More 
sensitive evaluation of drug-nutrient interactions is 
possible through use of an isotope of chromium in an animal 
model. Thus, our study was designed to evaluate effects of 
an antacid, ascorbic acid or water on 51chromium absorption 
by rats. 
MATERIALS AND METHODS 
Twenty-seven male Sprague Dawley rats wi~h a mean 
weight of 354 g were assigned randomly to three treatment 
groups. They were fasted 12 hr and intubated with 1 mL of a 
suspension of calcium carbonate (150 mg), 1 mL of a 55 mM 
solution of ascorbic acid (10 mg), or 1 mL of distilled 
"Water. The pH of the.distill~d water, antacid, and ascorbic 
acid was 7.21, 8.21, and 2.88 respectively. Immediately 
after intubation, animals were dosed with 50 uL of 
51chromium chloride (20 uCi) in dilute hydrochloric acid 
(pH=1.89) by micropipette and placed in individual metabolic 
cages. Rats had access to water for the entire collection 
period and to a standard pelleted laboratory animal· diet 
' ' 
after 6 hrs. 
Three and six hours after intubation of the test 
substance and dosing with 51chromium chloride, blood samples 
were collected from the tail and the accumulated urine 
samples were removed from the metabolic cages. Urine was 
collected to avoid contamination with feces. At 24 hr, rats 
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were anesthetized with ether, exsanguinated by cardiac 
puncture, and tissues were collected. 
51chromium in each tissue and in total urine was 
expressed as percent of the 51chromium dose. Total 
51chromium in blood was estimated assuming that blood was 
equal to 7% of body weight. The Statistical Analysis System 
(SAS) was used for analysis of variance and calculation of 
least squares means (20). 
RESULTS 
A time by treatment interaction affected 51chromium in 
blood. Blood collected at 3 hr from rats intubated with 
antacid contained- less 5lchromium than following ascorbic 
acid or water dosage (Figure 1). At 24 hr the groups were 
not different (p>0.05) from each other. 
In total kidney, testes-and spleen obtained 24 hr post 
dosing less (p<0.05) 51ch~omium was present in rats dosed 
with antacid compared with rats dosed with ascorbic acid or 
water (Table 1). In total liver, dosing with antacid tended 
to reduce (p=0.06) 51chromium compared to dosing with 
ascorbic acid or water. 
In the cumulative 24 hr urine collection, excretion of 
5lchromium of rats intubated with ascorbic acid was higher 




Twenty-four hours after dosing, total recovery of 
51chromium in urine plus in the tissues sampled accounted 
for only 0.13% for the group dosed with antacid, 0.20% for 
the group dosed with water, and 0.42% for the group dosed 
with ascorbic acid. Although these figures do not represent 
total chromium absorption, they do'confirm that absorption 
of ingested chromium chloride is low and suggest that drugs 
may affect chromium uptake. In a study of iron absorption 
in humans, hydroxide-containing antacids did not decrease 
iron absorption; but two carbonates, sodium bicarbonate and 
calcium carbonate, reduced iron absorption (19). Although 
the hydroxide-containing antacid had greater acid-
neutralizing capacity .than d~ses of sodium bicarbonate or 
calcium carbonate; its effect on iron absorption was less 
(19). The carbonates·may form insoluble complexes with 
soluble minerals in the gut. The effects of calcium 
carbonate on chromium .may be similar depending not only upon 
pH but also upon formation of insoluble complexes and 
competition for absorption. 
Compared with water or calcium carbonate, ascorbic acid 
increased cumulative urinary 51chromium excretion at 24 hr 
after dosing. In blood at 3 hr, 51chromium was higher 
(p<0.05) in rats dosed with either ascorbic acid or water 
than with calcium carbonate. 51chromium content of tissues 
was not increased by dosing with ascorbic acid compared to 
91 
water. However, dosing with antacid markedly reduced 
51chromium content in tlssues compared to rats dosed with 
ascorbic acid or water. 
On a'body weight basis, the doses of ascorbic acid and 
antacid fed to the rats were 28 and 424 mgjkg. These dose 
levels were selected to investigate acute effects of the 
compounds on chromium absorp~ion. At the dosage used, 
calcium carbonate reduced 51chromium in blood at 3 hr, 
spleen, kidney, testes, and urine of rats intubated with 
antacid compared with those intubated with ascorbic acid or 
water. Further studies are needed to,investigate chronic 
effects of moderate antacid or ascorbic acid use on chromium 
retention and excretion. 
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Legend for Figure 
FIG 1. 51chrg~ium in blood of rats at 3 hr and 24 hr after 
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51 chromium in liver, kidney, testes, spleen and cumulative urine of rats 24 hr 


















Analysis of Variance 
P values 0 .. 06 <0.04 <0.05 <0.003 
~ Means are least squares· means ± SEM (Water, n=7-8; antacid, n=8, ascorbic acid, n=10). 









EFFECTS OF ASCORBIC ACID DEPLETION AND CHROMIUM STATUS ON 
RETENTION AND EXCRETION OF 51CHROMIUM 
C. Seaborn and B. Stoecker 
Oklahoma State University, stillwater, OK 74078 
Ascorbic acid affects the absdrption and retention of 
several minerals. Increased iron absorption from 
Fe(III)EDTA {2602} and decr~ased hepatic copper {2300} have 
been reported with dietary ascorbate supplementation. 
Likewise decreased uptake of selenium {2604} and nickel 
{2603} were observed with concurrent doses of ascorbate. 
Less than 2% of dietary inorganic chromium is absorbed 
{1054}. Chromium absorption may be impaired in chronic 
vitamin c deficiency. In scorbutic guinea pigs the total 
acidity of gastric juice was decreased {2411} which could 
reduce chromium ~bsorption if elation and precipitation 
occurred in the more alkaline environment {1841}. 
The effects of chromium status on chromium absorption 
and excretion have not been clarified {999}. Chromium 
absorption (estimated by urinary excretion) was inversely 
98 
related to dietary intake in human subjects {1141}. Hopkins 
and Schwarz {998} concluded that the amount of chromium 
absorbed from an oral dose of 51crc1 3 was independent of 
chromium status of the rat. 
99 
Ascorbic acid deficiency affected the d,igesti ve and 
absorptive functions of the intestinal epithelium of guinea 
pigs {2601}. The intestinal uptake of glucose was augmented 
and the uptake of amino ·acids was appreciably impaired in 
chronic ascorbic acid deficiency {42}~ A rapid uptake of 
glucose could also.affect chromium retention. Glucose 
loading resulted in increased urinary excretion of chromium 
in human subjects not receiving chromium supplements {93}. 
Hypoinsulinism and hyperglycemia have been observed in 
guinea pigs with ascorbate deficiency {2231}. Mertz 
proposed that chromium potentiates the action of insulin 
{135}. Insulin administration resulted in increased tissue 
retention of 51chromium from 51crc13 in diabetic rats {298}. 
Insulin deficiency and hyperglycemia impaired the uptake of 
ascorbic acid into cells {2206}. Diabetic subjects had 
lower blood vitamin C values than healthy subjects {183} and 
lower hepatic chrc::>mium { 66} ... Because of the reported 
derangement of glucose absorption and insulin in ascorbate 
deficient guinea pigs and of the debated role of previous 
dietary intake of chromium on chromium retention, we 
investigated the effects of chromium depletion andjor 
chronic ascorbic acid deficiency on tissue accumulation and 
urinary excretion of 51cr from a dose of 51crc13 followed by 
a glucose load. 
Weanling male Hartley guinea pigs were randomly assigned 
to chromium andjor ascorbate depletion groups in a 2 x 2 
factorial design. Animals were deprived to 0.5 mg 
ascorbate/day (-C) or supplemented with 10 mgjday (+C). 
Diets contained .2' ugjg Cr (-Cr) or were supplemented with 2 
ugjg chromium as CrCl3 (+Cr) and were fed for 24 weeks. 
100 
At the end of the experiment, the guinea pigs were 
fasted overnight. Three hours before necropsy, animals were 
dosed with 100 ul (80 uCi) of 51crcl3. One and one-half 
hours before necropsy a glucose load (50% solution) of 1 
gjkg body weight was fed., Samples of blood, urine, liver, 
spleen and kidney were counted in a gamma counter. Total 
blood was estimated as 7% of body weight. 
Means of tissue ascorbate in spleen, adrenal and liver 
of -c animals were 0.17, 0.38, and 0.15 mgjg respectively; 
means of +C animals were 0.'51, 1.35, and 0.24 mgjg, 
respectively. With ascorbate depletion urinary excretion of 
51cr was higher (p<0.02) than in +C animals. Tissue 51cr at 
3 hours after the dose was not affected by ascorbate status. 
Thus ascorbate depletion did not inhibit Cr uptake as 
evidenced by tissue retention and urinary excretion of 
51chromium at 3 hr. 
Animals fed -cr diets had higher 51cr in blood (p<0.05) 
and liver (p<0.04) than those fed +Cr diets but urinary 
excretion of 51Cr was not affected by prior chromium intake. 
An effect of dietary chromium on 51cr retention has not been 
seen in shorter studies {1157}; however, in this 24 week 
experiment, chromium deprivation enhanced the uptake of 51Cr 
from a dose of 51crc13 . 
The increased urinary excretion of 51cr in ascorbate 
depleted animals given a glucose load has not been reported 
previously. Elevated urinary chromium values have been 
found in runners who exhibited elevated cortisol {3}, trauma 
patients {31}, and untreated diabetic humans {2242}. Brush 
border disaccharidases were stimulated in diabetes, a 
disorder resulting from lack of· insulin {2605}, and cortisol 
elicited intestinal sucra-se activity {2606}. Increased 
urinary excretion of 51cr may reflect a more rapid glucose 
uptake by intestinal epithelial 'and endocrine disturbances 
associated with the stress of ascorbate deficiency. 
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Cr x C 
TABLE 1 
cgTparison of ascorbic acid status and chromium supplementation on 
chromium excreted in urine and retained in blood and tissues of 
guinea pigs supplemented with chromium and or ascorbate 
Blood Liver Spleen Kidney 3 h Urine 
% Dose 
0.089±0.016 0.012±0.003 0.0005±0.0002 0.0073±0.0016 0.0202±0.0064 
0.059±0.015 0. 017±0. 003 0.0006±0.0002 0.0053±0.0014 0.0525±0.0170 
0.041±0.015 0 .-008±0. 003 0.0006±0.0002 0.0054±0.0015 0.0219±0.0078 
0.039±0.016 0.009±0.003 0.0004±0.0002 0.0059±0.0015 0.0859±0.0346 
of Variance p values 
<0.04 <0.04 0.88 0.68 0.34 
0.33 0.24 0.68 0.61 0.02 
0.36 0.54 0.50 0 .41• 0.39 
CHAPTER VI 
CHROMIUM AND CHRONIC ASCORBIC ACID DEPLETION EFFECTS ON 14c 
RETENTION FROM 14c-ASCORBATE, TISSUE ASCORBATE, AND 
AND TISSUE MINERALS IN GUINEA PIGS 
CAROL D. SEABORN, NANCY CHENG, BERNICE ADELEYE, FRED OWENS, 
AND BARBARA J. STOECKER 
ABSTRACT 
Chromium potentiates the effects of insulin; a role for 
insulin in ascorbic acid transport has been reported. 
Therefore, chromium and ascorbate depletion effects on 14c 
distribution after a 14c ascorbate dose were investigated in 
guinea pigs. For twenty weeks, forty weanling animals were 
fed either chromium deficient (-Cr) or chromium adequate 
casein-based diet (2 ug Cr from CrCl3/g diet) and were 
deprived to 1 mg ascorbatejd (-C) or supplemented with 10 mg 
ascorbatejd (+C) for 20 weeks. Animals fed the chromium 
depleted diet exhibited decreased growth (p<0.01). However, 
creatinine and hydroxyproline con~entrations in urine from 
fasted guinea pigs were unaffected by Cr or ascorbic acid 
status. Cr supplementation decreased plasma cortisol, brain 
14 c and expired 14c from a 14c-ascorbate dose. Ascorbate 
supplementation increased hepatic 14c, tissue ascorbate, and 
iron concentration in most analyzed tissues. Both 
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separately and interactively, ascorbate and chromium 
affected manganese concentration in several tissues. Cr 
supplementation increased cr in liver, brain, adrenal, 
kidney, and spleen. The stress of confinement necessary to 
collect expired carbon dioxide may have affected 
distribution, of 14c from 14c-ascorbate and tissue mineral 
concentrations. 
KEY INDEXING WORDS: Chromium; guinea pigs; cortisol; iron; 




Chromium has been shown to potentiate the effect of 
insulin on glucose entry into cells (1) and a role for 
insulin in ascorbic acid transport in human red blood cells 
has been reported by Mann and Newton (2). They found that 
glucose competitively inhibited transport of ascorbic acid 
and that hyperglycemia impaired intracellular ascorbic acid 
content. Kapeghian and Verlangieri (3) confirmed that 
ascorbic acid uptake by heart endothelial cells was 
compromised by decreased insulin andjor increased 
extracellular glucose levels. Diabetic rats have decreased 
tissue ascorbate concentrations (4) and diabetic humans have 
low tissue ascorbate concentrations (5). The major purpose 
of this study was to determine if chromium and ascorbic acid 
status would affect tissue ascorbate concentration and 14c-
ascorbate retention and excretion in guinea pigs. 
A close correlation between hydroxyproline excretion and 
growth rate has been determined (6). However, Bates (7) 
reported that hydroxy~roline excretion was increased in c-
deficient animals. Higher-plasma corticosteroids were found 
in ascorbic acid deficient guinea pigs (8). Cortisol 
decreased total exc~etion of hydroxyproline in urine (9). 
Creatinine excretion increased with growth (10) and a high 
positive correlation between total body muscle mass and 
urinary creatinine excretion has been reported (11). 
Diabetic subjects had decreased plasma creatinine and 
increased creatinine excretion (12J. Lack of chromium has 
been reported to affect growth in malnourished children (13) 
and in rats deprived of chromium (14). Therefore, in 
addition to body weight, other indicators of growth and 
protein utilization including creatinine, urinary 
hydroxyproline, and blood urea nitrogen were investigated in 
this study. 
Absorption and metabolism of chromium are affected by 
' ' 
interactions with other metals including zinc, iron, and 
manganese. Whole body contents of an oral dose of 
radioactive Cr were greater in zinc-deficient than zinc-
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supplemented rats (15). Chromium and iron may share a 
common gastrointestinal transport mechanism. Iron deficient 
animals absorbed more Cr from CrCl3 than iron supplemented 
controls; iron depressed chromium binding to transferrin 
(16). Transferrin formed a complex with manganese as well 
as chromium (17). Manganese (Mn) deficiency in the guinea 
pig induced a diabetes-mellitus like syndrome {18) which may 
reflect an interaction between Cr and Mn. 
Major objectives of this study were to determine whether 
chromium depletion or chronic ascorbic acid defici~ncy 
andjor chromium and .ascorbic acid supplementation in guinea 
pigs would affect tissue concentrations of certain trace 
minerals {manganese, iron, copper and zinc) and tissue 
ascorbate, blood concentrations of urea nitrogen and 
cortisol, hydroxyproline and creatinine excretion, and 14c 
retention from a 14c-ascorbate dose. 
MATERIALS AND METHODS 
Animals and Diets 
Forty male Hartley guinea·pigs (Sasco, Inc., Omaha, NE) 
with a mean weight of 165 g were assigned randomly to Cr and 
ascorbate treatment groups in a '2x2 factorial design. The 
basal diet contained <0.06 ugjg Cr (-Cr) or was supplemented 
with 2 ugjg Cr as CrCl3 (+Cr) and were fed for 20 wk (Table 
1). The mineral mix was prepared in a porcelain ball mill 
from minerals selected to be low in Cr. Diets were 
formulated after all individual components were assayed for 
chromium content. Copper, zinc, manganese, and iron 
concentrations of the -cr and +Cr diets did not differ. To 
increase acceptability, the diet was mixed with deionized 
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water to form balls approximately 35 em in diameter. 
Animals were dosed daily by micropipette with 1 mg 
ascorbatejd (-C) or 10 mg ascorbatejd (+C) dissolved in 100 
ul deionized water. 
Animals wer,e hc:msed in plexiglass cages with plastic 
grate floors. Animals had ad libitum access to food and 
deionized water from cera~ic cups. 
Sample Collection and Necropsy 
Guinea pigs were weighed at 7 d intervals. Following a 
~ 
12 h fast, urine was collected in a metabolic cage at week 8 
and both fasted and nonfasted 12 h urine collections were 
obtained before the animals were sacrificed at week 20. 
Urine was measured and frozen for hydroxyproline, 
creatinine, and cortisol analyses. 
Prior to necropsy, animals were weighed and fasted 
overnight. Six hours before sacrifice, each guinea pigs was 
dosed by micropipette with 90 ul (1.8 uCi) of L-[carboxyl-
14C] ascorbate and placed in sealed metabolic cages. 
Expired carbon dioxide was trapped in three consecutive 
tubes of ethanolamine (40 ml per tube) and urine was 
collected. Vacuum pumps pulled expired air from the cages 
through the ethanolamine·. Tissues, plasma and urine were 
frozen and processed later for scintillation counting of 14c 
from the 14c-ascorbate dose. 
Animals were anesthetized in the metabolic cages with 
nitrogen gas and then exsanguinated by cardiac puncture. 
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Tissue samples for ascorbic acid analysis were frozen 
immediately in liquid nitrogen. Plasma was held on ice for 
ascorbate analysis or frozen for other analyses. The 
remaining tissues and bone (femur) were handled so as to 
avoid chromium contamination and were packaged individually 
in sealed plastic bags before freezing. 
Biochemical,Analyses 
Hydroxyproline was determined in urine by the method of 
Bergman and, Loxley (20) using internal standards. Urinary 
creatinine was determined by colorimetric analysis using a 
modification of the Jaffe reaction (alkaline picrate 
determination) (Method #555, Sigma Chemical Co, St. Louis, 
MO) (21). Urinary and plasma cortisol values were obtained 
by radioimmunoassay (Diagnostic Products Corporation, Los 
Angeles, CA). Plasma urea nitrogen was determined 
calorimetrically (Method #535, Sigma Chemical, st. Louis, 
MO) ( 23) . 
The tissues frozen in liquid nitrogen at necropsy were 
analyzed for ascorbic acid within 4 h of necropsy. These 
samples were ground in cold glass homogenizers and 
deproteinized in 5 ml of cold 10% trichloroacetic acid 
(TCA). Plasma was deproteinized using 2 volumes of cold 10% 
TCA. Ascorbate was analyzed using the ferrozine method 
(22). Interference by metals was minimized by using acid 
washed glassware and deionized water for all reagents. 
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Treatment of samples for scintillation counting of 14c 
involved solubilization of 60-100 mg of tissue in 1 ml of 1N 
sodium hydroxide and incubation at 80° c for 15 min. The 
samples then were decolorized by adding 200 ul of hydrogen 
peroxide and incubating at 80° c for 30 min. The samples 
were mixed with 100 ul o·f 80% acetic acid, followed by 15 ml 
Insta-gel (Packard Inc., Downers Grove, IL) and were 
counted. Plasma (200 ul) was treated similarly before 
counting. Ethanolamine (0.2 ml) was added to 20 ml Insta.-
Gel and urine (0.6 ml) was added to 5.0 ml Insta-Gel. All 
samples were counted for 5 min in a Tri-Carb 1900CA Liquid 
Scintillation Analyzer (Packard, Laguna Hills, CA). 
Samples of diet for chromium analysis (200-250 mg wet 
weight) were weighed into acid-washed borosilicate glass 
tubes and dried for 24 h at 100 degrees c. Samples then 
were ashed in a muffle furnace with no exposed metal heating 
elements (Lindberg, General Signal, Watertown, WI) using a 
modification of the method of Hill and co-workers (24) with 
a dry ashing temperature of 375° c. After ashing, these 
samples were diluted with 0.5% nitric acid (double 
distilled, G. Fredrick Smith, Columbus, OH) and analyzed at 
357.9 nm using a Perkin~Elmer Model 5100 atomic absorption 
spectrophometer with a HGA 600 graphite furnace and Zeeman 
background correction (Perkin Elmer, Norwalk, CT). 
Drying and ashing procedures for tissues and bone were 
identical to those for diet. Glass knives were used to cut 
tissue and clean bone before Cr analysis. Manganese and 
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copper tissue concentrations also were determined by 
graphite furnace atomic absorption spectroscopy (AAS); zinc 
and iron were determined by flame AAS. 
Statistical Analysis 
The Statistical Analysis System (SAS) was used to 
evaluate treatment effects. Data were analyzed as a 2x2 
factorial design. The generalized linear model (GLM) was 




Body and tissues weights of guinea pigs are shown in 
Table 2. starting at we~k 13, animals fed the Cr depletion 
diet (-Cr) weighed significantly less than animals fed the 
supplemented diet with 2 ugjg Cr (+Cr). Ascorbate treatment 
did not affect body weight. we"ights of the liver, kidney, 
testes, and epididymal fat pad were lower for animals fed 
the Cr depleted diet. Chromium treatment did not affect 
weights of brain, adrenal and spleen. 
At week eight, .the urine volume was higher for -cr fed 
animals. Urine volumes were not significantly different for 
either the fasted or fed urine collections at week twenty 
(data not shown). N~ither ascorbic acid or chromium intake 
affected urinary creatinine or hydroxyproline (Table 3) at 
week eight or week 20. Cortisol excretion in urine of 
fasted animals at week 20 was not affected by Cr or ascorbic 
acid treatment. 
Plasma cortisol concentration after animals had been 
restrained in metabolic cages for 6 h was higher (p<0.05) in 
-cr animals than in +Cr animals. Ascorbic acid treatment 
did not affect plasma cortisol concentration. There was a 
significant interaction between Cr and ascorbic acid on 
blood urea nitrogen. In animals supplemented with 10 mgjday 
ascorbate, chromium supplementation increased blood urea 
nitrogen. 
Tissues analyzed 'for ascorbic acid are shown in Table 4. 
Ascorbic acid supplementation of 10 mgjd increased 
(p<0.0001) ascorbate in all tissues. Ascorbic acid 
concentration in liver was 0.07 mgjg 'for those animals 
receiving 1 mg ascorbate per day versus 0.28 mgjg for those 
animals receiving 10 mg ascorbate per day. Plasma ascorbate 
was lower than tissues but was increased by the 10 mg 
ascorbic acid supplement. Cr treatment affected ascorbate 
concentration in the testes. The chromium-supplemented 
animals had lower (p<O.OJ) testes ascorbate concentration 
than animals maintained on chromium deficient diets. 
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The primary route of excretion of ascorbate in the 
guinea pig is via expired carbon dioxide. As shown in Table 
5, the percentage of the 14c-ascorbate dose that was expired 
as carbon dioxide in the 6 h collection period was greater 
(p<0.04) in guinea pigs fed the low chromium diet than in 
guinea pigs fed the chromium supplemented diet. The low Cr 
diet also increased (p<0.001) retention of 14c in the brain. 
However, retention of the ascorbate dose by the brain (0.04 
to 0.06%) was very low compared to the liver which had a 
retention of 1.6 to 2.4% of the dose. The animals 
supplemented with 10 mg ascorbate retained a greater 
percentage of the 14c ascorb'ate dose in the liver than 
animals given 1 mg asco+bate per day (p<O.OJ). 
There was an interaction between intakes of Cr and 
ascorbic acid on 14c retention in certain tissues. In the c 
depleted animals cr decreased retention of 14c from the 14c-
ascorbate dose but increased the fraction found in plasma 
and recovered in urine. Urine of all groups contained less 
than 4% of the dose at 6 hr. When blood volume was 
estimated at 7% of animal weight, plasma contained less than 
2% of the 14c dose at 6 hr. 
Manganese in liver was higher in +Cr animals (Table 6) . 
In the kidney, manganese was higher in -cr animals. Splenic 
manganese tended to be increased (p<0.06) with cr 
supplementation. Ascorbic acid supplementation increased 
manganese concentration in the adrenal, and testes but 
decreased manganese in the, spleen. Interactions between 
chromium and ascorbic acid were found for manganese 
concentrations in bone and brain. In ascorbic acid depleted 
animals, Cr supplementation tended to increase Mn in bone 
but decreased Mn content of brain. 
Zinc tissue levels were not affected by cr or ascorbate 
treatment (data not shown). Copper concentration was 
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decreased (p<0.007) by ascorbate supplementation in kidney 
only. The kidney of animals receiving 10 mg ascorbate per 
day had 16 ug copperjg dry wt, whereas animals receiving 1 
mg ascorbate had 19 ug copperjg dry wt in the kidney. 
Tissue copper concentrations were not affected by Cr 
treatment. Ascorbate supplementation increased iron 
concentrations in the liver, brain, testes, kidney and 
spleen (Table 7), but no differences were seen in tissue 
iron concentration as a result of chromium treatment. 
Chromium supplementation increased Cr concentration in 
liver, brain, adrenal, kidney, and spleen (Table 8). In 
contrast, chromium in thEa testes was'higher for Cr depleted 
than Cr supplemented animals. The Cr concentration in 
these tissues was not affected by ascorbate treatment. 
However, bone had a lower Cr concentration when 10 mg than 
when 1 mg ascorbatejd was fed. 
DISCUSSION 
The lower body weight of -cr guinea pigs supports 
findings in the rat, mouse, and turkey and emphasize the 
essentiality_of Cr for animal growth (25). The larger 
liver, kidney, testes, and epididymal fat pad weights of Cr 
supplemented animals suggest that Cr is involved in both 
protein synthesis (26) and glucose incorporation into fatty 
acids (27). However, no detrimental effect of -Cr diets on 
growth was evidenced by hydroxyproline and creatinine 
excretion. In animals supplemented with 10 mg ascorbate/d, 
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chromium supplementation decreased plasma urea nitrogen. 
Plasma cortisol measured in guinea pigs after being 
restrained for 6 h in metabolic cages was higher for -cr 
animals. Elevated cortisol in the chromium deprived group 
may be induced by stress. The fasted urinary values for 
cortisol obtained at week 20 prior to immobilization in the 
metabolic cage showed no significant differences for Cr or 
ascorbate treatment. Also, adrenal weights were not altered 
by Cr treatment. Plasma cortisol values of guinea pigs 
receiving all treatments were double values reported by Kipp 
and Rivers (28) for non-stressed guinea pigs but similar to 
or below cortisol. concentrations of guinea pigs which had 
been injected with adrencorticotrophin {ACTH). 
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The higher tissue ascorbate concentrations with 
ascorbate supplementation were expected (29). Plasma 
ascorbate concentrations were similar to values reported for 
guinea pigs 4 h after ACTH (30). Their plasma 
concentrations were elevated only 'slightly with their ACTH 
treatment (30). Tissue ascorbate concentrations in our 
guinea pigs also were similar to values of animals treated 
with ACTH at 4 h. Kipp and Rivers did not find tissue 
values of guinea pigs fed 500 mg ascorbate/kg diet to be 
changed by ACTH injection. Adrenal ascorbate values in 
guinea pigs treated wi~h ACTH were higher at 4 hours (0.39 
mgjg) than untreated guinea pigs. Adrenal ascorbate values 
of guinea pigs in this study (0.45 to 2.1 mgjg) were higher 
than in guinea pigs treated with ACTH. However, guinea pigs 
subjected to the stress of swimming had decreased ascorbate 
in the adrenal glands, spleen and brain (31). Testes had 
lower ascorbate when treated with +Cr; this seems to 
parallel the 14c ascorbate data. 
Considering the indication of stress (cortisol values), 
the 14c ascorbate data ptobably reflects the disposition of 
ascorbate under stress rather than under physiological 
distribution. In rats, acute immobilization stress 
increased serum ascorbic acid levels (32). Distribution of 
a dose of newly absorbed ~scorbic acid in these guinea pigs 
may be altered by stress. ACTH treated animals retained 
0.01% of an ascorbate dose in plasma at 4 h (30); by 
comparison, our guin~a pigs retained nearly 2% of the dose 
in the plasma. The percent of dose retained in the tissues 
of immobilized guinea pigs was less than for non-stressed 
animals (30). 
The 14c in expired carbon dioxide by 6 hours was at the 
lower end of the expected range (5-24% of the dose) (33). 
The amount of 14c in expired C02 was higher in -Cr treated 
guinea pigs. This indicates utilization or metabolism of 
the 14c-ascorbate dose was increased by ~r deficiency. In 
other work, keto~e bodies brought about a significantly 
higher destruction of ascorbic acid (34). Whether -cr 
animals developed ketosis during immobilization stress was 
not determined. However, because the -cr animals expired 
similar amounts of 14c in carbon dioxide to that reported in 
untreated guinea pigs, some physiological condition existed 
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in +Cr animals that increased retention or conservation of 
the ascorbate during immobilization stress. Whether 
retention would be increased similarly by cr in non-
immobilized animals was not confirmed. Chromium at 5 ugjg 
diet increased the concentration of ascorbic acid in liver 
and adrenals of rats (35). 
Effects of Cr on manganese concentrations have not been 
reported previously. Liver manganese was higher (p<0.05) 
and kidney manganese was lower (p<0.02) with Cr 
supplementation. Splenic manganese tended to be higher 
(p<0.06) in +Cr animals. Tissue manganese also reflected 
ascorbate supplementation; 10 mg ascorbatejd increased Mn in 
adrenals (p<0.05) and testes (p<O.Ol) but decreased Mn in 
spleen (p<0.05). The interaction,between Cr and ascorbate 
on Mn in bone and brain indicate further that both Cr and 
ascorbate status may affect manganese retention. 
In male Hartley guinea pigs, supplementation with 
ascorbic acid (25 mg/100 g bw per day) decreased liver 
copper by 200 to 300% (19). In men, ascorbic acid (500 mg) 
also was antagonistic to copper status (36). In our study 
10 mg ascorbate/d reduced kidney copper concentration. 
Hepatic iron concentration was increased in guinea pigs 
when a high level, 25 mg ascorbate/100 g bw, was fed (19, 
37). In our study providing 10 mg ascorbatejd, iron 
concentration was increased in four of the seven tissues 
analyzed. These results indicate that effects of ascorbate 
supplem~ntation on mineral status in animals and man should 
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be re-evaluated considering the possibility of 
hemochromatosis. Increased iron in tissues also may 
interfere with absorption and transport of manganese and 
other minerals (17). An increased iron concentration in 
tissues was associated with increased utilization of 
ascorbate (38). 
Chromium concentrations ,in the liver, brain, kidney, and 
spleen although variable, increased with Cr supplementation. 
Concentrations in this study might be altered due to the 
stress of immobilization,. In contrast to other tissues, 
chromium in testes was higher (p<0.04) in -cr than in +Cr 
animals. Fertility and sperm count have been decreased in 
animals fed chromium deficient diets (39), but no 
information has been reported previously on Cr concentration 
of the testes in Cr deficiency. Bone chromium was decreased 
by ascorbate supplementation. As bone represents a Cr 
storage site, size of the Cr pool available for mobilization 
during stress may be decreased by ascorbate deficiency. 
' ' 
Stress affects chromium metabolism (40). Trauma, 
infection, surgery, intense heat or cold, all elevated 
secretion of hormones and either directly or indirectly 
affected chromium metabolism (41). After trauma in humans, 
plasma cortisol ~as elevated (42). The animals that were 
fed -cr diets in this study exhibited increased cortisol 
after confinement stress. Urinary chromium excretion and 
plasma cortisol increased in runners (43); urinary chromium 
excretion was 10 times greater by traumatized patients 42 h 
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following hospital admission than by normal, healthy 
subjects. Whether the tissues give up their chromium or 
take up the circulating Cr in response to stress is not 
known. Pekarek and co-workers reported that subjects 
infected with sandfly fever had lower fasting serum chromium 
than heal thy subjects (4'4) , 'but their serum chromium 
concentrations are high by today's standards. 
In summary, asc?rbate and Cr status altered tissue 
ascorbate concentrations and distribution of 14c from 14c-
ascorbate in confined animals. Adrenal ascorbate of all 
treatment groups (under immobilization stress) was higher 
than previously reported; ascorbate concentrations in other 
tissues were similar to previously reported values for 
guinea pigs. Testes had higher ascorbate and Cr 
concentrations in animals given the low cr diets; however, 
some of this increase may be due to the 26% decrease in 
testes weight of guinea pigs' on this diet. Expired 14c was 
lower in +Cr animals indicating that some mechanism may 
exist to protect the ascorbate from oxidative destruction in 
+Cr animals. Manganese concentration of liver was increased 
and kidney was decreased ~y Cr supplementation; Mn 
concentrations in brain, adrenal and testes increased but 
spleen decreased:with ascorbate supplementation and 
interactions of Cr and ascorbate on bone and brain Mn were 
detected. These interactions require further investigation 
to determine whether cr, ascorbic acid, and Mn in 
combination may interact to affect lipid metabolism and 
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glucose utilization. The immobilization stress of our 
guinea pigs (necessary to collect expired co2) raises the 
question of the role of stress in chromium metabolism and 
whether cortisol may change Cr distribution. The increased 
iron in several tiss.ues, decreased copper in kidney and 
decreased bone Cr with 10 mgjd ascorbate supplementation are 
of concern. The effects of ascorbic acid supplementation on 
chromium and manganese status in stress need evaluation. 
'• 
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Composition of the Diet1 
Component 
Vitamin mix3 (without ascorbic acid) 
Potassium a~etate , 










1By analysis the -cr diet contained <50 ppb cr and the 
+Cr diet contained 2 ppm. 
2us Biochemical Corp. .· 
3The vitamin mix contained per kg (in g except as noted) 
alpha-tocohperol 5.0; choline chloride 75.0; d-
calcium pantothenate, '3.0; inositol, 5.0; menadione, 2.25; 
niacin, 4.5; paraaminobenzoic acid, 5.0; pyridoxine HCl, 
1.0; riboflavin, 1.0; thiamine HCl, 1.0; vitamin A acetate, 
900,000 units; calciferol (D2) 100,000 units; biotin, 20 
mg; folic acid, 90 mg; and vitamin B12' 1.35 mg. 
4The mineral mix contained (gjkg): CaHP04, 600.0; NaCl, 
80.0; MgO, 100.0; ZnC03 , 0.9; MnC03 , 1.8; Cuco3 ·cu(OH) 2 














Cr X C 
TABLE 2 
Body and tissue wet.weights of guinea pigs fed diets with or without added Cr and given marginal 
ascorbate. (1 mg/day) or supplemented with ascorbate (10 mg/day) 1 
Body Wt. liver Epididymal Spleen Testes Heart Kidney Adrenal 
fat pad 
g g g g g g g g 
635±18 21.07±0.88 4.72±0.35 0.99±0.06. 1.03±0.09 1.97±0.07 4.77±0.19 0.39±0.03 
733±17 23.72±0.84 6.08±0.33 1.00±0.06 1.39±0.09 2.17±0.07 5.39±0.19 0.41±0.03 
702±18 2A .. 45±0.90 5.82±0.36 1.07±0.07 1. 28±0 .09 2.03±0.07 5.33±0.19 0.39±0.03 
666±17 20.34±0.82 4.97±0.32 0.92±0.06 1.14±0.09 2.11±0.07 4.83±0.18 0.41±0.03 
653±26 22.81±1.34 5.·20±0.53 1. 06±0 .10 1.17 ±0 .13 2.01±0.11 >4. 71±0.28 0.40±0.04 
618±23 19.33±1.12 4.23±0.44 0.93±0.09 . 0.89±0.12 1. 94±0 .·10 4.83±0.25 0.38±0.04 
752±25 26.08±1.19 6.44±0.47 1. 08±0. 09 1. 38±0.13 2.06±0.10 5.95±0.26 0.38±0.04 
. 715±25 21. 35±1.18 5. 71±0.47 0.91±0.09 1. 39±0 .13 2.28±0.10 4.83±0.26 0.43±0.04 
of Variation P Values 
<O.Ol <0.04 <0.01 0.99 <0.01 0.06 <0.03 0. 71 
0.16 <0.01 0.08 0.11 0.30 0.47 0.06 0.68 
. 0.98 0.61 0.81 0.83 0.24 0.18 <0.03 0.35 















Creatinine and hydroxyproline in fed and fasted urine, plasma and urinary cortisol and blood urea nitrogen of guinea 
pigs with or without added Cr and given marginal ascorbate (1 mg/day) or supplemented with ascorbate (10 mg/day)1 
Urinary Creatinine Urinary Hydroxyproline Cortisol PlaSIIa Urea 
Nitrogen 
Fasted Fasted Fed Fasted Fasted Fed Plasma Fasted urine 
(week 8) (week 20) (week 20) (week 8) (week 20) (week 20) (week 20} (week 20) (week 20) 
mg/ml ug/ml ng/ml mg/dl 
-Cr 4.95±0.37 7.49±0.60 11.39±1.15 2247±470 751± 82 1070±105 910± 99 174±28 29±1 
+Cr 5.05±0.37 7.67±0.60 12.32±1.14 2187±467 644± 77 939±104 625± 94 175±27 27±1 
-c 5.15±0.38 7.97±0.62 12 .16±1.18 2119±481 649± 85 880±107 705±101 201±28 30±1 
+C 4.85±0.36 7.20±0.59 11:55±1.11 2315±455 746± 73 . 1130±101 830± 93 148±27 27±1 
-Cr-C 5.50±0.56 7.03±0.91 11.39±1. 72 2670±700 631±129 910±156 844±152 168±41 29±2 
-Cr+C 4.41±0.50 7.96±0.81 11.41±1. 54 1822±626 871±100 1230±139 977±127 181±39 30±2 
+Cr-C 4.82±0.52 8.90±0.85 12.94±1.62 1568±660 667±118 847±147 567±134 235±39 31±2 
+Cr+C 5.29±0.52 6.44±0.58 11. 69±1. 62 2806±660 621±105 1029±147 683±134 116±39 24±2 
Source of Variation P Values 
Cr 0.85 0.84 0.58 0.93 0.35 0.38. <0.05 0.99 0.26 
c 0.57 0.38 0.71 0.77 0.39 0.10 0.37 0.17 0.16 
Cr X C 0.15 0.06 0.70 0.12 0.21 0.65 0.95 0.10 <0.05 
1values are least squares means ± SEM (Cr, n = 18-20; C, n = 19). 
TABLE 4 
Ascorbate concentratio~s of plasma and tissue (wet wt) in guinea pigs fed diets with or without added Cr 
and given marginal (1 mg/day) or adequate ascorbate (10 mg/day) 1 
Plasma Adrenal Brain Kidney Liver Spleen 
mg/ml mg/g mg/g mg/g mg/g mg/g 
-er 0.006±0.0006 1.31±0.12 0.35±0.02 0.13±0.008 0.17±0.01 0.40±0.03 
+er 0.006±0.0005 1.18±0 .12 0 .'33±0. 02 0 .11±0. 008 0.17±0.01 0.40±0.03 
-e 0.003±0.0006 0.48±0.12 0.13±0.01 0.05±0.008 0.07±0.01 0.13±0.03 
+e 0.008±0.0005 2.01±0.12 0.57±0.01 0.18±0.008 0.28±0.01 0.67±0.03 
-er-e 0.002±0.0008 0.51±0.18 0 .. 13±0. 03 0.05±0.010 0.06±0.02 0.14±0.05 
-er+e 0.009±0.0007 2.11±0.16 0.58±0.02 0.20±0.010 0.28±0.01 0.65±0.04 
+er-e 0.003±0.0008 0.45±0.17 0.11±0.02 0 .05±0 .. 010 0.07±0.02 0.12±0.05 
+er+e 0.008±0.0008 1. 90±0.17 a·. 56±0. 02 0 .17'±0. 010 0.28±0.02 0.68±0.05 
Source of Variation' P Values 
er 0.96 0.44 0.39 0.25 0.98 0.95 
e <0.0001 ~0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
er X e 0.47 0.66 0.80 0.29 0.71 0.62 















14c-Ascorbate in tissues, urine, and expired as carbon dioxide by guinea pigs 6 h after oral dose1 
Plasma Adrenal liver Brain Spleen Testes Kidney Urine 
Percentage of 14e dosed 
-er 1.245±0.069 0.074±0.010 2.14±0.20 0.057±0.004 0.16±0.01 0.049±0.006 0.45±0.04 3.00±0.52 
+er 1.321±0.069 0.074±0.009 2.05±0.20 0.039±0.004 0.10±0.01 0.042±0.006 0.40±0.04 3.15±0.52 
-e 1. 227 ±0. 071 0.062±0.009 1. 78±0. 20 0.046±0.004 0.16±0.01 0.050±0.006 0.42±0.04 2.96±0.53 
+e 1.339±0.067 0.086±0.009 2.42±0.20 0.051±0.003 0.09±0.01 o.o41±0:oo6 0.44±0.04 3.18±0.50 
-er-e 1.037±0.103 0.066±0.014 1. 90±0. 30 0.055±0.005 0.22±0.02 0.065±0.009 0.45±0.05 2.13±0.78 
-er+e 1. 454±0. 092 0. 083±0. 013 2.38±0.27 0.060±0.004 0.11±0.02 0.034±0.009 0.46±0.05 3.86±0.69 
+er-e 1.417±0.097 0.057±0.012 1. 66±0. 27 0. 037±0. 0,05' 0.11±0. 02 0.036±0.009 0.40±0.05 3.79±0.73 
+er+e 1. 224±0. 097 0.090±0.012 2.46±0.28 0.042±0.005 ' 0.09±9.02 0.048±0.009 0.41±0.05. 2.50±0.73 
Source of Variation p Values 
\ 
er 0.45 0.95 0.76 <0.001 <0.0010 0.44 0.33 0.84 
e 0.26 0 .. 06 <0.03 0.25 <0.005 0.33 0.82 0.76 
er X e <0.004 0.54 0.59 0.92 <0.01 <o.o3 0.99 <0.05 


















Tissue manganese concentration (ng/g dry wt) of guinea pigs fed diets with or without added Cr and given marginal 
ascorbate (1 mg/day) or supplemented with ascorbate (10 mg/day) 1 
Bone Liver Brain Adrenal Testes Kidney Spleen 
-Cr 273±28 6323±585 1245±55 4675±500 3846±327 5392±280 765±47 
+Cr 327±28 8048±581 114 7 ±55 3941±500 4157±325 4355±278 895±47 
-c 292±28 7804±599 1107 ±57 3585±512 3381±335 4909±287 899±48 
+C 308±27 6568±567 1285±54 5031±485 4621±317 4838±271 761±46 
-Cr-C 224±42 6583±872 1245±83 4036±727 3514±487 5648±417 839±70 
-Cr+C 322±38 6064±780 1245±74· 5314±687 4178±436 513.6±373 691±62 
+Cr-C 361±39 9026±822 968±78 3134±729 3249±459 4170±393 959±66 
+Cr+C 293±39 •7072±822 1326±78 4748±687 5065±459 4541±393 831±66 
Source of Variation P Values 
Cr 0.18 <0.05 0.22 0.30 0.50 <0.02 0.06 
c 0.70 ,0 .14 <0.03 <0.05 <0.01 0.86 <0.05 
Cr x c <0.05 0.39 <0.03 0.81 0.22 0.27 0.87 













Tissue iron concentration (ug/g dry wt) of guinea pigs fed diets with or without added Cr and given marginal 
ascorbate (1 mg/day) or supplemented with ascorbate (10 mg/day) 1 
Bone Liver Brain Adrenal Testes Kidney · Spleen 
-er 36±3 208±18 83±4 221±16 157±14 128± 7 1136± 87 
+er 30±3 193±18 84±4 212±16 142±14 132± 7 1137± 86 
-e 36±3 159±19 75±4 210±16 122±15 114± 7 1008± 89 
+e 30±3 242±18 92±4 224±15 178±14 147± 7 1266± 84 
-er-e 38±4 158±27 77±5 215±23 124±21 113±10 1001±129 
-er+e 33±4 258±25 80±5 227±21 190±19 143± 9 1272±115 
+er-e 34±4 160±26 73±5 205±22 120±20 114±10 1014±122 
+er+e 26±4 226±26 94±5 220±22 165±20 150±10 1260±122 
Source of Variation P Values 
er 0.17 0.57 0.92 0.71 0.47 0.68 0.99 
e 0.12 <0.01 <0.01 0.54 <0.01 <0.01 <0.04 
er X e 0.67 0.52 0.42 0.95 0.60 0.77 0.92 
1values are least squares means ± SEM ( er, n = 18-20; e, n = 19). 
TABLE 8 
Tissue chromium concentration (ng/g dry wt) of guinea pigs fed diets with or without added Cr and given 
marginal ascorbate (1 mg/day) or supplemented wjth ascorbate (10 mg/day) 1 
Bone Liver Brain Adrenal Testes Kidney 
-Cr 378±108 116±77 95±41 229±89 755±135 53±157 
+Cr 416±104 451±74 230±35 518±86 309±143 741±156 
-c 566±106 313±79 173±41 329±89 469±138 483±161 
+C 228±104 254±72 152±35 418±85 594±140 310±152 
-Cr-C 511±157 123±118 117±66 177±129 682±201 51±234 
-Cr+C 245±147 110±99 73±49 280±121 827±160 53±210 
+Cr-C 621±147 502±104 229±49 481±121 257±190 914±221 
+Cr+C 211±147 399±104 231±49 555±121 360±215 567±221 
Source of Variation P Values 
Cr 0.80 <0..0.1 <0..0.2 <0..03 <0..04 <0..0.1 
c <0..0.4 0.59 0.70. 0..48 0..53 0..44 
Cr x C .0..64 0..67 0..68 0.91 0..92 0..44 

















CHROMIUM AND ASCORBATE EFFECTS ON 3-HYDROXY-3-METHYLGLUTARYL 
COENZYME A REDUCTASE.IN GUINEA PIGS 
carol D. Seaborn, M.S., Nancy Cheng, M.S.,M.D., Earl 
Mitchell, Ph.D and Barbara J. Stoecker, Ph.D. 
Department of Food, Nutrition and Institution Administration 
Oklahoma State University 
Stillwater, Ok~ahoma 74078 
ABSTRACT 
Supplemental chromium has sometimes decreased blood 
cholesterol; ascorbate deficiency has contributed to 
elevated serum cholesterol. Therefore, chromium and 
ascorbate depletion effects on 3-hydroxy-3-methylglutaryl 
coenzyme A were investigated in guinea pigs. Weanling male 
guinea pigs were randomly assigned -to· groups in a.2x2 
factorial design. Animals were fed 1 mg ascorbate per day 
(-C) or 10 mg ascorbate per day (tC). Diets contained <.07 
ugjg chromium or were' supplemented with 2 ugjg chromium as 
crc13 and were fed for 21 weeks. Activity of 3-hydroxy-3-
methyl-glutaryl coenzyme A reductase (HMG CoA) was 
determined using 3-14c-HMG-CoA with 3H-mevalonate as an 
internal standard. Tissue minerals were determined by flame 
134 
or graphite furnace atomic absorption spectroscopy. Body 
weight was not significantly affected by dietary treatments. 
Plasma cortisol and cholesterol were not affected by 
chromium or ascorbate treatments. Iron in the liver was 
increased by ascorbate supplementation. Cr supplementation 
decreased hepatic iron. An interaction between chromium 
and ascorbate affected activity of HMG CoA reductase, the 
rate limiting enzyme in cholesterol biosynthesis. In 
ascorbate depleted animals, chromium supplementation 
increased HMG CoA reductase activity, while in ascorbate 
supplemented animals, Cr supplementation decreased activity. 
The mean dpm values per mg protein from 14c mevalonate for 
-er-e, -Cr+C, +Cr-c, and +Cr+C groups were 8998, 14,947, 
14,500, and 7628, respectively. 
Key Words: Chromium, ascorbic acid, 3-hydroxy-3-
methylglutaryl coenzyme A reductase, iron 
INTRODUCTION 
Chromium affects lipid metabolism·. under, some 
experimental conditions but mechanisms for its effects have 
not been resolved. Serum cholesterol was elevated in rats 
fed sucrose as a carbohydrate source; rats supplemented with 
chromium had lower se,rum cholesterol ( 1) . Feeding 1 ug 
chromiumjg diet decreased serum cholesterol in male rats, 
while 5 ugjg chromium lowered serum cholesterol in female 
rats {2). Potassium chromate injected intraperitoneally 
135 
into rabbits fed a high cholesterol diet reduced the size of 
aortic plaques and decreased aortic cholesterol (3). 
Curran (4) demonstrated in vitro that trivalent chromium 
enhanced the synthesis of cholesterol and fatty acids in rat 
liver. When chicks were fed 20 ug Crjg diet the chromium 
increased 14c incorporation into hepatic fatty acids 
compared to controls (5). Xu and co-workers reported 
increased plasma cholesterol in .guinea pigs supplemented 
with 4 ug trivalent chromiumjg diet versus 2 ug Cr/g (6), 
yet chromium has not been implicated in the function of 3-
hydroxy-3-methylglutaryl coenzyme reductase, the rate 
limiting step in cholesterol biosynthesis. 
136 
Ascorbate deficiency also has contributed to elevated 
serum cholesterol. In chronic vitamin c deficiency, guinea 
pigs produced less bile .acid and had higher h~patic and 
serum cholesterol than controls (7) while serum cholesterol 
elevation was exacerbated by combined chromium and vitamin c 
deficiencies in guinea pigs (8). 
' Interaction of chromium and ascorbate in cholesterol 
synthesis has not been investigated. · The purpose of this 
study was to determine if hepatic 3-hydroxy-3-methylglutaryl 
coenzyme A reductase activity, the rate limiting step in 
cholesterol synthesis (9,10), would be affected by chromium 
depletion and/or chronic vitamin C deficiency. 
MATERIALS AND METHODS 
Weanling male Hartley guinea pigs weighing approximately 
200 g were randomly assigned to chromium andjor ascorbate 
treatment groups in a 2x2 factorial desig~. Animals were 
fed 1 mg ascorbatejd (-C) or 10 mg ascorbatejd (+C). Diets 
contained <.070 ug Cr/g diet (-Cr) or were supplemented with 
2 ug Cr from CrCl3/g diet were fed for 21 weeks. Diets and 
mineral mix were formulated in our laboratory after te~ting 
individual components for chromium contamination (Table 1) • 
Animals were housed in plexiglass cages with floors of 
plastic grating. Food and distilled deionized water were 
available ad libitum in ceramic cups. Guinea pigs were 
weighed weekly. Two weeks before necropsy, animals in the 
minus ascorbate group were _de.creased to 0. 5 mg 
ascorbate/day. For last 11 days of the experiment, animals 
were fed at 0200 h and food was removed at 1400 h so that 3-
hydroxy-3-methylglutaryl coenzyme A reductase activity would 
peak between 0800-1100 h. At 0200 h prior to autopsy, 
guinea pigs were fed 15 g of diet. Six to seven hour~ 
later, animals were anesthetized with halothane gas and 
exsanguinated by cardiac puncture using heparinized 
syringes. Plasma was frozen for cholesterol and cortisol 
analysis. 
The guinea pig livers were rapidly excised, and 
approximately 1 9 was weighed, wrapped in foil, and placed 
on ice until homogenization in 5 volumes of Krebs-Ringer 
137 
phosphate buffer (pH 7.4) in a mechanical homogenizer. The 
homogenate was centrifuged at 15000 x g for 20 min. and the 
supernatant was recentrifuged at 15000 x g for 20 min. The 
resultant supernatant was centrifuged at 105,000 x g for 2 
h. Supernatant protein was measured by Brilliant Blue G-250 
(US Biochemical Corporation, Cleveland OH). Activity of 3-
hydroxy-3-methylglut'aryl coenzym~ A (HMG CoA) reductase was 
measured in a ·-reaction mixture (1 mL) containing glucose 6-
phosphate (10 mM), NADP (1 mM), EDTA (1 mM), dithiothreitol 
(1 mM), potassium phosphate buffer pH 7.4 (0.1 M), glucose 
6-phosphate dehydrogenase (2 units), 100 ug protein, and [3-
14C] HMG-CoA (7.9 x 104 dpm). After a 1 h incubation at 37° 
c, HCl (200 ul) was added to stop the reaction, and the 
samples were frozen. , 
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Aliquots (100 u;L) were chromatographed on a 0.5 x 5 em 
Dowex-1-formate colum~ (Bio-Rad'Laboratories, Richmond, Ca) 
with 3H-Mevalonate (2 x 105 dpm) as an internal standard. 
Mevalonolactone was eluted with 5 ml water. A 100 ul 
aliquot of the eluant co~taining mevalonolactone was counted 
in Insta-Gel (5ml) using the 3H and 14c channels of a Tri-
Carb 1900CA Liquid Sc~ntillation Analyzer (Packard, Laguna 
Hills, CA) Final values were expressed as DPM/mg protein 
and were corrected-based on 3ij:-mevalonate recovery. 
Tissues samples frozen in liquid nitrogen at necropsy 
were homogenized in 5 ml 10% cold trichloroacetic acid 1 
deproteinized and analyzed for vitamin C within 4 hr using 
the ferrozine method. 
Cholesterol was measured in serum from blood drawn from 
the toenail at week 14 and from plasma at necropsy. 
Cholesterol concentrations were measured enzymatically 
(Method #352, Sigma Chemical Co., St. Louis, Mo) (11). 
Cortisol in the plasma was analyzed by radioimmunoassay 
(Diagnostic Products Corporation, Los Angeles, CA) . and 
cortisol concentrations were computer generated from a 
legit-log calibration curve. 
For dietary chromium analysts, samples of diets (200-250 
mg) were ashed in acid-washed borosilicate glass tubes in a 
muffle furnace witQ no exposed metal heating elements 
(Lindberg, Watertown, WI) using the method of Hill and co-
workers (12). Samples were diluted with 0.5% nitric acid 
(double-distilled; G. Fredrick Smith, Columbus, OH) and 
analyzed for manganese and chromium using a Perkin-Elmer 
Model 5100 PC atomic absorption spectrophotometer with a 
graphite furnace and Zeeman background correction (Perkin 
Elmer, Norwalk, CT). 
Tis,sue samples were cut with glass knives,in a clean air 
hood. Drying and ashing procedures for tissues were 
identical to those for diet. Chromium and manganese were 
determined by graphite furnace atomic absorption 
spectroscopy (AAS); iron was 'determined by flame AAS. 
Data were analyzed as a 2x2 factorial design using the 
generalized linear model procedure of the Statistical 
Analysis System (SAS). 
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RESULTS 
Body weight was not affected by treatment (Table 2); nor 
were there differences in tissue weights except heart. 
Guinea pigs fed the phromium depleted diet had lower heart 
weights. Liver weight tended.to be higher in ascorbate 
depleted guine~ pigs {p<O.OS). 
Tissue ascorbate was increased by ascorbate 
supplementation (p<0.0001). Ascorbate concent~ations of 
adrenal, kidney, liver, and testes for animals depleted to 
0.5 mg ascorbate per day were 0.16, 0.01, 0.02 and 0.07, 
respectively and values for animals fed 10 mgjd were 1.53, 
0.14, 0.27 and 0.46, respectively. Chromium did not affect 
tissue ascorbate in this study. 
Serum cholesterol at week 14 was not affected by 
I 
chromium or ascorbate treatment (Table 3). Plasma 
cholesterol at necropsy (week 21) also was not affected by 
chromium treatment, but cholesterol values tended to be 
elevated with ascorbate'depletion (p<0.10). Likewise, 
plasma cortisol values were not affected by chromium or 
ascorbate treatments. -
Chromium in the liver and kidney were increased by 
< < 
chromium supplementation (p<0.03) but were not affected 
significantly by ascorbate treatment (Table 4). There was 
high variability in chromium of the liver and neither 
chromium or ascorbate treatments affected hepatic chromium. 
Liver and kidney manganese values were not affected by 
chromium or ascorbate treatment. Iron in the kidney was 
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increased by ascorbate (p<0.0001) and was decreased by 
chromium supplementation {P<0.04). 
There was an interactive effect (p<0.0002) of ascorbate 
and chromium on 3-hydroxy-3-methylglUtaryl coenzyme A 
reductase activity (Figure 1). Iri ascorbate depleted 
animals, chromium supplementation increased HMG CoA 
reductase activity, while in ascorbate-supplemented animals, 
Cr supplementation decreased activity. 
DISCUSSION 
Guinea pigs in ,this experiment did not demonstrate 
growth differences drle to chromium or ascorbate treatments. 
Tissue weights were not affected except for heart which was 
decreased by the chromium depl~tion diet. The guinea pigs 
had an initial weight of 205 g: growth effects due to 
chromium depletion were noted previously in guinea pigs with 
mean initial weights of 165 g. Chromium content of diet 
used in this study was similar (<0.070 ugjg) to the one used 
in the previous experiment (<0.060 ug/g): the guinea pigs in 
the present experiment may have higher initial chromium 
stores due to longe~ time with the dams or they may have 
received laboratory chow diets for a few days before 
shipping. However, in comparis'on _to animals from the 
previous experiment, these animals had lower hepatic and 
kidney chromium. 
The 0.5 mg/d ascorbate given to these animals the last 2 
wk before autopsy resulted in lower tissue ascorbate than in 
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animals receiving 1 mg ascorbate in our previous study 
(chapter VI). For example, values in mgjg for animals 
receiving 0.5 mgjd ascorbate in the adrenal, kidney, liver 
and testes were 0.16, 0.02, 0~02, and 0.07, respectively, 
while values for animals receiving 1 mg ascorbate were 0.48, 
0.05, 0.07, and 0.13 respectively. 
Chromium supplementation increased chromium in both 
kidney and liver. Increased chromium in kidney has been 
reported with chromium supplementation (13) and higher 
chromium levels of both ~iver and kidney were found in the 
previous experiment. Manganese concentrations in liver and 
kidney were not affected by either chromium and ascorbate. 
Hepatic iron was significantly increased by ascorbate and 
decreased by chromium supplementation. An increase in iron 
due to ascorbate supplementation has been reported in male 
(25 mg ascorbate/100 g bW) '(14) and female guinea pigs (225 
mg ascorbate/d) (15). A decrease in iron due to chromium 
supplementation has not been reported previously. However, 
iron deficient animals absorb~d more chromium than iron-
supplemented controls and ·iron depressed chromium binding to 
transferrin in vitro (16). In inverted sac experiments iron 
appreciably depressed 51cr transport (17). 
When serum cholesterol is lowered by drugs, cholesterol 
synthetic enzymes increase their activity. In this study 
HMG CoA reductase activity in the presence of either 
supplemental vitamin c or chromium was elevated. However, 
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when both ascorbate and chromium (+Cr+C) were present, 
values comparable to those in the -er-e group resulted. 
Neither plasma cholesterol nor cortisol were affected by 
chromium or,ascorbate depletion. As 3-hydroxy-3-
methylglutaryl coenzyme A reductase activity is affected by 
circulating' cholesterol (18), the variation in HMG CoA 
reductase activity cannot be explained by the cholesterol 
data. Because cortisol values are not different, it does 
not appear cortisol affected HMG CoA activity in this study. 
However, cortis9l may be necessary for maximal functioning 
of HMG CoA reductase (19). Increased cortisol values were 
found in chromium depleted guinea pigs in experiment 6, and 
chronic administration of cortisol induced hyperinsulinemia 
in mice (20). A consequence of,hyperinsulinemia is a 
decrease, in. number of· insulin-receptor sites (21). 
Insulin appears to have a dominant role in the 
regulation of the phosphorylation state of HMG CoA reductase 
(22). Insulin signaled net dephosphorylation enhancing 
reductase ~c~ivity and glucagon, signaled phosphorylation 
depressing reductase activity (23). Neither glucagon nor 
insulin was measured in these guinea pigs, but Banergee and 
Ghosh reported that ascorbate deficiency resulted in 
hypoinsulinism (24). Chromium in the form of CrCl3 
inhibited insulin secretion by isolated pancreatic islets 
(25). In cultured lymphocytes, insulin binding was 
inversely proportional to insulin concentration (21). Mertz 
reported that chromium potentiates the action of insulin 
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(26). HMG CoA reductase activity as a result of the 
experimental treatments may reflect effects of circulating 
insulin and chromium. 
HMG CoA reductase activity is depressed in guinea pigs 
by both excessive and deficient ascorbic acid (29). 
Ascorbic acid has a hypocholesterolemic effect only within a 
certain range of intakes (30). Ascorbate may be protected 
from oxidative destruction in chromium-supplemented animals. 
~n experiment 6 there was less 14co2 from 14c-ascorbate 
oxidation expired by chromium supplemented animals. 
Brown, Dana, and Goldstein (Jl) reported that 
apolipoprotein B, a component 'of low density lipoproteins 
and very low density lipoproteins was involved in the 
suppression of HMG CoA reductase. Chronic vitamin C 
deficiency lowered catabolic rate of low-density 
lipoproteins in guinea pigs and deceased LDL receptors on 
the surface of liver cells (32). 
Ascorbic acid is required for the hydroxylation of 
cholesterol to form bile acids (33). The 7 alpha-
hydroxylase,activity was markedly reduced in ascorbate-
deficient animals. Both biliary obstruction (34) and 
biliary diversion (18) in,creased hepatic bile acids and 
resulted in increased, cholesterol synthesis. However, when 
bile acids were fed at 1% of the diet, HMG CoA reductase 
activity was reduced (35). Thus hepatic bile acids or their 
enterohepatic circulation may regulate HMG CoA reductase. 
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Catacholamines (36), cortisol (19), thyroid (37) and 
insulin (38) increased, whereas glucagon (19) and 
hydrocortisone (19) depressed cholesterol synthesis. 
Measurement of fecal bile acids,.plasma insulin, glucagon, 
and thyroid would provide important clues to factors 
controlling HMG CoA reductase activity. These will be 
analyzed in our laboratory in future studies. 
ACKNOWLEDGEMENTS 
The authors wish to thank Marie Campbell, Keith Nehls, 
and Karen Kirby Rogers for valuable technical assistance. 
This research was supported by USDA Competitive Research 
Grant #86-CRCR-1-2276, Oklahoma Agricultural Experiment 
Station Hatch Grant #2041 and the American Dietetics 
Association General Foods Fund Fellowshlip. 
145 
REFERENCES 
1. SCHROEDER, H. A. (1969) Serum cholesterol and glucose 
levels in rats fed refined and less refined sugars and 
chromium. J. Nutr~ 97: 237-242. 
2. SCHROEDER, H. A. (1968) Serum cholesterol levels in 
rats fed thirteen trace elements. J. Nutr. 94: 475-480. 
3. ABRAHAM, A. S., SONNENBLICK, M., EINI, M., SHEMESH, 0. & 
BATT, A. P. (1980) The effect of chromium on established 
atherosclerotic plaques in rabbits. Am. J. Clin. Nutr .. 33: 
2294-2298. 
4. CURRAN, G. L. (1954) Effect of certain transition group 
elements on hepatic synthesis of cholesterol in the rat. J. 
Biol. Chern. 210:'765-770. 
5. CUPO, M. A. & DONALDSON, W. E. (1987) Chromium and 
vanadium effects on glucose metabolism and lipid synthesis 
in the chick. Poultry Science 66: 120-126. 
6 . XU, X. X. , LIN, .H. C. , ~I , Y. C. & STOECKER, B. J. 
(1988) Effect of chromium supplementation on serum 
cholesterol and 'on tissue chromium concentrations of 
ascorbate-depleted guinea pigs. ~ASEB J. 2: A1103. 
7. GINTER, E., CERVEN, J., NEMEC, R~ & MIKUS, L. (1971) 
Lowered cholesterol catabolism in guinea pigs with chronic 
ascorbic acid deficiency. Amer. J. Clin. Nutr. 24: 1238-
1245. 
8. STOECKER, B. ·J. & OLADUT,. W. K. (1985) Effects of 
chromium arid ascorbate deficiencies on glucose tolerance and 
serum cholesterol of guinea pigs. Nutr. Rep. Inter. 32: 
399-405. 
9. RODWELL, V. W., NORDSTROM, J. L. & MITSCHELEN, J. J. 
(1976) Review of HMG-CoA. Adv. Lipid Res~ 14: 1-74. 
10. RODWELL, V. W., MCNAMARA, D. J. & SHAPIRO, D. J. (1973) 
Review of HMG-CoA. Adv. Enzym. 38: 373-412. 
11. ALLAIN, C. C.,.POON, L. S., CHAN, C. S. G., RICHMOND, W. 
& FU, P. c. (1974) Enzymatic determination of total serum 
cholesterol. Clin. Chern. 20: 470-475. 
146 
147 
12. HILL, A. D., PATTERSON, K. Y., VEILLON, C. & MORRIS, E. 
R. (1986) Digestion of biological materials ,for mineral 
analyses using a combination of wet and dry ashing. Anal. 
Chem. 58: 2340-2342. 
13. LI, Y. -C. & STOECKER, B. J. (1986) Chromium and yogurt 
effects Ol!'hepatic lipid and plasma glucose and insulin of 
obese mice. Biol. Trace Elem. Res. 9: 233-242. 
·' 
14. MILNE, B. B. & OMAYE, S .. T. (1980) Effect of vitamin C 
on copper and iron metabolism in the guinea pig. Int. J. 
Vit. Nutr. Res·. 50: 301-308 .. , 
15. SMITH, C~ H. & BIDLACK, W. R. (1980) Interrelationship 
of dietary ascorbic acid and .. iron on the tissue distribution 
of ascorbic acid, iron and ,copper in female guinea pigs. J. 
Nutr. 110: 1398-1408. · 
16. HOPKINS, L. 'L. 1 JR. & SCHWARZ, K. (1964) Chromium 
(III) binding to serum proteins, specifically siderophilin. 
Biochim. Biophys. Acta 90: 484-491. 
17. MERTZ, W. & ROGINSKI, E.E. (.1971) Chromium metabolism: 
The glucose tolerance' factor. In: Newer Trace Elements in 
Nutrition (Mertz, W.'and Cornatzer, W.E., eds)· pp. 123-213, 
Marcel Dekker, Inc., New York. 
18. WEIS, H. J. & DIETSCHY', J. M. (1969) Failure of .bile 
acids to control hepatic cholesterogenesis: Evidence for 
endogenous cholesterol feedback. J. Clin. Invest. 48: 
2398-2408. 
19 . MITRO POULOS, K. ,A. & BALASUBRAMANIAM, s . ( 19 7 6) The 
role of glucocorticoids in the. regulation.of the qiurnal 
rhythm of hepatic B-hydroxy-B-methylgl~taryl-coenzyme A_ 
reductase and cholesterol ?-hydroxylase. Biochem. J. 160: 
49-55. 
20. BAILEY, ·c. J. & FLATT~ P. R.· (1982) Hormonal control of 
glucose homeostasis during development and ageing in mice. 
Metabolism 31·: 238-246. ' 
21. ETHERTON, T. D. (1982) The role· of insulin-receptor 
interactions in regulation of nutrient utilization by 
skeletal muscle and adipose tissue: A review. J. Anim. 
Sci. 54: 58-67. 
22. EASOM, R. A. & ZAMMIT, V. A. (1987) Acute effects of 
starvation and treatment of rats with anti-insulin serum, 
glucagon and catecholamines on the state of phosphorylation 
of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase in vivo. 
Biochem. J. 241: 183-188. 
23. INGEBRITSEN, T. S., GEELEN, M. J. H., PARKER, R. A., 
EVENSON, K. J. & GIBSON, D. M. (1979) Modulation of 
hydroxymethylglutaryl-CoA reductase activity, reductase 
kinase activity, and cholesterol synthesis"in rat 
hepatocytes in response to insuli~ and glucagon. J. Biol. 
Chem. 254(20): 9986-9989. 
24. BANERJEE, S. & GHOSH, N~ C. (1949) Relation of scurvy 
to glucose tolerance test, l'iver.glycogen, -and insulin 
content of pancreas of guinep pigs. J. Biol. Chem. 168: 
207-211. 
25. GHAFGHAZI, T., MCDANIEL, .M. L. & LACY,· P. E. (1980). 
Chromium-induced inhibition of insulin secretion from 
isolated islets of Langerhans. Diabetologia 18: 229-232. 
26. MERTZ, W., ROGINSKI, E. E. & SC:t!WARZ., K. (1961) Effect 
of trivalent chromium complexes on glucose uptake by 
epididymal fat tissue of rats. J. Biol. Chem. 236: 318-
322. 
27. YOUNG, N. L., SAUDEK, C. D.'& CRAWFORD, S. A. (1982) 
Total hydroxymethylg~utaryl CoA reductase activity in the 
small intestine and liver of insulin-deficient rats. J. 
Lipid Res. 23(2): 266-275. 
28. GOODMAN, M. W.,- MICHELS, L. D. & KEANE, W. F. (1982) 
Intestinal and hepatic cholesterol synthesis in the alloxan 
diabetic rat. Proc. Soc .. Exp~ Biol. Med. 170(3): 286-.~90. 
29. HOLLOWAY, D. E., PETERSON; F. J., PRIGGE, W. F. & 
GEBHARD, R. L. (1981) Influence of dietary as9orbic acid 
upon enzymes of sterol biosynthesis in the guinea pig. 
Biochem. Biophys. Res. Comm. 102(4): 1283-1289. 
30. HORNIG, D. & WEISER,· ·H. (1976) Ascorbic acid and 
cholesterol: effect of graded oral intakes on cholesterol 
conversion to bile acids in guinea-pigs. Experientia 32: 
687-688. 
31. BROWN, M. S., DANA, S. E. & GOLDSTEIN, J. L. (1974) 
Regulation of 3-hydroxy-3-methylglutaryl coenzyme A 
reductase activity in.cultured.human fibroblasts. J. Biol. 
Chem. 249(3): 789-796. · 
32. GINTER, E. & JURCOVICOVA, M •. (1990) .. Chronic vitamin C 
deficiency lowers fractional catabolic rate of low-density 
lipoproteins in guinea pigs. Ann. N. Y. Acad. Sci. 498: 
473-474 •. 
33. SHEFER, S., HAUSER, S., BEKERSKY, I. & MOSBACH, E. H. 
(1970) Biochemical--site of regulation of bile acid 
biosynthesis in the rat. J. Lip. Res. 11: 404-411. 
148 
34." HARRY, D. S. 1 DINI, M. & MCINTYRE, N. (1973) Effect of 
cho'!esterol feeding and biliary obstruction on hepatic 
cholesterol biosynthesis in the rat. Biochimica et 
Biophysica Acta 296: 209-220. 
35. SHEFER, S., HAUSER, S., LAPAR, V." & MOSBACH, E. H. 
(1973) Regulatory efects of .sterols and bile acids on 
hepatic 3-hydroxy-3-methylglutaryl CoA reductase and 
cholesterol ?-hydroxylase in the rat. J. Lipid Res. 14: 
573-580. 
36. EDWARDS, P. A. (1975) The influence of catecholamines 
and cyclic AMP on 3-:t'lydroxy-3-methylglutaryl coenzyme A 
reductase activity and lipid biosynthesis in isolated rat 
hepatocytes.: Arch. Biochem. Biophys. 170: ·188-2,03. 
37. GUDER, w., NOLTE, I. & WIELAND, O. (1968) The influence 
of thyroid hormones on B-hyd~oxy-B-methylglutaryl-coenzyme A 
reductase of rat liver. Eur. J. Biochem. 4: 273-278. 
38. HUBER, J., GUDER, W., LATZIN, S. & HAMPRECHT, B. ( 1973) 
The influence of insulin and glucagon on 
hydroxymethylglutaryl coenzyme A reductase activity in rat 











Vitamin mix3 (without ascorbic acid) 
Potassium a~etate 










1By analysis the -cr diet contained <70 ppb Cr and the 
+Cr diet contained 2 ppm. 
2us Biochemical Corp. , , 
3The vitamin mix contained per kg (in g except as noted) 
alpha-tocohperol 5.0; choline chloride 75.0; d-
calcium' pantothenate, 3.0; inositol, 5.0; menadione, 2.25; 
niacin, 4. 5; paraaminobe'nzoic acid, 5. 0; pyridoxine HCJ,., 
1.0; riboflavin, 1.0; thiamine HCl, 1.0; vitamin A acetate, 
900 1 000 units; calciferol (D2) 100,000 units; biotin, 20 
mg; folic acid, 90 mg; an~ vitamin B12' 1.35 mg. 
4The mineral mix contained (g/kg): CaHP04, 600.0; NaCl, 
80.0; MgO, 100.0; ZnC03, 0.9; MnC03, 1.8; Cuco3 ·cu(OH)2 




Body and tissue weights of guinea pigs fed diets with or without added Cr and given minimal 






















Analysis of Variance 
Cr 0.38 
c 0.58 




2 .. 02±0.08 
1. 97±0. 06 
1.·80±0. 08 
1.95±0.09-
1. 53±0 .10 
1.98±0.09 
2.06±0.13 
<0. 01 ' 
0.10 
<0.03 
Liver Kidney Testes 
g g g 
23. 40±1. 39 5 .11±0 .17 1. 73±0 .14 
23. 87±1. 61 5.29±0.20 1. 97±0 .16 
25.53±1.31 5.23±0.16 L 78±0.13 
21. 74±1. 67 5.18±0.21 1.92±0.17 
26.87±1.85 5.34±0.23 1.80±0 .19 
19.93±2.08 4.89±0.26 1..6Z±O. 21 
2'4. 20± 1. 86 5.12±0.23 1. 77±0.19 
23.55±2.63 5.47±0.33 2.17±0.27 
p values 
0.82 o·. 49 ., 0.29 
0.08 0.85 0.54 











Blood cholesterol and cortisol of guinea pigs fed 
diets with or without added Cr and given minimal ascorbate 
(.5 mg/day) or supplemented with ascorbate (10 mg/day) 
Cholesterol Cholesterol 
in serum in plasma 




75±4· - 68±3 
69±5 60±4 




Analysis of Variance p values 
Cr 0.15 0.28 
c 0.32 0.10 

















Liver and kidney mi_nerals of guinea pigs fed diets with or without added Cr ·and 
given minimal ascorbate (.5 mg/day) or supplemented with ascorbate (10 mg/day) 
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1 Data for 1 iver ch-romium was not normally distributed and log 















Legend for Figure 
FIG 1. Activity of 3-hydroxy-3-methylglutaryl coenzyme A 
reductase of guinea pigs fed diets with or without added Cr 
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SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS 
summary 
This research evaluated nutrient and drug interactions 
affecting chromium retention and excretion and the effects 
of chromium and·vitamin C depletion and supplementation on 
cholesterol synthesis, on tissue trace minerals, on vitamin 
C retention, and on some indices of growth including 
hydroxyproline, creatinine, and blood urea nitrogen. 
Five objectives and hypoth~ses are listed in the 
introduction of this dissertation. Each will be addressed 
individually; then other general conclusions and 
recommendations will be discussed. 
Hypothesis one stated that there will be no 
statistically significant effects of carbohydrate (glucose, 
fructose, sucrose or starch), chromium :supplementation, or 
genetic obesity on tissue chromium or on retention and 
urinary excretion of 51cr,from 51crcl3. 
A load of 2 mg starch/g body weight increased 51cr 
retention compared with loads of glucose, fructose or 
sucrose in all tissues analyzed except kidney. Chromium 
concentrations generally were higher in tissues from animals 
consuming the starch diet than in tissues from 
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those consuming diets containing simple carbohydrates; 
differences paralleled data 2 h after the 51crc13 dose. 
Chromium concentrations after 26 d of feeding the 
experimental diets were higher in the testes, spleen and 
bone and lower in the liver of obese mice compared to values 
in lean mice. Chromium supplementation incre~sed chromium 
in the kidney (p<0.0005) and bone (p<O.OOOl) in this study. 
Based on these results, the first null hypothesis is 
rejected. 
Hypothesis two.stated that there will be no 
statistically significantly differences in 51cr tissue 
accumulation or excretion in rats dosed with 51crc13 and 
vitamin C or calcium carbonate antacid compared with rats 
dosed with water. 
Twenty-four hours after dosing, 51cr in cumulative urine 
was lower in the group dosed with the calcium carbonate 
antacid than in the groups dosed with vitamin C or water. 
Accumulation of 51chromium in the kidney, testes, and spleen 
was lower in rats dosed with the antacid than in those dosed 
with vitamin cor water. In blood at 3'hr, 51chromium was 
higher in rats dosed with either vitamin C or water than 
with the calcium carbonate antacid. Hypothesis two was 
rejected based on these results. 
Hypothesis three stated there will be no statistically 
significant differences in 51cr in tissues, blood, and urine 
of guinea pigs deprived of chromium and/or vitamin c 
compared with those fed adequate chromium and vitamin c. 
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With vitamin C depleted animals, following a glucose 
load, urinary excretion of 51chromium was higher than in 
glucose loaded vitamin C adequate animals. Tissue 
51chromium at 3 h after the dose was not affected by vitamin 
c status. Animals fed -Cr diets had higher 51cr in blood 
and liver than those fed +Cr diets but urinary excretion of 
51cr was not affected by prior chromium intake. Based upon 
these results null hypothesis' three was rejected. 
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Hypothesis four stated there will be .no statistically 
significant differences in 14c in blood, tissues, urine and 
expired carbon dioxide from a,, 14c vitamin c dose and no 
differences in tissue mineral concentrations, tissue vitamin 
c, blood urea nitrogen, cortisol, and urinary excretion of 
hydroxyproline and creatinine due to chromiumjvitamin c 
status. 
In experiment 4, beginning at week 13, animals fed the 
Cr depletion diet weighed less than animals fed diet 
supplemented with 2 ug Crjg. There were no differences in 
urinary hydroxyproline or creatinine values at week 8 or 
week 20 due to chromium treatment. Vitamin c status, 
likewise, did not affect creatinine or hydroxyproline 
excretion. cortisol in urine at week 20 was not affected by 
Cr or vitamin c treatment. The plasma cortisol of animals 
restrained in metabolic cages for six hours was higher 
(p<0.05) in -cr animals, but was not affected by vitamin c 
treatment. In animals supplemented with 10 mg/d ascorbate, 
there was an effect of chromium on plasma urea nitrogen. 
The tissue and plasma vitamin C of animals in experiment 
4 was increased by vitamin c supplementation but was not 
affected by Cr treatment except for testes in which vitamin 
c decreased with Cr supplementation. Expired 14co2 from a 
14c-ascorbate dose was greater in -cr animals and was not 
affected by vitamin c treatment. There was increased 14c -in 
the brain of guinea pigs fed a low Cr diet. Animals 
supplemented with 10 mg/d of vitamin c retained more 14c in 
the liver than animals which received 1 mg/d vitamin c. 
There were significant interactive effects of Cr and vitamin 
c on 14c in testes, spleen, urine, and plasma. 
Tissue minerals of animal~ in experiment 4 were 
affected by treatment. _copper in the kidney was decreased 
by the 10 mg/d vitamin-C supplementation. Vitamin C 
supplementation resulted in increased iron concentrations in 
the liver, brain, testes, kidney,- and spleen. No 
differences were seen in tissu~ copper, zinc, or iron 
concentrations due to chromium treatment. Manganese was 
higher (p<O.OS) in liver and,lower (p<O.Q2) in kidney of 
chromium supplemented animals~ Splenic manganese tended to 
increase (p<0.06) with cr supplementation. Vitamin C 
supplementation increased manganese in the adrenal (p<O.OS) 
and testes (p<O.Ol) and decreased manganese in the spleen 
(p<O.OS). Interactive effects of chromium and vitamin C 
treatments were found on manganese concentrations in bone 
and brain. Based on these results, null hypothesis 4 was 
rejected. 
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Hypothesis 5 stated that there will be no statistically 
significant differences in hepatic 3-hydroxy-3-
methylglutaryl coenzyme A reductase activity due to chromium 
depletion andjor chronic vitamin C deficiency. Although no 
differences in plas~a cholesterol were found, a signif~cant 
interaction of Cr and vitamin c on HMG CoA reductase 




The conclusion from experiment 1 was that a carbohydrate 
load of starch facilitated 51cr uptake compared with a 
carbohydrate load of sucrose, fructose or glucose. 
Similarly, starch-fed mice had higher tissue chromium than 
did fructose-, glucose-, or sucrose-fed mice. Thus, the 
type of dietary carbohydrate affected chromium absorption 
and retention. Genetic obesity and chromium supplementation 
also affected tissue chromium concentration. 
In experiment 2, at the dose level used, a c~lcium 
carbonate antacid reduced 51chromium in blood at'3 hr and in 
spleen, kidney, testes, and urine of rats compared with 
animals intubated with vitamin C or water. Compared with 
water or calcium carbonate, vitamin-C increased cumulative 
urinary 51chromium excretion at 24 hr after dosing. This 
experiment illustrated that absorption of ingested chromium 
chloride is low and suggested that drugs may affect chromium 
uptake. 
An effect of prior chromium status on 51cr retention in 
blood and liver (experiment 3) has not been seen in shorter 
studies; however, in this 24 week experiment, chromium 
deprivation enhanced the uptake of 51cr from a dose of 
51crcl3. It may no longer be appropriate to maintain that 
past dietary chromium has no effect on retention and 
excretion of chromium. The finqing of increased urinary 
excretion of 51cr in response to a glucose load in vitamin c 
depletion has not been reported previously. 
The lower body weight of -cr animals in experiment 4 
supports the essentiality of Cr for animal growth. An 
effect of dietary Cr and ascorbate on protein metabolism ~s 
indicated by the interaction of cr and vitamin c on plasma 
urea nitrogen. Elevated cortisol was found in plasma of 
chromium depleted animals confined to cages for 6 h, but no 
differences were found in urinary cortisol collected prior 
to confinement. 
The alterations in tissue vitamin C and distribution of 
14c-ascorbate as affected by Cr and vitamin c in 
immobilization stress were measured in experiment 4'. Plasma 
cortisol after guinea pigs had been immobilized for 6 hr, 
was double reported normal values for these animals. Tissue 
vitamin c was not affect~~ by Cr treatment except for testes 
which had higher vitamin C concentration in animals fed low 
cr diets. The expired 14co2 of all groups was at the lower 
end of the reported range. The fact that -cr animals 
expired more than +Cr animals, suggests that Cr 
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supplementation may protect vitamin C from utilization or 
oxidative destruction. Chromium and vitamin c status of 
stressed animals affected 14c tissue distribution and 
excretion. 
In experiment 4, liver manganese was higher (p<0.05) and 
kidney manganese was lower (p<0.02) with Cr supplementation. 
Tissue manganese also reflected ascorbate supplementation. 
Higher Mn in adrenal (p<0.05) and testes (p<O.Ol) and lower - . 
Mn in spleen (p<0.05) were observed in animals receiving 10 
mg ascorbate. Vitamin C increased iron concentrations of 
several tissues and decreased kidney copper and bone 
chromium. Cr supplementation increased chromium values in 
several tissues but did not affect either iron or copp~r in 
the tissues analyzed. Thus, ,specific minerals in tissues 
may be impacted by dietary chromium andjor vitamin c. 
Increased activity of HMG CoA was observed in experiment 
5 in the presence of either,vitamin C or in the presence of 
chromium, but plasma cholesterol was not affected. However, 
when both chromium and vitamin C were present,'they acted in 
a synergistic manner on HMG CoA reductase activity resulting 
in lower activity similar to the situation fo,und when both 
Cr and vitamin c were absent. Vitamin c hydroxylates 
cholesterol in bile acid synthes'i's thus lowering serum 
cholesterol. The blood cholesterol values which were 
unaffected by cr or vitamin C when HMG CoA was increased, 
suggest Cr may also be involved in the catabolism or 
synthesis of bile acids. 
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Recommendations 
In experiment 1, starch facilitated 51chromium uptake 
compared with-a carbohydrate load of sucrose, fructose or 
glucose. Similarly, animals fed starch-as 50% of their diet 
had higher tissue chromium than did fructose-, glucose-, or 
sucrose-fed mice. Urinary chromium excret~on increases in 
subjects consuming simple sugars. Effects on urinary Cr 
excretion of soft drinks and other beverages such as orange 
juice containing simple sugars could be studied. Also, how 
lactose in milk affects chromium retention should be 
investigated. Furthermore, chromium may travel with water 
in the intestine. Future experiments might test various 
fiber sources capable of bind,ing water which might slow the 
intestinal movement of chromium thus facilitating 
absorption. 
At the dosage used in experiment 2, calcium carbonate 
antacid decreased 51chromium ret~ntion in blood, spleen, 
kidney, and testes, and decreased urinary 51chromium 
excretion. The dose.was chosen to study acute effects of 
calcium-carbonate on 51chr~mium absorption. A future 
investigation of calcium ca~bonate should involve lower 
graded doses of the antacid. Also~ the antacid should be 
given over time to investigate the chronic effects of 
antacid on chromium retention. Antacids composed of 
compounds other than calcium carbonate also should be 
tested. In vitro studies would be appropriate to determine 
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whether compounds such as antacids result in 51chromium 
elation and subsequent precipitation. 
The increased urinary excretion of 51chromium after a 
glucose load in vitamin C depleted animals in experiment 3 
may be due to brush border disaccharidases which 
proliferated when insulin was lacking or due to hormonal 
changes as a result of vitamin c deficiency. An' interesting 
follow-up to experiment 3 would be to analyze 
disaccharidases and enzymes associated with glucose 
absorption to determine if enzyme activity is affected by 
vitamin c or chromium deficiency. A critical problem 
continues to be the determination of insulin values which 
may affect 51chromium retention. Insulin was reported to be 
affected by ascorbate deficiency. The effect of a chromium 
deficient diet on insulin of guinea pigs is not known. 
The 14c data from exp·eriment 4 reflects the 
physiological distribution of 14c-ascorbate under stress. 
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In order to determine effects of Cr andjor vitamin c 
depletion on the distribution of ·14c without the effect of 
stress, it would be necessary to repeat this experiment in a 
situation in which animals were not immobilized. 
Relationships between stress, cortisol, and urinary chromium 
excretion should be investigated. The effect of ACTH on 
5lchromium retention and excretion would be an interesting 
project. Caffeine seems to have an similar effect as 
cortisol in the elevation of blood glucose. Another 
interesting study would be evaluate the effects of caffeine 
on retention and excretion of 51cr. 
The interaction of Cr and vitamin c on HMG CoA reductase 
in experiment 5 may be due to effects on bile acid 
metabolism. Therefore, a recommendation for future study 
would be to' analyze fecal bile acids and hepatic cholesterol 
7 alpha-hydroxylase activity to determine if bile synthesis 
as a result of chromium andjor ascorbate supplementation was 
influencing 3-hydroxy-3-methylglutaryl coenzyme A reductase 
activity. It would also be desirable to determine if Cr and 
vitamin Cmay interactively affect low density and very low 
density lipoproteins and phospholipids. Due to the 
acknowledged role of insulin on HMG CoA reductase, 
regulation, it is important to measure guinea pig insulin in 
response to the dietary treatments. 
Work with anima~ models is essential to further 
ascertain the effects of dietary chromium and vitamin c on 
cholesterol and tissue vitamin c as well as to ascertain 
effects of selected nutrients and drugs on chromium 
retention and excretion. For such work to make great 
strides, however, it is esseptial to determine a biochemical 
measure of chromium status. 
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